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Stellingen 
1. Calciumfosfaat in de voeding remt de translocatie en kolonisatie van salmonella. 
(dit proefschrift) 
2. Suppletie van de voeding met calciumfosfaat beschermt beter tegen een 
salmonella infectie dan suppletie met lactulose, (dit proefschrift) 
3. In voedingsonderzoek naar de mogelijk positieve effecten van fermenteerbare 
vezels en oligosacchariden dient men rekening te houden met de interactie met 
calciumfosfaat. (dit proefschrift) 
4. Precipitatie van surfactants in de darm door calciumfosfaat beschennt tegen een 
infectie met een Gram-negatief pathogeen zoals salmonella, maar verergert een 
darminfectie veroorzaakt door een Gram-positief pathogeen zoals listeria. 
5. De recentelijke moleculair-biologische bevinding, dat ieder persoon een unieke 
mix van lactobacillen in zijn darmflora heeft, impliceert dat het prebiotica-
concept kansrijker zal zijn dan het probiotica-concept. (Kimura et al., Appl 
Environ Microbiol 1997; 63: 3394-3398) 
6. In de huidige definities van pre- en probiotica ontbreken eenduidige functionele 
effecten. (Gibson et al., J Nutr 1995; 125: 1401-1412 en Tannock, Tibtech 
1997; 15: 270-274) 
7. De veelgehoorde vergelijking van het schrijven van een proefschrift met een 
bevalling getuigt meestal van onervarenheid van promovendi op dit laatste 
gebied. 
8. Beklimmingen van 's werelds hoogste toppen leveren bergen afval op. 
}^c%?£», z s e*\ 
9. Gemeenten die eigen inwoners voorrang verlenen bij het kopen van nieuwbouw 
bevorderen het woon-werkverkeer en zijn dus weinig milieubewust. 
10. Het succes van het nieuwe Nederlandse donorregister kan worden verhoogd door 
alleen aan geregistreerde donoren transplantaties aan te bieden. 
11. Door de enorme aandacht in de media is Viagra in potentie eerder een financieel 
dan een sexueel succes. 
12. Het aantal vrouwen in topfuncties zal sterker toenemen door maatschappelijke 
acceptatie van een 4-daagse werkweek voor mannen dan door uitbreiding van het 
aantal crecheplaatsen. 
Stellingen behorend bij het proefschrift 
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Incidence of gastrointestinal infections 
Gastrointestinal infections are still a major health problem. The worldwide incidence 
of acute infectious diarrheal disease is estimated to be 3-5 billion cases per year, resulting 
in 3-5 million deaths each year [1]. The increased transport of perishable foods, changes in 
consumer food preferences and food processing practices, and international travel may all 
add to an increased exposure to foodborne pathogens from all parts of the world. In 
addition, the use of immunosuppressive drugs, aging, and extension of life expectancy for 
the chronically ill through medical technology, have increased the population susceptible to 
severe illness after infection with foodborne or nosocomial pathogens [2]. Among 
foodborne disease outbreaks of known etiology the leading cause is bacterial pathogens 
(35%), followed by toxins, viruses and parasitic organisms other than bacteria and viruses. 
Cause of illness is determined in less than half of the outbreaks [2]. In the Western world, 
the bacterial pathogen most frequently isolated from patients suffering from acute gastro-
enteritis is Campylobacter spp. (50%), followed by salmonella spp. (25%) [2, 3]. 
Moreover, infections caused by these two pathogens have emerged importantly in the last 
two decades [2]. Salmonella epidemiology has shown that Salmonella enteritidis has now 
outnumbered Salmonella typhimurium as the most frequently isolated salmonella species 
[4]. 
While most intestinal infections result in a self-limiting gastroenteritis, the regular 
occurrence of gut-derived septicemia in people receiving immunosuppresive drugs, patients 
suffering from inflammatory bowel diseases and patients in intensive care units on 
(par)enteral nutrition regimen is a major complication [5-7]. Treatment of many foodborne 
infections by antibiotics is often discouraging, since it hardly ameliorates the severity of 
illness and often prolongs asymptomatic carriage [8, 9]. Another concern is the growing 
resistance of bacterial pathogens, including salmonella species [10, 11], to clinically 
important antibiotics [8]. It is even possible that some formerly treatable diseases may 
become incurable [12, 13]. The high frequency of antimicrobial resistance today is 
probably a consequence of the widespread use or the inappropriate therapy of infections in 
both humans and animals [8]. This stresses the importance of prevention to cope with the 
problem of emerging infections. Therefore, an important challenge of modern medicine is 
to understand what defenses are most important in preventing bacterial disease, how to 
identify people who lack the necessary defenses, and how to restore or replace these 
defenses [12]. 
Critical steps in the etiology of intestinal infections 
Before discussing host defenses, it is useful to outline some important steps of the 
course of an intestinal infection. Although different (potential) pathogens use different 
tactics to resist host defenses in order to gain access to the intestinal mucosa [14, 15],some 
general strategies can be observed. Once a bacterium reaches the intestine, it must penetrate 
the mucus layer and adhere to host cells to colonize them (Figure 1, part A). Only bacteria 
that can adhere to the mucosa will be able to resist the constant flow of gut contents due to 
intestinal motility. Flexible glycoprotein structures extending from the bacterial surface, 
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Figure 1 Schematic reproduction of the course of intestinal infections by invasive 
bacteria: A microbial adhesion to epithelial cells, B bacterial translocation 
across the epithelial barrier, C reaction of the immune system. 
called pili or fimbriae, are sometimes involved in establishing contact between the 
bacterium and the apical cell membrane of enterocytes [16, 17]. Some pathogens, for 
instance yersinia [18] and salmonella [15, 19], also seem to use specialized antigen-
sampling M cells to gain access to extra-intestinal tissues. After traversing the epithelial cell 
layer, the bacteria encounter the basement membrane, which acts as a filter and can to some 
extend hold up the infection, but its functional integrity is soon broken by epithelial cell 
damage or inflammation. At this site, the invaders are ingested by macrophages or other 
phagocytic cells (Figure 1, part B) and transported to the mesenteric lymph nodes [20, 21]. 
When massive translocation occurs, bacteria will spread to the blood stream and invade 
other organs, a life-threatening situation called bacteremia or septicemia [21]. 
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Host defenses against bacterial pathogens 
Of course, the most effective way of protecting the human body from pathogenic 
bacteria is to prevent contact with the bacterium in the first place. Fortunately, an array of 
host defenses is present to attack disease-causing bacteria, which succeeded in gaining 
access to the body by mouth. The first line of defense is non-immunological (Figure 2). 
The low pH of gastric juice (<3) has strong sterilizing properties, because many food-
pathogens are acid-sensitive [22, 23]. Hypochlorhydria, in otherwise healthy elderly or in 
users of H2 receptor antagonists and proton pump inhibitors, leads to increased intragastric 
bacterial counts and susceptibility to gastrointestinal infections [23-26], including 
salmonella [27]. Buffering of gastric content and physical protection of bacteria by food, in 
combination with the rate of gastric emptying, are additional factors influencing the amount 
of pathogens surviving the gastric barrier [23, 24]. 
The small intestine is protected to infective bacteria by a thick mucus layer covering 
the epithelium. Mucus not only acts as a lubricant to protect the relatively delicate epithelial 
cells from gastric acid, bile acids, chemical irritants and physical damage, but is also a trap 
for microbes to prevent their attachment to the mucosa. The mucus layer obtains its 
viscosity from mucins. Mucins are glycoproteins and its oligosaccharide units protect it 
from proteolytic enzymes. Furthermore, the sugar chains mimic epithelial receptors for 
bacteria and act like a physical sieve trapping microbes and bringing them in close contact 
with secreted antibodies (slgA), lactoferrin, lysozyme and lactoperoxidase [26]. The small 
intestine has a relatively high motility, which prevents adhesion to the mucosal epithelium 
and subsequently bacterial overgrowth [24]. Duodenal secretions, as pancreatic enzymes 
and bile, have potent bactericidal activity. For instance, Escherichia coli and salmonella 
species are sensitive to pancreatic fluid in-vitro, as determined by Rubinstein et al. [28]. 
Considering that many bacterial toxins are proteins [29], the proteinases in pancreatic 
secretions might also protect against damage caused by intestinal infections. Although in-
vitro studies demonstrated that surface-active bile acids exert a potential inhibitory effect on 
micro-organisms [30, 31], in-vivo studies in support of this observation are lacking. As a 
result of the combination of gastric acid, bile salts and rapid flow of contents, the small 
intestine is relatively sparsely populated by bacteria. Though not very numerous, the 
endogenous microflora colonizing the ileal mucosa might still be important in host defense, 
considering that many foodborne pathogens mainly elaborate their noxious effects in this 
region of the gastrointestinal tract [32]. 
In contrast to the small intestine, the most important defense mechanism of the colon 
is the presence of its luxuriant microflora [24]. Probably due to the slow flow of contents, 
the bacterial density is so great that nearly half of the volume of human colon contents is 
accounted for by bacteria [33]. Potential invaders have to compete with this extensive 
established bacterial population for nutrients and adhesion sites on the epithelium. 
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Figure 2 Host defenses of the gastrointestinal tract 
The production of antibacterial substances by the colonic microflora, such as lactic acid, 
short-chain fatty acids and bacteriocins, may also inhibit growth of pathogenic bacteria [12, 
24]. Several human [34, 35] and animal [36, 37] studies have shown that use of antibiotics, 
affecting the endogenous microflora, increases the susceptibility to contract intestinal 
infections. 
All the above mentioned non-immunological defense mechanisms cooperate with the 
gut-associated lymphoid tissue (GALT) in eliminating microbial pathogens. The GALT is a 
combination of the Peyer's patches, lymphoid follicles, lymphocytes and mesenteric lymph 
node cells [26, 37]. The Peyer's patches in the small intestine are separated from the 
intestinal lumen by a single layer of columnar epithelium that includes microfold cells or M 
cells (Figure 1). M cells appear to be specialized in antigen uptake. Absorbed antigens are 
transported to the basolateral cell membrane and delivered to macrophages and other 
antigen-presenting cells. Antigen-presenting cells couple antigen with MHC class II 
receptors and activate T cells to secrete cytokines [26]. These cytokines in turn, stimulate B 
cells within the Peyer's patches to produce immunoglobulins, especially secretory IgA 
(slgA, Figure 1 part C). slgA plays an important role in antigen exclusion and bacterial 
agglutination, which prevents microbial contact with- and uptake by the intestinal 
epithelium [38, 39]. Translocation of bacterial pathogens (or components like endotoxin) 
strongly attracts and activates macrophages and neutrophils, which belong to the non-
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specific immune system. These phagocytic cells produce a wide variety of cytotoxic 
metabolites (oxygen or nitrogen radicals and enzymes) in order to inhibit or kill the 
bacterial invader (Figure 1 part C) [40, 41]. 
Impairment or failure of these host defenses might result in an intestinal infection. 
In general, one or more of three basic pathophysiological conditions are necessary for 
bacterial translocation to occur. These are: (1) disruption of the ecological balance of the 
normal endogenous microflora, resulting in bacterial overgrowth of Gram-negative enteric 
bacteria; (2) physical loss of the intestinal mucosal barrier; and (3) impaired host immune 
defenses [7]. 
Composition of the intestinal microflora 
The extensive differences that exist between the microfloras of various species, 
reported by various research groups, are in part obscured by the sampling and 
microbiological methods used and by the convention to describe the flora in terms of a 
relatively small number of bacterial genera or groups, neglecting bacterial species. Besides 
these shortcomings, some general trends can be observed. Bacterial counts in the proximal 
small intestine reflect the number of bacteria surviving the gastric barrier [42]. Probably 
due to the slower rate of transit and some bacterial multiplication, bacterial population 
levels in the ileum increase to ± 107/g contents in humans and + 108/g in rats (Table 1). 
The human and rat colon harbours more than 400 different species in numbers up to 10 /g 
contents. As a result of water resorption in the distal colon, viable counts in feces are even 
Table 1. Differences in bacterial flora of the ileum, colon and feces of humans and 
rats (logio bacteria per gram wet weight; Table adapted from Drasar BS 
[42]). 
Bacteroides 
Eubacteria 
Peptococci 
Bifidobacteria 
Lactobacilli 
Clostridia 
Fusobacteria 
Enterobacteria 
Streptococci 
ileum 
3-7 
5 
-
5-7 
3-7 
-
-
3-4 
6 
Human 
colon 
7-9 
-
-
5-7 
3-7 
-
-
6-7 
2-7 
feces 
10-11 
9-10 
10 
10 
4-6 
6-9 
-
7-8 
8 
ileum 
6-8 
-
-
6-8 
6-8 
-
-
3-5 
2-6 
rat 
colon 
7-8 
-
-
8-9 
8-9 
2-6 
-
5-7 
5-7 
feces 
7-10 
9-10 
9-10 
8-9 
8-9 
2-6 
9 
5-7 
5-8 
-: not measured 
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higher [42, 43]. It should be noted that the composition of the luminal flora (as measured in 
intestinal lavages or feces) may differ from the mucosal flora [44]. In contrast to large 
inter-individual variations in gut flora, the composition of major bacterial groups within an 
individual remains quite constant in time, even when dietary regimens change drastically 
[43]. Whether this is due to lack of sensitivity of the classical microbiological techniques 
used, will be elucidated in future experiments using specific molecular probes to identify 
and quantitate bacterial species. 
Role of the gut flora in colonization resistance 
The population of bacteria comprising the intestinal microflora continually exerts 
strong forces to maintain community stability. A practical effect of these activities is the 
exclusion of ingested exogenous bacteria, preventing their attempt to colonize the intestinal 
tract from time to time. Potentially pathogenic inhabitants of the gut are suppressed to 
harmless levels by the same forces [45]. This barrier formed was called "colonization 
resistance" by Van der Waay and coworkers [46]. Several studies are performed to unravel 
which components of the autochtonous intestinal microflora are responsible for this 
protection. Administration of more or less selective antibiotics, in order to eliminate 
particular bacterial groups of intestinal bacteria, showed that especially the anaerobic flora 
determines the colonization resistance to foodborne pathogens and potentially pathogenic 
indigenous bacteria [37, 46, 47]. Impairing the colonization resistance by administration of 
metronidazole, which eliminates obligate anaerobes, favored the translocation of the 
endogenous aerobic flora from the intestinal lumen to the mesenteric lymph nodes and 
beyond [37, 47]. However, facultative anaerobic, Gram-negative bacteria play at least some 
role in preventing the intestinal colonization and subsequent translocation of an exogenous 
pathogen (such as Salmonella enteritidis), as shown by oral streptomycin administration 
[37, 47, 48]. The consequences of reducing the colonization resistance by upsetting the 
autochtonous microflora are evident in clinical practice, considering the high incidence of 
antibiotic-associated diarrhea. Particularly, overgrowth of endogenous Clostridium difficile 
resulting in pseudomembranous colitis, is a regular occurring severe complication of recent 
exposure to antimicrobial agents [34]. 
Several mechanisms are proposed by which the resident microflora inhibits the 
establishment of invading bacteria in the intestine. Indigenous bacteria adhere to specific 
glycoprotein receptors on intestinal epithelial cells. The resulting barrier of microflora, 
which is firmly attached to the mucosa, prevents contact and colonization by pathogenic 
organisms. Mucosal attachment is a prerequisite for successful colonization and possible 
translocation of a pathogen. Without adhesion, bacterial multiplication is inadequate to 
compensate for the wash out of bacteria with the flow of intestinal contents [45]. Pathogens 
also have to compete with the resident flora for nutrients [45]. Metabolic products of 
fermentation, for instance lactic acid and short-chain fatty acids, and the concomitant 
decrease in pH and oxidation-reduction potential of intestinal contents are inhibitory for 
many intestinal pathogens [22, 45, 49]. Already in the ileum, conjugated bile acids are 
hydrolyzed by the indigenous microflora to their surface-active free counterparts [50]. The 
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subsequent flora-mediated dehydroxylation releases even more cytotoxic, secondary bile 
acids. Inhibitory effects of bile salts on bacterial growth in-vitro are documented [30, 31, 
51]. On the other hand, experimental evidence for the relevance of bile acids for the 
resistance to intestinal infections in-vivo is lacking. Only a few human studies touch lightly 
on this subject. Tazume et al. [52] found that infectious diarrhea in humans coincided with 
a shift in fecal bile acid profile from the toxic unconjugated secondary bile acids to the less 
toxic primary and conjugated bile acids. However, no cause and effect relationship can be 
deduced from these results. Williams et al. [53] found that oral administration of a mixture 
of conjugated bile acids to human volunteers decreased the number of ileal anaerobes. 
However their results were inconsistent. The concentration of ileal bile salts did not 
significantly correlate with the number of ileal anaerobes. Moreover, administration of 
cholestyramine, which binds and precipitates bile acids, also decreased the anaerobes in the 
ileum. Likewise, bactericidal effects of bacteriocins are demonstrated in-vitro but not in-
vivo [54]. 
The intestinal microflora and inflammation 
Inflammatory bowel diseases (IBD), such as ulcerative colitis (involving the colon) 
and Crohn's disease (involving the ileum and colon), occur in regions of the intestine 
highly colonized by bacteria and their pathology resembles certain bacterial infections. 
Despite much effort, no convincing evidence incriminates a single bacterium as the cause. 
However, luminal bacteria and their products certainly play an important role in the 
exacerbation and recurrence of inflammation, considering that inflammation can hardly be 
induced in germfree animals [55, 56]. In addition, human studies showed that inflammation 
subsides in sections of the intestine that are operatively excluded from the fecal flow and 
that it deteriorates again when intestinal continuity is restored [57, 58]. Both commensal 
and pathogenic bacteria produce potent inflammatory molecules, including 
lipopolysaccharides (LPS or endotoxin), peptidoglycan polymers and N-formylmethionyl 
peptides [55]. Normally these strong activators of the immune system stay in the intestinal 
lumen. However, patients suffering from IBD have increased mucosal permeability, 
allowing uptake of bacteria and their immunogenic products, even during quiescent phases 
of the disease [59]. This implies that leakage is a primary abnormality rather than a 
secondary result of inflammation. Contact with the autochtonous microflora is necessary for 
normal development and maintenance of the intestinal immune system. Duchmann et al. 
[60] provided evidence that healthy individuals are tolerant to their own bacterial flora, but 
respond to the flora of others. In contrast, breakdown of tolerance to antigens (for instance 
LPS) of an individual's own intestinal flora occurs in IBD. Conversely to healthy subjects, 
high serum titers of antibodies to commensal bacterial species are observed in IBD patients 
[55,56]. 
Besides a genetic component, an interesting hypothesis regarding the cause of 
Crohn's disease is postulated by Demling [61]. The increased incidence of this 
inflammatory disease in the last 50 years parallels the increased use of antibiotics in human 
and veterinary medicine. Considerations that insufficient doses of antibiotics liberate LPS 
General introduction 
from Gram-negative bacteria, induce bacteria to produce toxins or to invade host tissues 
and the observation that prior antibiotic therapy promotes relapses in Crohn's disease, 
formed the base for this hypothesis. 
IBD is characterized by an overproduction of the pro-inflammatory cytokines IL-1, 
IL-6 and TNFot. Though therapeutic values remain to be established, experimental studies 
indicate that the diet can modulate the production of these cytokines and may be of help to 
regress the inflammation [62,63]. For instance, increasing the intake of fish oil or (n-3) 
fatty acids reduces inflammatory responses, probably by decreasing the production of the 
eicosanoids prostaglandin E2 and leukotriene B4. These eicosanoids are synthesized from 
arachidonic acid by cyclooxygenase and lipoxygenase respectively, and trigger leucocytes 
to release IL-1, IL-6 and TNFa. Replacement of arachidonic acid by (n-3) fatty acids in 
cell membrane phospholipids results in the production of the biologically less active 
prostaglandin E3 and leukotriene B5 [62]. Besides the type of dietary fat, dietary protein and 
antioxidants may also affect the activity of cytokines and the course of IBD [63]. 
Dietary modulation of the resistance to infection 
Diet directly affects the non-immunological host defenses of the gastrointestinal 
tract, which are particularly important to withstand the first encounter with a pathogen 
(Figure 3). It is obvious that the composition of the diet determines the composition of 
gastrointestinal contents. The latter affects the survival of pathogenic bacteria in the gastro-
intestinal tract. In addition, intestinal contents may influence the composition and the 
activity of the protective endogenous microflora and subsequently their antagonistic activity 
towards pathogens. Besides an effect on bacteria, luminal contents also affect functioning of 
the intestinal epithelium and its barrier function against invading microbes. Diet also 
indirectly affects host defense. For instance, if the habitual diet is deficient in one or more 
essential nutrients, normal functioning of all cells, including these belonging to the immune 
system, is impaired [64]. 
Currently, there is a keen scientific and commercial interest in foods containing 
specific ingredients that modulate the intestinal microflora and subsequently the resistance 
to infection. The majority of these ingredients can be divided in two classes, the so-called 
probiotics and prebiotics. Besides these pro- and prebiotics, other dietary components (like 
minerals) may influence the course of an intestinal infection as well. These specific 
ingredients are discussed below in more detail. 
Probiotics 
By definition, probiotics are live micro-organisms which beneficially affect the host 
by improving its intestinal microbial balance [65]. This rather vague definition evokes 
several questions: what is microbial balance and which host functions are beneficially 
affected? Though the specific answers to these questions are certainly subject of debate, 
some general consensus does exist. Intestinal microbial balance is often associated with the 
suppression of putrefactive (protein degrading) and potentially pathogenic bacteria to 
harmless levels, and a stimulation of carbohydrate fermenting genera such as lactobacilli 
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Figure 3 Dietary modulation of non-immunological host defenses of the intestinal 
tract, which determine the severity of an intestinal infection. 
and bifidobacteria. Often mentioned benefits to the host upon ingestion of probiotic strains 
are reduction of symptoms of lactose intolerance, suppression of bacterial enzymes 
responsible for the production of toxic metabolites for the intestinal epithelium, 
amelioration of infectious diarrheal diseases and stimulation of the immune system [65-67]. 
Lactobacilli and bifidobacteria are the genera most frequently studied in probiotic research. 
However, these two genera are also normal residents of the intestinal tract of the majority 
of humans [42]. This implies that ingested probiotic strains have some health-promoting 
characteristics that the resident lactic acid bacteria lack and that they are able to compete 
sufficiently with the resident flora for the expression of these beneficial attributes [65]. 
Many investigations have shown that lactobacilli may exert antagonistic activity 
against intestinal and foodborne pathogens. In-vitro growth of pathogens, like Escherichia 
coli, salmonella, Campylobacter, listeria, shigella and Vibrio cholerae, is inhibited in the 
presence of lactobacilli or bifidobacteria [68-70]. Administration of lactobacilli to rodents 
reduced the severity of a Salmonella typhimurium [68, 71] and shigella [72] infection, as 
measured by delayed or reduced mortality and fecal shedding of these pathogens. In a 
murine model, lactobacilli prevented Helicobacter pylori infection of the stomach [73]. A 
number of clinical studies showed that ingestion of lactobacilli resulted in shortening of the 
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duration of antibiotic-associated diarrhea [74], the prevention of recurrent relapses of 
Clostridium difficile colitis [75], amelioration of shigella infections [76] and acute rotavirus 
enteritis [77] in children. Consumption of formula supplemented with bifidobacteria also 
reduced the incidence of diarrhea and rotavirus shedding in hospitalized infants [78]. 
Though the protective effects observed in human intervention trials are often small and 
interpretation of results is sometimes hampered due to the inclusion of inappropriate control 
groups, they certainly justify the effort currently spend on probiotic research. 
Several mechanisms are proposed for the improvement of the resistance to intestinal 
infections by lactobacilli or bifidobacteria. As shown in in-vitro experiments, the inhibitory 
action may result from competition for nutrients and adhesion sites on the intestinal 
epithelium [68, 79]. Lactic acid and acetic acid produced during bacterial metabolism 
inhibit the growth of many bacteria, including Gram-negative pathogens [80]. While 
lowering of the pH of intestinal contents is certainly a factor in such inhibitions, lower pH 
values also potentiate the bactericidal activity of these organic acids. Neutral, protonated 
organic acids traverse the bacterial cell membrane, accumulate intracellular due to 
dissociation, and subsequently disturb the bacterial cell membrane potential [81]. In 
addition to these organic acids, the production of hydrogen peroxide and bacteriocin-like 
compounds may also play a role in the antagonistic activity of lactobacilli [67], though their 
in-vivo relevance has not been demonstrated yet. 
Lactobacilli are also reported to affect the immune response. First, consumption of 
lactic acid bacteria may stimulate the aspecific cell-mediated immune system, as measured 
by an enhanced proliferation and phagocytic acitivity of lymphocytes of rodents [71, 82] 
and humans [83]. Second, lactobacilli also stimulate the specific humoral immune response. 
For example, animal studies showed increased antibody titers against salmonella [71] and 
shigella [72] upon administration of lactobacilli. In addition, treatment of rotavirus-infected 
children with lactobacillus GG was associated with an enhancement of serum antibody-
secreting cells and specific IgA against rotavirus at convalescence [84]. Furthermore, 
human volunteers consuming fermented milk containing L. acidophilus had significantly 
higher serum antibody titers against an orally administered attenuated Salmonella typhi 
strain [85]. 
It is not clear yet, how lactobacilli gain access to the host immune system. 
Lactobacilli may stimulate the immune system without leaving their luminal habitat, since it 
is now recognized that enterocytes are immunocompetent cells and produce cytokines 
involved in immuno-regulation [86]. It is also possible that lactobacilli (or their cell wall 
components) are sampled by M cells of the Peyer's patches of the distal small intestine [65, 
87]. At present, intestinal inflammation or even translocation can not be excluded as the 
base for the observed immuno-stimulation by lactobacilli. Indeed, serum antibodies (IgM 
and IgG) against lactobacilli can be detected in healthy human subjects, whereas antibodies 
reactive with bifidobacteria are absent [87]. Additionally, the effects of lactobacilli on 
immune parameters in animal infection experiments do not always correlate with an 
indisputable functional parameter as mortality [71]. Therefore, at least some caution is 
warranted to interpret probiotic-induced immune stimulation as an always beneficial effect. 
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Prebiotics: dietary fibers and non-digestible oligosaccharides 
Most of the predominant species of the intestinal microflora require a fermentable 
carbohydrate for growth. It is generally assumed that the carbon and energy needed to 
maintain bacterial mass are derived from host secretions or from dietary carbohydrates (or 
other components) that escape digestion in the small intestine. Mucins, extensively 
glycosylated proteins secreted by goblet cells, might be excellent endogenous bacterial 
growth substrates [88]. Dietary fibers (vegetable polysaccharides) and oligosaccharides are 
also more or less fermented in the intestinal tract, depending on their sugar composition, 
type of glycosidic linkages and degree of branching. Dietary fibers are essential for 
maintenance of intestinal mucosal integrity, which can be deduced from animal [89] and 
human [90] studies showing that oral administration of fiber-free elemental liquid diets 
induces spontaneous translocation of the gut microflora. Some say that the protective effects 
of fiber on the mucosal barrier function are independent of their fermentability and are 
mediated by stimulating the release of trophic gut hormones, preventing mucosal atrophy 
[91, 92]. By definition, prebiotics are fermented by the endogenous microflora in contrast 
to the non- or low-fermentable dietary fibers (for instance lignin and cellulose). Selective 
stimulation of the growth or activity of a limited number of resident bacteria and 
improvement of the host health are often mentioned criteria a prebiotic should meet [93, 
94]. Polysaccharides like inulin, pectin, resistant starch and guar gum, and oligosaccharides 
based on galactose, fructose, and xylose are potential prebiotics [93]. 
A characteristic all the above mentioned potential prebiotics share is that they are 
fermented by the intestinal microflora in the lower gut to lactic acid and short-chain (C2-C6) 
fatty acids, resulting in a decreased pH of luminal contents [93, 95]. Consumption of 
prebiotics may change the composition of the intestinal microflora. For instance, dietary 
inulin and fructosyloligosaccharides may increase fecal bifidobacteria counts of rodents and 
humans [95-98]. Whether the in-vivo growth advantage of bifidobacteria is due to selective 
utilisation of these non-digestible sugars by this genera or due to their relative resistance to 
the organic acids formed is not established yet. The latter explanation seems more likely, 
considering that other genera (for instance bacteroides) can also degrade 
fructosyloligosaccharides in-vitro [93]. Moreover, increasing the number of bifodobacteria 
or inducing a change in gut flora composition as such, is not directly a functional effect nor 
a direct health advantage. The intestinal effects of oligosaccharides might depend on their 
composition and structure. In contrast to the above mentioned bifidogenic effect of inulin 
and fructosyloligosaccharides, no change in the composition of the fecal microflora was 
observed in a recently performed, placebo-controlled human study with galactosyl-
oligosaccharides in doses up to 15 g/d (Alles MS, personal communication). 
One of the benefits to be gained by the host upon consumption of non-digestible 
food ingredients is an improved resistance to intestinal infections. During fermentation of 
dietary fiber or non-digestible oligosaccharides, the organic acids generated and the 
concomitant drop in luminal pH may kill or inhibit the growth of acid-sensitive pathogens 
like salmonella, Escherichia coli, Vibrio cholerae and Clostridium difficile, as shown in-
vitro [99, 100]. Surprisingly, data showing the efficacy of fermentable dietary fibers to 
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reduce the severity of intestinal infections in strictly controlled in-vivo experiments are 
rare. Lactulose therapy has been investigated in the management of salmonella and shigella 
infections in humans. This non-digestible disaccharide increased fecal clearance of 
salmonella and shigella in a significant proportion of the patients [101, 102]. Studies on 
inflammatory bowel diseases have shown that short-chain fatty acids are important for 
normal functioning of the intestinal epithelium and the maintenance of the mucosal barrier 
function [103]. Though the etiology and pathology of inflammatory bowel diseases are 
certainly different from an intestinal bacterial infection, gut bacteria play a crucial role in 
the mucosal inflammation [55, 56]. Increasing intestinal fermentation by supplementing the 
diet with lactulose or pectin reduced the severity of chemical-induced enterocolitis in 
rodents, with concomitantly decreased serum endotoxin levels and translocation of 
endogenous bacteria [104, 105]. Short-chain fatty acids or butyrate enemas also ameliorate 
the inflammatory process in patients suffering from ulcerative colitis and pouchitis [105, 
106]. Short-chain fatty acids, and butyrate in particular, are normal substrates for energy 
production of intestinal epithelial cells. The prevailing hypothesis is that stimulation of 
intestinal fermentation replenishes the frequently observed low luminal concentrations of 
short-chain fatty acids or overcomes the impaired 6-oxidation of butyrate of enterocytes in 
inflammatory bowel disease patients [106]. Notwithstanding the beneficial effects of 
fermentable dietary fibers on intestinal physiology, some restraint should be applied in 
increasing the intake of non-digestible oligo- or polysaccharides. High concentrations of 
short-chain fatty acids may damage the intestinal epithelium, resulting in an increased 
permeability and epithelial cell proliferation [107-109]. 
Besides stimulation of intestinal fermentation, soluble oligosaccharides might also 
improve the colonization resistance by decreasing adhesion of pathogens to the gut mucosa. 
Many pathogenic bacteria use (glyco)proteins (called variously adhesins, fimbriae, lectins 
or hemaglutinins) to attach to carbohydrate structures expressed on epithelial cells. 
Competitive inhibition by oligosaccharides of this lock-and-key interaction may decrease 
attachment of pathogens to the mucosa and prevent the crucial step in the initiation of an 
infection [110]. For instance, a-methyl-D-mannoside injected into the urine bladder of mice 
significantly decreased the extent of bacteriuria caused by mannose-sensitive, type-1-
fimbriated Escherichia coli. Glucoside derivatives were ineffective [111]. The addition of 
D-mannose to drinking water reduced the incidence and extent of Salmonella typhimurium 
colonization of young chickens [112]. Additionally, diarrhea-causing enterotoxins produced 
by many pathogenic bacteria also recognize carbohydrate structures on epithelial cells. As 
an example, cholera toxin B recognizes monosialoganglioside 1 on the cell surface. 
Sialyllactose could inhibit the cholera toxin-induced fluid accumulation in a rabbit intestinal 
loop model. Neither sialic acid nor lactose was effective, demonstrating the specificity of 
the interaction [113]. The membrane-associated lectins of bacteria differ per strain and the 
glycoproteins expressed on epithelial cells are highly species specific [114]. Based on this 
mechanism, the application of oligosaccharides to increase the resistance to infection is 
limited, unless a cocktail of inhibitors is used. In contrast, the above-mentioned stimulation 
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of intestinal fermentation by dietary oligo- or polysaccharides has a more general effect, 
because protection against several acid-sensitive pathogens might be expected. 
Minerals 
Very little is known about the effects of dietary minerals on the course of an 
infection. Only data about the role of iron and zinc are reported. Individuals with iron-
overload, whether induced by excess dietary iron intake or due to diseases like B-
thalassaemia major and sickle cell disease, are more susceptible to infection [115]. Iron is 
essential for bacterial growth and may increase oxidative damage to host membranes or 
DNA during inflammation, as it is a catalyst in the production of hydroxy 1 radicals [116]. 
The observed drop in plasma iron levels during infectious diseases, the so-called anemia of 
infection, is a protective response of the body to combat the infection and to limit oxidative 
damage [117, 118]. On the other hand, there is also evidence that severe iron deficiency is 
associated with an increased incidence of infections [115]. Iron deficiency compromises 
host resistance by suppressing the cellular immune response [119]. 
Zinc is a cofactor of about 120 enzymes of mammals. Zinc deficiency has a 
pronounced effect on nucleic acid metabolism, thus influencing protein synthesis and cell 
growth. Furthermore, an inadequate zinc intake is associated with an impaired immune 
function [120]. Zinc supplementation can reduce the incidence and prevalence of acute 
infectious diarrhea [121] and reverse the increased intestinal permeability during shigellosis 
[122] in children with a marginal or deficient zinc status. Besides restoration of immune 
cell functioning, normalization of intestinal epithelial cell proliferation and strengthening of 
the mucosal barrier might be responsible for the observed beneficial effects of zinc 
supplementation. 
The effects of calcium on the resistance to intestinal infections are unknown. At the 
same time, evidence accumulates showing the protective effects of dietary calcium on the 
development of colorectal cancer [123, 124]. A substantial amount of dietary calcium 
reaches the lower gut because the intestinal absorption of calcium is limited [125]. Calcium 
forms and insoluble complex with phosphate, which strongly adsorbs and precipitates 
intestinal surfactants, like bile acids and fatty acids [126]. Bile acids and fatty acids are 
damaging to the intestinal epithelium and stimulate epithelial cell proliferation [127], which 
may increase the risk of colon cancer [128]. It can be speculated that these cytoprotective 
effects of dietary calcium on the intestinal epithelium are not only relevant to colon 
carcinogenesis but also have major implications for the resistance to intestinal infections. 
Diminishing epitheliolysis, by decreasing the cytotoxicity of gut content, might strengthen 
the mucosal integrity. Conversely, increased epithelial cell damage provoked by dietary 
lectins [129], chemical irritants [130] or ischemia/reperfusion [131] leads to disruption of 
the physical barrier function of the intestinal mucosa and gut-derived septicemia. 
Besides the above mentioned proposed effect of dietary calcium on the mucosal 
barrier function, calcium may directly affect pathogens or the endogenous microflora. For 
instance, the in-vitro expression of some virulence genes of pathogenic bacteria is 
decreased by extracellular calcium [132]. Additionally, calcium facilitates the adhesion of 
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Figure 4 Hypothetical mechanism by which dietary calcium phosphate may decrease 
the severity of an intestinal infection. 
lactobacilli to intestinal epithelial cell lines [133]. However, these results are not verified 
in-vivo and their relevance for the resistance to intestinal infections is yet unknown. By 
precipitating and thus inactivating intestinal bile acids, calcium may also indirectly affect 
the intestinal microflora. Bile is a classical supplement used in the preparation of several 
selective microbiological culture media to suppress contaminating flora. This indicates that 
bacterial species differ in their sensitivity to bile acids, at least in-vitro. In the seventies, 
Floch et al. [134, 135] reported that bile acids were especially inhibitory to anaerobes and 
Gram-positive aerobes, whereas Gram-negative bacteria were rather insensitive in-vitro. He 
also noticed that certain strains deconjugate bile acids, subsequently resulting in an 
inhibition of that particular bacterial strain. He postulated that bile acids may control 
bacterial populations in the intestinal tract and that bile acids are part of an autoregulatory 
system in which individual bacteria may control their own population. The restraining 
effect of bile in general on the intestinal microflora can be deduced from in-vivo studies on 
obstructive jaundice. A reduced or absent bile flow results in intestinal bacterial overgrowth 
and an increased risk for endotoxemia and septic complications. Oral administration of bile 
acids can normalize intestinal bacterial numbers and alleviate some of the symptoms in such 
cases [136]. In conclusion, only scattered data, mostly obtained from in-vitro experiments, 
indicate an effect of calcium or bile acids on bacteria. At present, no well-controlled studies 
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are available showing the effect of diet-induced changes in the intestinal bile acid 
concentration on intestinal ecology and its consequences for the resistance to invading 
pathogens. 
Scope and outline of this thesis 
As mentioned above and outlined in Figure 3, diet may modulate the resistance to 
intestinal infections by affecting the gastrointestinal killing of a pathogen, the protective 
endogenous microflora and the mucosal barrier function. Though, the importance of these 
three determinants of resistance is generally recognized, strictly controlled in-vivo 
experiments showing the impact of the diet on the severity or the course of a foodborne 
intestinal infection are lacking. This thesis mainly focuses on the possible protective effects 
of dietary calcium on the resistance to intestinal infections. The emphasis is laid upon the 
mechanism by which calcium may improve the resistance to intestinal infections. The 
hypothesis concerning this mechanism is outlined in Figure 4. Considering that only 
circumstantial evidence is present in literature, the performance of human studies is 
ethically not justified in this phase. Therefore, strictly controlled infection experiments 
were performed with rats. Salmonella enteritidis was chosen as the infective agent, because 
non-typhoidal salmonellosis is one of the most common, foodborne, bacterial infections in 
Europe and the United States [137]. Equally important, the development and pathology of 
salmonellosis in humans and rodents is largely similar and well-described in literature 
[138]. Because S. enteritidis has invasive properties, dietary modulation of the resistance to 
intestinal bacterial translocation could be studied in addition to modulation of the 
colonization resistance. 
The first study described in this thesis concerns the development of a new method to 
determine intestinal bacterial translocation because classical organ cultures suffer from 
some major drawbacks. Bacteriological determination of pathogens in tissue samples is 
invasive, laborious, rather insensitive and only applicable as a one-point measurement. 
Therefore, it was evaluated whether daily nitric oxide-derived urinary nitrate excretion 
could be used to quantitate intestinal bacterial translocation (chapter 2). Second, the effect 
of different (fermented) milk products on the colonization resistance of rats to S. enteritidis 
was studied. Diet-induced as well as infection-induced changes in intestinal physiology 
were measured (chapter 3). Subsequently, a strictly controlled infection experiment was 
performed with rats consuming purified diets differing only in calcium phosphate. The 
effects of supplemental calcium phosphate on the translocation and colonization resistance 
were studied. In addition, several fecal bacterial mass markers were analyzed to verify the 
proposed stimulating effect of calcium phosphate on the endogenous microflora (chapter 4). 
The main purpose of the next study was to test whether supplemental calcium phosphate 
adds to the potential beneficial effect of lactulose fermentation on a salmonella infection in 
rats (chapter 5). The final study is an extension of the experiment described in chapter 4 
and adresses the question whether a calcium phosphate-induced decrease in intestinal 
surfactants affects the intestinal lactobacilli and changes the resistance of rats to salmonella. 
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Special attention was given to the ileal flora, because this is the most relevant part of the 
intestinal tract in salmonellosis (chapter 6). 
The thesis is closed with a summary and concluding remarks (chapter 7). 
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ABSTRACT 
Bacterial translocation across the gut wall may lead to bacteremia and sepsis. 
Bacteriological analyses are laborious and time consuming, which precludes a rapid 
diagnosis of bacterial translocation. Synthesis of nitric oxide by macrophages is a primary 
response to bacterial infections. Therefore, the aim of this study was to examine whether 
NO-derived nitrite and nitrate (summed as NOx) excretion can be used as a rapid and 
quantitative marker of intestinal bacterial translocation. The kinetics of urinary NOx 
excretion was determined in rats intraperitoneally injected with increasing doses of 
Salmonella enteritidis lipopolysaccharide. Subsequently, the response to bacterial 
translocation was studied in rats infected orally with different doses of viable, invasive S. 
enteritidis. Increasing the lipopoly saccharide dose from 0.05 to 0.50 mg/kg resulted in a 
transient, dose-dependent, almost 10-fold increase in urinary NOx excretion. Administration 
of the NO synthase inhibitor NG-nitro-L-arginine methyl ester merely inhibited the increase 
in NOx excretion after lipopolysaccharide injection. Increasing the infective dose of viable 
salmonella resulted in a time- and dose-dependent exponential increase in NOx output. 
Translocation was a prerequisite for provoking a NOx response. Total urinary NOx 
excretion after infection and classical infection parameters, such as weight of the mesenteric 
lymph nodes and population levels of salmonella in feces, were highly correlated. In 
conclusion, urinary NOx excretion is a quantitative, non-invasive biomarker of intestinal 
bacterial translocation, which can be used to follow the course of a systemic infection. 
INTRODUCTION 
Gut-derived bacteremia and sepsis can be a severe clinical complication in 
traumatized or immunocompromised patients [1] as well as in patients with cirrhosis and 
portal hypertension [2,3]. Unfortunately, bacteriological determination of pathogens in 
tissues or fecal samples is laborious, time consuming, and often a one-point measurement. 
Therefore, these analyses are less suitable for a rapid diagnosis and monitoring of bacterial 
translocation across the intestine. Because induction of nitric oxide synthesis is a primary 
reaction of macrophages to bacteria, fungi, and protozoa [4-14], we considered whether this 
parameter can be used as an alternative method to follow the course of systemic infections. 
In-vivo, the NO generated during infections is rapidly oxidized to nitrite and nitrate 
(summed as NOx) and excreted in urine [14-16]. Direct proof that in such cases NO is the 
origin of NOx in urine or blood is derived from in-vivo studies using competitive inhibitors 
of NO synthase, such as NG-nitro-L-arginine and its methyl ester NG-nitro-L-arginine 
methyl ester (L-NAME) or NG-monomethyl-L-arginine [16-19]. These arginine analogs also 
exert a profound inhibition of NO synthesis in-vitro [20, 21]. When macrophages are 
activated in-vitro with increasing doses of lipopolysaccharide (LPS) or viable bacteria, the 
production of NOx or citrulline increases dose-dependently [4-6]. Animal studies have 
shown that administration of a single dose of LPS [9, 10] or viable mycobacteria [16] 
results in enhanced urinary NOx excretion. Patients with sepsis [8, 22] or acute diarrhea [7, 
10] also show elevated blood or urinary NOx levels. However, a dose-dependent 
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relationship between intestinal bacterial translocation and urinary NOx excretion has 
hitherto never been shown. 
Therefore, we studied whether urinary NOx excretion can be used as a sensitive and 
non-invasive marker of intestinal bacterial translocation. Two kinds of strictly controlled 
experiments with rats were performed to address (1) if urinary NOx excretion depends on 
the dose of intraperitoneally injected LPS and (2) what is the relationship between urinary 
NOx excretion and increasing doses of orally administered, viable, invasive bacteria such as 
Salmonella enteritidis. 
MATERIALS AND METHODS 
Animals 
In all experiments, specific pathogen-free, 8 weeks old, male Wistar rats (Cpb:WU 
derived from the Central Animal Laboratory, Catholic University, Nijmegen, The 
Netherlands) were housed individually in metabolic cages. Mean weight (± SE) of the 
animals was 256 ± 4 g in the LPS dose experiment (n=20), 233 + 3 g in the LPS/L-
NAME experiment (n=12), and 261 ± 3 g in the oral challenge experiment (n=24). Foods 
(purified diet consisting of 10% casein, 10% palm oil and 10% corn oil, 60% dextrose, 5% 
cellulose, vitamins, and minerals as described elsewhere [23]) and demineralized drinking 
water were supplied ad libitum. Food intake was recorded every 2-4 days. Complete 24 h 
urine samples were collected in plastic tubes containing oxytetracycline (twice the minimal 
inhibitory concentration; Pfizer Corp., Brussels, Belgium) to prevent bacterial deterioration 
and stored at -20 °C until analysis. Animals were acclimatized to housing and dietary 
conditions for at least 1 week before any experimentation. The experiments were approved 
by the Ethical Committee of Animal Experiments of the Catholic University, Nijmegen, 
The Netherlands. 
S. enteritidis LPS experiment 
After collection of urine for determination of basal NOx excretion (3 days), rats 
were intraperitoneally injected with either 0,0.05, 0.10, 0.50, or 1.0 mg/kg body wt S. 
enteritidis LPS (lyophilized phenol extract; Sigma Chemical Co., St. Louis, MO, USA) in 
sterile saline. After LPS administration, urine samples were collected during 5 consecutive 
days. An additional control experiment was performed to determine whether the increased 
urinary NOx excretion after LPS administration was caused by increased activity of NO 
synthase. Two groups of rats received a single intraperitoneal injection of 0.50 mg/kg body 
wt S. enteritidis LPS. L-NAME (Sigma Chemical Co.) in sterile saline was administered 
intravenously to the first group directly after the LPS injection and at the following 3 
consecutive days. The second group was intravenously injected with saline daily. 
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Oral challenge with viable 5. enteritidis 
The strain of S. enteritidis (clinical isolate, phage type 1) used in this infection 
experiment is passaged routinely in Wistar rats to sustain its virulence and stored as a pure 
culture at -80°C in Brain Heart Infusion broth (Difco, Detroit, MI, USA) containing 7% 
(vol/vol) sheep blood and 20% (vol/vol) glycerol. Before use, the culture was streaked on 
Blood Agar Base (Oxoid, Basingstoke, England) supplemented with 5% (vol/vol) sheep 
blood and incubated overnight at 37 °C. Colonies were inoculated in 1 mL of brain heart 
infusion broth and incubated for 18 h at 37 °C. Four groups of six rats each were infected 
orally by gastric gavage with 1 mL of saline containing 3 % (wt/vol) sodium bicarbonate 
with either 1.8X105, 1.8xl07, or 1.8xl09 viable S. enteritidis or 1.8x10' heat-killed S. 
enteritidis (incubation for 1 h at 56 °C). The exact number and viability of S. enteritidis in 
the inocula was determined by plating on Brilliant Green Agar (Oxoid). Complete 24 h 
urine samples were collected consecutively from 3 days before infection till 7 days after 
infection. On days 1 and 7 after infection, fresh fecal samples were collected. The number 
of salmonella in feces was quantified by a plating technique on Brilliant Green Agar as 
described and validated by Giaffer et al. [24]. To obtain representative cultures of the 
mesenteric lymph nodes (MLN), the experiment was terminated 7 days after infection to 
prevent progression to death [25]. That day, the rats were killed by carbon dioxide 
inhalation, and all MLN were excised aseptically, weighed, and homogenized (Ultraturrax 
TP 18.10; Janke & Kunkel, Staufen im Breisgau, Germany) in sterile saline. From several 
10-fold dilutions, 10 fiL was plated on Brilliant Green Agar and incubated at 37 °C for 24 
h. Dilutions yielding 30-200 colonies of salmonella on plate were considered appropriate 
for scoring. Salmonella counts were expressed as the total log10 colony-forming units (CFU) 
in the MLN. 
NOx analyses in urine and food 
The NOx concentration was determined by automated flow injection analysis. 
Briefly, urine is passed over a cadmium column that reduces nitrate to nitrite, followed by 
reaction of nitrite with Griess reagent [26] to form a red azodye that is measured 
spectrophotometrically at 538 nm. Nitrite concentration in samples was measured with the 
same procedure, but without reduction of nitrate by cadmium. No nitrite or nitrate could be 
detected in watery extracts of the food. Recovery of a nitrate standard added to rat urine 
preserved with oxytetracycline was always >96%. No nitrite was present in rat urine. 
Urinary NOx concentration was multiplied by the urine volume produced in 24 h to obtain 
total urinary NOx excretion per day. Creatinine excretion in urine was assayed chemically 
using a colorimetric kit (Creatinine procedure no. 555; Sigma Chemical Co.). 
Statistics 
Values are expressed as means + SE. After analysis of variance, the differences 
between the means of the groups were evaluated using Student's t test for a single 
comparison or Bonferroni's test for multiple comparisons [27]. When variances were not 
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equal among groups, the nonparametric Kruskal-Wallis test was performed [27]. 
Differences were tested one-sided and regarded as significant at P<0.05. 
RESULTS 
Effect of increasing doses of intraperitoneal 5. enteritidis LPS on kinetics of urinary 
NOx excretion 
Before LPS administration, food intake was 17.1 + 0.9 g/d, which decreased 21 ± 
4% after injection of either 0.10 or 0.50 mg/kg LPS and 39 + 7% after administration of 1 
mg/kg LPS (P<0.05). Mean basal urinary NOx excretion before LPS administration was 
4.28 + 0.32 /xmol/d (n=20) and did not differ between treatment groups. The kinetics of 
the NOx response to different doses of LPS is shown in Figure 1. Administration of 0.05 
mg/kg LPS had no effect on urinary NOx excretion. Rats that received 0.10 mg/kg LPS 
showed a slight increase in urinary NOx output to about 10 jumol during the first 24 h after 
LPS injection. NOx excretion rapidly decreased to the basal level within the second day. 
Increasing the dose of LPS to 0.50 mg/kg resulted in a sharp increase in NOx output to 
about 38 /imol during the first day. A slight elevation of NOx excretion could still be 
noticed on the second day. The initial course of NOx excretion of rats that received 1.0 
o 
E 
3. 
c 
o 
o 
X 
is 
c 
50 
40 
30 
20 
10 
I 
// XI 
tSl^sl^* fc= 
LPS (mg/kg) 
- • - 0 
- » - 0.05 
- a - 0.10 
- ° - 0.50 
- a - 1 
5 = ^ 
-2 
Day 
Figure 1. Urinary NOx excretion of rats before and after intraperitoneal injection of different 
doses of 5. enteritidis LPS. Results are expressed as means + SE (n=4). The 
control group received saline only. 
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Figure 2 Urinary NOx excretion of rats after a single intraperitoneal injection of S. enteritidis 
LPS (0.50 mg/kg) on day 0. Results are expressed as means ± SE (n=6). On day 0 
up to and including day 4, L-NAME (3 mg/kg) or saline was injected intravenously. 
mg/kg largely paralleled that of the 0.50 mg/kg treatment group. Total urinary NOx 
excretion after injection of 0, 0.05, 0.10, 0.50, and 1.0 mg/kg LPS was 21.60 ± 1.38, 
22.42 ± 1.48, 27.21 ± 3.85, 60.51 + 3.31, and 77.17 + 6.32 /xmol/5 days, respectively. 
Mean values of the last three groups were significantly different from those of the control 
group and from each other (P<0.05). 
Effect of L-NAME on urinary NOx excretion after LPS administration 
After LPS administration, food intake and body weight decreased equally in the L-
NAME-supplemented group and the saline-treated control group. On the first day after LPS 
challenge, urinary NOx excretion of rats treated with L-NAME was significantly less than 
that of rats receiving saline (P<0.05) (Figure 2). Total urinary NOx excretion after LPS 
injection was 49.18 + 9.08 /*mol/4 days for saline-treated rats and 25.58 + 1.93 for L-
NAME-treated rats (P<0.05). Administration of 3 mg/kg body wt L-NAME did not 
completely prevent the NOx response induced by LPS. A slight elevation could still be 
noticed. A previous tryout with a higher dose of LPS (1 mg/kg) and higher doses of L-
NAME (5, 10, and 20 mg/kg) was lethal for some rats. Sections showed vascular 
complications, particularly in the lungs. Rats that survived showed complete prevention of 
the increase in urinary NOx excretion (data not shown). 
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Table 1 Effect of oral S. enteritidis challenge on post-infection population levels of 
salmonella in feces and MLN. 
Challenge dose 
Control 
1.8x10s 
1.8xl07 
1.8x10" 
Feces (log,0 
Day 1 
n.d. 
2.3 ± 0.8a 
4.3 ± 0.8a 
7.1 ± 0 . 1 " 
Salmonella counts 
CFU/g) 
Day 7 
n.d. 
3.3 + 0.9" 
5.7 + 0.9ab 
7.1 + 0.3" 
MLN (log10 CFU) 
Day 7 
n.d. 
4.4 ± 0.V 
4.7 ± 0 . 1 a b 
5.0 ± 0.2" 
The control group received 1.8xl09 heat-killed 5. enteritidis. Results are expressed as means ± SE 
(n=6). Different superscripts in the same column indicate a significant difference (P<0.05; 
Kruskal-Wallis test). Abbreviations: n.d. not detected, CFU colony-forming units. 
Effect of oral administration of increasing doses of viable S. enteritidis on urinary NOx 
excretion 
During the course of the infection, the animals showed hardly any outward signs of 
illness. They were alert and did not have any diarrhea, and their food and drinking water 
consumption did not change. Only the rats that received the highest challenge dose 
consumed significantly less during the last 3 days of the experiment: food intake was 15.8 
± 0.6 g/d before challenge and decreased 35 ± 7% in the last 3 days. Table 1 
summarizesthe effect of different challenge doses of S. enteritidis on salmonella counts in 
feces and MLN. As expected, no viable salmonella could be shown in the feces of rats 
receiving 1.8xl09 heat-killed bacteria. Within treatment groups infected with viable S. 
enteritidis, the salmonella populations present in feces at day 1 and day 7 after infection 
were comparable. Cultures of the MLN of rats that received heat-killed S. enteritidis were 
negative. Rats infected with viable S. enteritidis had positive MLN cultures with absolute 
salmonella counts between 104 and 105. Increasing the infective dose had a dramatic effect 
on the weight of the MLN (Figure 3). The correlation coefficient between the salmonella 
counts in the MLN and weight of this organ was 0.80 (P<0.05). An interesting 
observation is that only in MLN cultures of rats infected with 1.8xl09 viable S. enteritidis 
were translocated Escherichia coli also observed. Macroscopic observations during the 
section showed that the colon or cecum of all rats challenged with 1.8xl07 or 1.8xl09 of S. 
enteritidis had marked hypervascularization. In 3 of 6 rats infected with the highest dose, 
this phenomenon extended to the MLN. Despite the appearance of the feces as separate 
pellets, the cecum contents were usually watery in this group compared with the control 
group. 
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Figure 4 shows the kinetics of urinary NOx excretion in response to the different 
challenge doses of S. enteritidis. Before induction of the infection, no differences in NOx 
excretion were observed between treatment groups. Administration of heat-killed S. 
enteritidis had no effect on urinary NOx output. As early as the second day after challenge, 
the rats inoculated with 1.8xl09 S. enteritidis showed an increase in urinary NOx excretion. 
During the subsequent days, there was a continuous, marked increase in NOx excretion. 
Rats infected with 1.8xl07 or 1.8X105 S. enteritidis showed a post-infection latency period 
of 4 and 5 days, respectively, until NOx excretion significantly increased. By adding up the 
NOx excretion of days 1 to 7, total urinary NOx excretion after infection can be calculated. 
The effect of different challenge doses of 5. enteritidis on total urinary NOx excretion after 
infection and weight of the MLN 7 days after infection is illustrated in Figure 3. The 
correlation coefficients between total NOx excretion in urine and fecal salmonella or MLN 
weight were 0.75 and 0.85, respectively (P<0.05). At day 7 after infection, urinary 
creatinine excretion was 74 ± 4 /miol/d and did not differ between treatment groups. Thus, 
instead of total urinary NOx excretion, the ratio of NOx to creatinine in incomplete urine 
samples can also be used to monitor bacterial translocation. 
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Figure 3 Effect of the oral challenge dose of 5. enteritidis on total post-infection urinary NOx 
excretion and weight of the MLN at day 7 after infection. Results are expressed as 
means ± SE (n=6). The control group received 1.8xl09 heat-killed bacteria. 
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DISCUSSION 
Two recent in-vitro studies with rodent macrophages have shown a dose-dependent 
induction of nitrite production by various LPS samples. Bogle et al. [4] found a nearly 
linear relationship between the LPS concentration, which varied over a narrow range, and 
nitrite formation in the culture medium. Keller et al. [5] examined the effect of more 
diverse LPS concentrations and described a sigmoid-like relation between LPS and nitrite 
production. The results of our LPS experiment in-vivo partially resemble the results of the 
in-vitro study of Keller et al. [5]. Urinary NOx excretion increased about fivefold in 
response to the dose of LPS injected from 0.10 to 0.50 mg/kg. LPS concentrations below 
0.10 mg/kg failed to induce a NOx response, whereas injection of 1 mg/kg compared with 
0.50 mg/kg only slightly increased urinary NOx excretion. Obviously, there is a threshold 
dose of LPS below which NOx excretion does not respond. On the other hand, there also 
seems to be a maximum urinary NOx excretion that LPS can induce the first day after 
administration. 
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Figure 4 Urinary NOx excretion of rats before and after oral challenge with different doses of 
viable S. enteritidis. Results ae expressed as means ± SE (n=6). The control group 
received 1.8xl09 heat-killed bacteria. 
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Intravenous administration of 3 mg/kg of the NO synthase inhibitor L-NAME 
merely prevented the increase in urinary NOx excretion after LPS injection. This agrees 
with the results of several other studies. Jaeschke et al. [19] found that pretreatment of rats 
with nitro-L-arginine (10 mg/kg) inhibited LPS-induced urinary nitrate excretion by 97%. 
Billiar et al. [17] showed that NG-monomethyl-L-arginine suppressed plasma nitrate levels 
in mice after LPS challenge. Studying the effect of L-NAME on urinary NOx excetion in 
rats orally infected with invasive pathogens is in our opinion not very relevant, because L-
NAME stimulates gastric and duodenal bicarbonate secretion [28] and increases intestinal 
epithelial permeability [29]. These effects promote the survival and translocation of 
invasive pathogens such as salmonella, thus precluding a straightforward interpretation of 
the effect of L-NAME on NOx excretion. Therefore, Granger et al. [16] and Boockvar et 
al. [18] studied the inhibitory effect of NG-monomethyl-L-arginine on urinary nitrate 
excretion of mice after intraperitoneal administration of Mycobacterium bovis and 
intravenous injection of Listeria monocytogenes, respectively. All these results indicate that 
the enhanced production and excretion of NOx after LPS or live bacterial challenge is 
caused by an increased activity of NO synthase. In view of the observed differences in 
urinary NOx excretion induced by different doses of LPS, the second infection experiment 
with orally administered viable S. enteritidis was performed. The population levels of 
salmonella in feces and MLN in the present study correspond with the observations in other 
infection studies [25, 30]. Weight of the MLN increased drastically with increasing 
challenge dose. This is probably caused by accumulation of increasing numbers of 
polymorphonuclear leukocytes and macrophages recruited from the blood [31, 32]. Despite 
this, relatively small differences in salmonella counts in the MLN were observed, especially 
when compared with the population levels of this pathogen in feces. This can be explained 
by the fact that the MLN do not inhibit the spread of S. enteritidis [31]. Rats infected with a 
higher dose of S. enteritidis could have had more severely infected livers or spleens [33]. 
Apparently, the severity of the infection is more accurately reflected by the observed 
enlargement of the MLN. Moreover, weight of the MLN was significantly correlated 
(r=0.85) with total urinary NOx excretion after infection. Analogous to our results, 
Yamada et al. [12] reported significant correlations between colon and liver weights and 
plasma NOx levels in mice after intramural injection of peptidoglycan-polysaccharide to 
initiate colonic inflammation. 
Because of the invasive character of S. enteritidis, translocation from the gut lumen 
to the MLN takes place within 2 days. Increasing the challenge dose shortens the latency 
period necessary to infect spleen and liver [31, 34]. These literature data are remarkably 
consistent with our results of urinary NOx excretion. As early as the second day after 
challenge with 1.8xl09 S. enteritidis, a response in urinary NOx excretion could be noticed. 
Decreasing the infective dose prolonged the time necessary to exceed basal urinary NOx 
excretion. Regarding the inefficacy of heat-killed S. enteritidis and orally administered, 
live, enterotoxigenic Escherichia coli (data not shown) in stimulating urinary NOx 
excretion, translocation is apparently a prerequisite for provoking a NOx response. This 
makes urinary NOx excetion a functional parameter for bacterial translocation. A major 
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advantage is that in contrast to tissue cultures, urinary NOx excretion reflects the systemic 
pathogen load of the host. This makes urinary NOx excretion a more accurate estimate of 
the severity of the infection. 
Comparison of the urinary NOx response to S. enteritidis LPS and viable 5. 
enteritidis showed distinct kinetics. LPS induced a short-term, transient enhanced urinary 
N05 excretion, whereas viable S. enteritidis resulted in a continuous increase in NOx 
output. In contrast to LPS, the effect of viable pathogens on NOx generation is determined 
by the resultant of bacterial multiplication and inactivation of the pathogen by the immune 
system. The exponentially increasing NOx output suggests that multiplication of S. 
enteritidis exceeded killing of the pathogen during the first 7 days after infection . This 
suggestion is supported by the observations of Gregory et al. [11]. In mice surviving an 
intravenously administered dose of listeria, the increased serum NOx levels declined to the 
uninfected control level. In mice injected with a lethal dose, the enhanced serum NOx levels 
did not decrease before death occurred. Another striking difference between urinary NOx 
excretion induced by LPS or viable bacteria concerns the extent of the NOx response. 
Approximately 45 nmol/d is the maximum urinary NOx excretion that S. enteritidis LPS 
can induce. In contrast, the results of the infection experiment with viable S. enteritidis do 
not indicate a maximum in response. At day 7 after infecction, urinary NOx excretion 
amounted to 80 fimol in rats infected with 1.8xl09 salmonella, and there were no signs that 
the exponential increase in NOx output would cease. It is well known that the rate of 
formation of macrophages and other phagocytes from stem cells in the bone marrow is 
greatly increased during infection [32]. Therefore, it is possible that the observed 
continuous increase in urinary NOx excretion in the experiment with viable S. enteritidis is 
caused by increasing numbers of circulating activated macrophages. 
In this study, we used S. enteritidis as a model for invasive pathogens because 
human salmonellosis is one of the most common intestinal infections [35]. Application of 
urinary NOx excretion as a parameter for bacterial translocation or systemic infections is 
certainly not restricted to salmonella infections only. The generation of NO is a nonspecific 
reaction of phagocytic cells to all kinds of microbial stimuli, such as a diversity of bacterial 
cell-wall fragments or intact bacteria, fungi, and protozoa [5, 6, 11-14, 16, 18]. 
Summarizing the present results, it can be concluded that a dose-dependent 
relationship exists between the degree of bacterial translocation and urinary NOx excretion 
in-vivo. To our knowledge, this is the first study showing that urinary NOx excretion can be 
used as a functional parameter to quantify the severity of a systemic infection and to follow 
its course. Regarding the rapid and easy determination of urinary NOx, the present results 
suggests several applications in clinical studies. For instance, by monitoring the urinary 
NOx to creatinine ratio (when a complete daily urine sample can not be obtained), sepsis 
can easily be recognized in patients in intensive care units who are likely to have bacterial 
translocation from the gut lumen into the systemic circulation [36, 37]. 
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ABSTRACT 
Calcium in milk products stimulates gastric acid secretion and inhibits the cytolytic 
activity of intestinal contents. Based on these effects, it was hypothesized that calcium might 
lessen the severity of foodborne intestinal infections. The possible differential effects of a 
low-calcium milk and normal milk products (e.g. milk, acidified milk and pasteurized yogurt) 
on the resistance of rats to a salmonella infection was therefore studied. Rats were infected 
orally with Salmonella enteritidis just after food consumption. The first day after infection, 
fecal salmonella counts of yogurt-fed rats were significantly lower compared to the other 
groups. Thereafter, fecal salmonella excretion declined rapidly in all high-calcium groups, 
whereas rats fed low-calcium milk continued to excrete high numbers of salmonella. The 
reduced colonization resistance to salmonella of rats fed low-calcium milk might be caused by 
the high cytotoxicity of fecal water or the high iron concentration in fecal water already 
present before infection, or both. The reduced resistance of these rats corresponded with a 
large infection-induced increase in the cytotoxicity of fecal water, a marked reduction in 
apparent iron absorption and a large increase in fecal mucin and alkaline phosphatase 
excretion. In yogurt-fed rats, only minor infection-induced changes in luminal parameters 
were noticed. The rats fed milk and acidified milk always showed intermediate reactions. In 
conclusion, in addition to fermentation by yogurt bacteria, calcium in milk products strongly 
enhanced the resistance to salmonella infection by lowering luminal cytotoxicity or 
diminishing the availability of iron for pathogen growth, or both. 
INTRODUCTION 
The first defense mechanism of host resistance to gastrointestinal infections is the 
gastric barrier [1]. Pathogens, for instance salmonella species, introduced into the stomach are 
effectively destroyed by gastric acid [2-4]. The interaction of gastric acid and ingested 
bacteria is conditioned by other variables in addition to gastric acid secretion, namely physical 
protection of bacteria by food, buffering of gastric content and rate of gastric emptying. The 
effectiveness of the gastric barrier can be influenced by milk products. By stimulating gastrin 
release, calcium in milk products induces gastric acid secretion [5, 6]. In addition, the gastric 
emptying rate of fermented milk is half that of milk [7], so simultaneously ingested pathogens 
have to endure a prolonged exposure to gastric acid as well as to lactic acid in the fermented 
milk. Beyond the gastric barrier, a second line of non-immunological defense mechanisms is 
situated in the intestine. Antibacterial effects of bile acids and pancreatic enzymes, the 
motility of the intestine, normal epithelial cell turnover, the presence of an autochthonous 
microflora and intestinal mucin secretion, act together to eliminate harmful exogenous 
bacteria [1]. Many of these intestinal parameters are influenced by diet [8-11]. For instance, 
calcium in milk products inhibits the cell damaging activity of intestinal contents and 
decreases epithelial cell proliferation by precipitating bile acids among others [11-14]. 
Considering the above mentioned effects of calcium on gastric acid secretion and the 
intestinal epithelium, the question arises whether calcium in milk products increases resistance 
to foodborne infections. To address that question, we performed a strictly controlled infection 
experiment, to compare the resistance of rats to a salmonella infection when fed low-calcium 
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milk, regular milk, milk acidified with hydrochloric acid, or pasteurized yogurt. In addition, 
growth of salmonella in these milk products was studied in-vitro. 
MATERIALS AND METHODS 
In-vitro study: growth of salmonella in milk products 
S. enteritidis (clinical isolate, phage type 1) was cultured and stored as described 
earlier [15]. S. enteritidis was precultured in Brain Heart Infusion broth (BHI; Difco, Detroit, 
MI, USA) for 1 day at 37 °C. Bacteria were collected by centrifugation(15 min at 5,000 g), 
washed once and resuspended in sterile saline to prepare a stock suspension containing 
approximately 109 bacteria/mL. Low-calcium milk (Calcinon, Nutricia, Zoetermeer, The 
Netherlands), milk (3.7% fat), milk acidified with (concentrated)hydrochloric acid to pH 4.2, 
and yogurt were inoculated with the stock suspension (final 1%), mixed, and subsequendy 
incubated in a shaking waterbath at 37 °C. At t=0, 0.5, 1,2,3, and 6 h a small sample of the 
incubates was taken, serially diluted in saline, and plated on Brilliant Green Agar (BGA; 
Oxoid, Basingstoke, England). The plates were incubated 1 day at 37 °C. 
Animals, diets and infection 
The experimental protocol was approved by the animal welfare officer of the 
Agricultural University, Wageningen, The Netherlands. Specific pathogen-free male Wistar 
rats (WU, Harlan, Zeist, The Netherlands), 10 weeks old and with a mean body weight of 
about 330 g, were housed individually (n=9 per diet) in metabolic cages in a room with 
controlled temperature (22-24 °C), relative humidity (50-60%) and light/dark cycle (light, 
6.00-18.00 h). 
The experimental milk products were manufactured by the Technology department of 
our institute. Because rats are lactose-intolerant, the milk (3.7% fat, 3.0% protein, 30 mmol 
calcium per L) and low-calcium milk (Calcinon, Nutricia; 3.8% fat, 3.1% protein; CaCQ 
was added to obtain 6 mmol calcium per L) were first treated with lactase (Maxilact LX5000, 
Gist-brocades, Delft, The Netherlands). Sugar determination of the lactase-treated products 
by HPLC analysis [16] showed complete hydrolysis of lactose. Thereafter the low-calcium 
milk and part of the normal milk were sterilized (15 s at 140 °C) and bottled aseptically. 
Yogurt was prepared from the (lactase treated) regular milk by standard procedures, using 
cultures of Lactobacillus bulgaricus and Streptococcus thermophilus. The yogurt was 
homogenized, pasteurized (15 s at 74 °C) and bottled aseptically. The milk products were 
stored at 4 °C until use. Acidified milk was prepared by acidifying (lactase-treated) regular 
milk with concentrated hydrochloric acid to pH 4.2, which was the pH of the yogurt. For 
animal food preparation 125 g of rice flour (Molenaar, Milupa B.V., Amersfoort, The 
Netherlands), 20 g cellulose, vitamins [17] and 0.1 mmol ferric citrate (BDH Chemicals Ltd, 
Poole, England) were added to 1 L of milk product. The dry weight percentage of these 
animal foods was 23.3%. Food was prepared freshly every 3 days and stored at 4°C; the 
food racks of the animals were changed every day. Food and demineralized drinking water 
were supplied ad libitum. Food intake was recorded every day and body weight every 3 days. 
Animals were acclimatized to the housing and dietary conditions for 9 days, after 
which they were infected with 5. enteritidis (same strain as used in the in-vitro experiment), 
which is an increasingly important food pathogen [18]. Details of the kinetics of a salmonella 
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infection in rodents [3] and the properties and maintenance of this pathogen [15] are described 
elsewhere. Before infection, the rats were starved overnight. At 9.00 AM the next day, food 
was supplied ad libitum. At 11.00 AM all rats were infected orally by gastric gavage with 1 
mL of saline containing 1.109 viable S. enteritidis. The exact viable counts of S. enteritidis in 
the inoculum were determined by plating on Brilliant Green Agar (Oxoid). Before, and on 
days 1, 5 and 12 after salmonella infection, fresh individual fecal samples were collected. The 
number of salmonella in feces was quantified by plating on Modified Brilliant Green Agar 
(Oxoid) supplemented with sulfamandelate (Oxoid) as described and validated by Giaffer et 
al. [19]. 
Total feces analyses 
Feces were quantitatively collected 2 days before salmonella infection and on days 5 
and 6 post-infection. Feces were freeze dried for dry weight determination. After dry ashing 
and destruction (15 minutes at 180 °C) with a perchloric acid (70 %)/hydrogen peroxide (30%) 
mixture (3:1 vol/vol) of freeze dried feces, iron was measured using an atomic absorption 
spectrophotometer (Model 1100, Perkin Elmer Corp., Norwalk, USA). Inorganic phosphate 
was extracted from freeze dried feces with 5% (wt/vol) trichloroacetic acid and measured 
according to the method of Fiske and Subbarow [20]. Total bile acids were extracted from 
freeze-dried feces with a t-butanol/water mixture (1:1 vol/vol) as described previously [21]. 
Extracts were assayed for bile acids using a fluorimetric enzymatic assay [22]. For mucin 
determination, freeze dried feces was suspended in 20 volumes of phosphate-buffered saline, 
mixed, and immediately incubated in a shaking waterbath at 95 'C for 10 minutes to denature 
glycosidases. Control experiments showed no degradation of purified mucin (crude porcine 
stomach mucin, Sigma, St. Louis, USA) during this heat-treatment. Thereafter, mucins were 
solubilized by incubating for 90 min at 37 °C. After centrifugation for 1 min at 15,000 g 
(Eppendorf 5415), mucins were measured using a fluorimetric assay that discriminates O-
linked glycoproteins (mucins) from N-linked glycoproteins [23]. Standard solutions of N-
acetylgalactosamine (Sigma) were used to calculate the amount of oligosaccharides liberated 
from mucins during the procedure. Recovery of porcine stomach mucin added to dry feces 
varied between 95 and 105 %. For alkaline phosphatase (ALP) determination, 30 mg of freeze 
dried feces was suspended in 5 mL saline. After homogenization, the suspensions were 
centrifuged for 5 min at 1,500 g (Heraeus, Boom B.V., Meppel, The Netherlands). ALP 
activity in the supernatants was determined spectrophotometrically as described elsewhere 
[13], except that inhibition with L-phenylalanine was omitted. In our earlier studies [11-14], 
inhibition of the intestinal isoenzyme with L-phenylalanine was used to quantify the 
contribution of bacterial ALP to total ALP activity. However, we now performed control 
experiments with feces from germfree and conventional rats, which showed that the 
remaining activity in the presence of L-phenylalanine was exactly the same for both feces 
(10% of total ALP activity, data not shown). 
Fecal water analyses 
Fecal water was prepared by adding double-distilled water to freeze dried feces to 
obtain 35% dry weight, which mimics the conditions in the colon. Individual deviations of the 
mean dry weight percentage were proportionally corrected for. After homogenizing, the 
samples were mixed regularly while incubated in a shaking waterbath (1 h at 37 °C), followed 
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by centrifugation for 20 min at 12,000 g (Hettich, Micro-rapid 1306, Tuttlingen, Germany). 
The aspirated supernatant was centrifuged for 2 min at 14,000 g (Eppendorf 5415). After 
determination of the pH of the supernatants at 37 °C, fecal water was stored at -20 °C until 
further use. For determination of cytotoxicity, human erythrocytes (20 ^L of a 25% 
hematocrit suspension) were mixed with 80 ^L of fecal water or 40 /*L fecal water plus 40 ^L 
saline. Before addition to the erythrocytes, the fecal waters were warmed to 37 °C. Mixtures 
were incubated for 2 h at 37 °C in a shaking waterbath. The intact erythrocytes in the pellet 
were washed three times with saline (centrifugation 1 min 1,500 g (Eppendorf 5415)). After 
lysing the erythrocytes in the pellet with double-distilled water, trichloroacetic acid (final 5% 
wt/vol) was added, followed by centrifugation for 1 min 14,000 g (Eppendorf 5415). The 
potassium content of the supernatant was measured by atomic emission spectrophotometry 
(Model 1100, Perkin Elmer). Simultaneously, erythrocytes were incubated in saline (0% 
hemolysis, corresponding to 100% potassium release) and in double-distilled water (100% 
hemolysis, corresponding to 0% potassium release). Percentage hemolysis was calculated 
from these 0% and 100% controls. The relevance and validation of this cytotoxicity assay is 
described elsewhere [24]. Iron was measured in saline-diluted fecal water, using an atomic 
absorption spectrophotometer (Model 1100, Perkin Elmer). Bile acid determination in 
samples taken before infection was performed directly in diluted fecal water as described 
elsewhere [22]. In contrast to pre-infection samples, the recovery of cholic acid added to post-
infection samples was often poor, indicating that fecal water components interfered with the 
enzymatic assay. Therefore an alternative procedure was carried out as follows; post-infection 
samples were acidified (final 1 M HC1) and subsequently extracted three times with diethyl 
ether. After evaporation of diethyl ether, the residue was resolubilized in methanol. This 
solution was hydrolyzed in 80% (v/v) methanol and 1 M NaOH for 1 h at 80 °C. After 
evaporation of methanol and subsequent acidification with HC1 (final 1 M), bile acids were 
again extracted with diethyl ether. After evaporation of diethyl ether, bile acids were 
resolubilized in methanol and measured as described above. Using this procedure, the 
recovery of a mixture of cholic acid/deoxycholic acid/lithocholic acid (4:3:1) added to fecal 
water always exceeded 90%. Control experiments showed that the bile acid concentration in 
fecal waters of the pre-infection period was identical when using the direct or the alternative 
procedure. Free fatty acids were analysed by gas chromatography as described earlier [14]. 
Statistics 
Results are presented as means ± SE, with n=8 for the yogurt group and n=9 for the 
other groups. Within one dietary group, differences between the means of the pre-infection 
period and the post-infection period were tested by Student's? test for paired samples (two-
sided). Within one period, differences between diet groups were tested on their significance, 
using analysis of variance (ANOVA). Additionally, Fisher's protected least significant 
difference test (two-sided), modified for multiple comparisons, was used to identify dietary 
groups that differed from each other. The level of significance was preset at P<0.05. A 
commercially available statistical package was used for all statistics (SPSS/PC + v2.0, SPSS 
Inc. Chicago, USA). 
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Figure 2 Fecal excretion of salmonella (means + SE, n=8 or 9) after oral administration of 
1.109 CFU of this pathogen on day 0. Symbols: O low-calcium milk, • milk, T 
acidified milk and • yogurt. * Denotes that fecal salmonella excretion of the indicated 
group is significantly different from all other groups (P<0.05). Abbreviations: CFU 
colony-forming units, DL detection limit of the microbiological assay. 
Colonization resistance 
The first day after salmonella infection, rats fed yogurt had a significantly lower 
salmonella excretion in feces than rats fed the other diets (Figure 2). On day 5, population 
levels of salmonella in feces were decreased notably in the high-calcium diet groups. In 
contrast, rats fed the low-calcium milk continued to excrete high salmonella levels in their 
feces. This was also the case on day 12 post-infection. Thus, rats fed the low-calcium milk 
had a much lower colonization resistance to salmonella than rats fed the high-calcium diets. 
Cytotoxicity of fecal water 
The pH of fecal water of the yogurt group (6.54 ± 0.06) was higher (P<0.05) than 
values in the other groups (acidified milk 6.30 ± 0.03, milk 6.21 ± 0.01, and low-calcium 
milk 6.21 + 0.05). Salmonella infection had no effect on the pH. Before infection, the 
cytotoxicity of fecal water from the high-calcium groups (milk, acidified milk and yogurt) did 
not differ from each other and varied between 10 and 22% (Figure 3). The cytotoxicity of 
fecal water of rats fed the low-calcium milk was 100% when the standard assay using 80 pL 
of fecal water was applied. To study whether salmonella infection increased the cytotoxicity 
any further in this group, erythrocytes were also incubated with a smaller volume (40 /*L) of 
fecal water. After salmonella infection, the largest increase in cytotoxicity of fecal water 
occurred in the group fed the low-calcium milk. Rats fed regular milk showed a smaller, but 
significant, increase. Remarkably, salmonella infection had no significant effect on the 
cytotoxicity of fecal water of rats fed acidified milk or yogurt. 
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Figure 3 Cytotoxicity of fecal water (means ± SE, n=8 or 9) before and after infection. For all 
groups 80 ixh of fecal water was used in the hemolyses assay. To detect the difference 
in cytotoxicity before and after infection in the low-calcium milk group, 40 ^ L of fecal 
water was also used in the assay for this group. Abbreviations: LCM low-calcium 
milk, M milk, AM acidified milk, Y yogurt. Bars not sharing the same letter are 
significantly different from each other (P < 0.05). 
Concentration of bile acids, fatty acids and iron in fecal water 
Compared with the three high-calcium groups, the concentration of bile acids in fecal 
water of rats fed low-calcium milk was much higher (low-calcium milk 2.40 ± 0.17 mM, 
milk 0.77 + O.lOmM, acidified milk 1.09 ± 0.16 mM, yogurt 0.69 + 0.05 mM (P< 0.05)). 
Salmonella infection had no effect on the bile acid concentration in fecal water. Before 
infection, the mean free fatty acid concentration in fecal water was 0.46 + 0.10 mM in the 
low-calcium milk group, 0.31 + 0.03 mM in the milk group, 0.76 + 0.16 mM in the 
acidified milk group, and 1.62 ± 0.52 mM in the yogurt group. The infection had no 
significant effect on the concentration of free fatty acids in fecal water. Despite an equal 
dietary iron intake of about 7.7 /xmol/d, the iron concentration in fecal water of rats fed low-
calcium milk was at least 5 times higher than that in fecal water of rats fed the high-calcium 
diets (Figure 4). Post-infection, soluble iron increased significantly only in the groups fed 
low-calcium milk and regular milk. 
Apparent iron absorption and fecal excretion of mucin, ALP, and phosphate 
The apparent iron absorption is calculated by subtracting the fecal iron excretion from 
the dietary iron intake. As mentioned above, dietary iron intake was about 7.7 ^mol/d and 
was not affected by diet or by the infection. Before infection, all groups had an apparent iron 
absorption of about 2.7 /xmol/d (Figure 5). After infection, the apparent iron absorption 
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Figure 6 Daily mucin excretion in feces (means + SE, n=8 or 9) before and after salmonella 
infection. Abbreviations: LCM low-calcium milk, M milk, AM acidified milk, and Y 
yogurt. Bars not sharing the same letter are significantly different from each other 
(P<0.05). 
salmonella levels in feces of rats fed low-calcium milk corresponded with a significant 
reduction in the percentage dry weight of the feces in this group (Table 1). 
Dietary calcium greatly reduced the cytotoxicity of fecal water in the pre-infection 
period (Figure 3). This agrees with previous work from our laboratory [11-14]. The high 
luminal cytotoxicity in the low-calcium milk group coincided with a reduced colonization 
resistance to salmonella. Considering these results, it is tempting to speculate that a high 
luminal cytolytic activity predisposes to salmonella infection. By lowering the cytolytic 
activity of luminal contents and reducing epithelial cell damage [11-14], the mucosal integrity 
and resistance to infection might be enhanced. In addition, we have now shown that 
salmonella infection has a striking effect on the cytotoxicity of fecal water. In accordance with 
high population levels of salmonella in feces of rats fed low-calcium milk, the cytotoxicity of 
fecal water of this group increased strongly after infection. No significant change could be 
noticed in rats fed acidified milk or yogurt. The concentrations of bile acids and fatty acids, 
important cytotoxic surfactants in fecal water [11-14], did not rise post-infection. This 
indicates that these surfactants were not responsible for the increase in cytotoxicity of fecal 
water after infection. Some salmonella strains seem to be able to produce enterotoxins, but 
none of these toxins has been shown to play a role in the virulence of this pathogen or the 
production of symptoms [25, 26]. The production of reactive oxygen metabolites or 
bactericidal proteinases by attracted inflammatory cells (like macrophages) may have 
contributed to the pathogenesis of infection. Investigations are now being carried out to 
identify the infection-related toxic substances in fecal water. 
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Figure 7 Fecal alkaline phosphatase (ALP) excretion (means ± SE, n=8 or 9) as a marker of 
intestinal epitheliolysis. Abbreviations: LCM low-calcium milk, M milk, AM acidified 
milk, and Y yogurt. Bars not sharing the same letter are significantly different from 
each other (P< 0.05). 
Soluble iron plays a critical role in inflammatory processes induced by bacterial 
infections. First, Fe2+/Fe3+ is an important redox couple in the formation of reactive oxygen 
metabolites [27]. Second, the bactericidal action of lysosomal proteins of neutrophils is 
neutralized by excess iron [28]. Third, iron is an essential nutrient for bacterial growth [28]. 
To minimize epithelial cell damage and to maximize the resistance against pathogens, the 
soluble iron concentration in the intestinal lumen should be kept as low as possible. Our 
results showed that calcium in milk products strongly reduced the soluble iron concentration 
in fecal water (Figure 4). The phosphate content of the various diets was not different (mean 
112 mmol/kg dry weight). However, in contrast to the high-calcium diets, the rats fed low-
calcium milk almost completely absorbed the phosphate (Table 1) because hardly any 
precipitation with calcium could occur. These results suggest that luminal iron is 
coprecipitated by a calcium-phosphate complex. The relatively small, but significant increase 
in the iron concentration in fecal water after infection in the low-calcium milk and milk group 
might originate from iron in hemoglobin, due to salmonella-induced intestinal bleeding [29]. 
Because iron-withholding is a defense system of the host against bacterial infections [30], the 
apparent iron absorption, defined as dietary iron intake minus fecal iron excretion, was 
quantified. After salmonella infection, the apparent iron absorption had decreased towards 
zero in the low-calcium milk, milk and acidified milk group (Figure 5). Bezkorovainy also 
showed that iron absorption in the small intestine was decreased during infections [31]. 
Remarkably, in rats fed yogurt the infection had no significant effect on this parameter. 
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ABSTRACT 
Dietary calcium decreases the cytotoxicity of intestinal contents and intestinal 
epitheliolysis by precipitating cytotoxic surfactants, like bile acids. A decreased luminal 
cytotoxicity might not only strengthen the barrier function of the gut mucosa, but also 
reinforce the protective, endogenous microflora. We hypothesized, therefore, that dietary 
calcium increases the resistance to intestinal infections. Rats on a low-, medium- or high-
calcium purified diet were orally infected with a single dose of Salmonella enteritidis. The 
kinetics of fecal salmonella excretion was studied to determine the colonization resistance. 
Intestinal bacterial translocation was quantitated by measuring urinary NOx excretion and 
culturing bacteria from tissues. Compared with the low-calcium group, the medium- and 
high-calcium fed rats had a substantially improved colonization resistance. Calcium 
supplementation also reduced translocation of salmonella, considering the diminished urinary 
NOx excretion and viable salmonella counts in the ileal Peyer's patches and spleen. Dietary 
calcium decreased the bile acid concentration and cytotoxicity of fecal water. Several 
indicators of fecal bacterial mass were significantly increased by supplemental calcium. In 
conclusion, dietary calcium improves the colonization resistance and reduces the severity of 
gut-derived systemic infections, which is probably attributable to its luminal cytoprotective 
effects. 
INTRODUCTION 
Gastrointestinal bacterial infections are still a formidable health problem, mostly 
because of the increase in antibiotic resistance [1]. Of particular concern is the increased 
incidence of systemic infections [1]. Gut-derived septicemia occurs regularly in people 
receiving immunosuppressive drugs, patients suffering from inflammatory bowel diseases and 
patients in intensive care units on (par)enteral nutrition regimen [2, 3]. Non-typhoidal 
salmonellosis is one of the most common, foodborne, bacterial infections in the USA and 
Europe [4]. Most patients experience a self-limiting gastroenteritis, but 2-5% develop 
bacteremia and sepsis-associated complications [5]. Antibiotic treatment of gastroenteritis 
caused by salmonella species has been discouraging, because it does not reduce the duration 
or severity of illness and may prolong asymptomatic carriage [6]. Combined with the growing 
resistance of salmonella species to clinically important antibiotics [1], the prevention of 
salmonellosis becomes more important. 
Many studies in the field of colon carcinogenesis have shown that supplemental 
dietary calcium precipitates intestinal cytotoxic surfactants and thus inhibits epithelial cell 
damage and epithelial proliferation, which may decrease the risk of colon cancer [7, 8]. It can 
be speculated that these cytoprotective effects of dietary calcium on the intestinal epithelium 
are not only relevant to colon carcinogenesis, but also have major implications for the 
resistance to intestinal infections. Diminishing epitheliolysis, by decreasing the cytotoxicity of 
gut contents, might strengthen the mucosal integrity. Conversely, increased epithelial cell 
damage provoked by administration of lectins [9], chemical inflammatory irritants [10] or 
ischemia/reperfusion[ll] leads to disruption of the physical barrier function of the intestinal 
mucosa and translocation of potential pathogens to extra-intestinal organs. The calcium-
dependent reduction in cytotoxicity of intestinal contents may not only protect the enterocytes, 
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but also favor growth of the endogenous microflora, thereby improving their antagonistic 
action towards (potential) pathogens. Recently, we showed that rats on a low-calcium milk 
diet had a significantly impaired colonization resistance to S. enteritidis compared with rats on 
high-calcium diets containing regular milk, acidified milk or yogurt [12]. 
In view of the above-mentioned protection of the intestinal epithelium by calcium-
dependent precipitation of cytotoxic bile acids and the possible beneficial effects of calcium on 
the intestinal microflora, we performed strictly controlled infection experiments. After 
adaptation to purified diets differing only in calcium content, the resistance of rats to S. 
enteritidis was studied. The main purpose of the present experiments was to test the 
hypothesis that dietary calcium increases the colonization resistance to S. enteritidis and 
reduces translocation of this invasive pathogen to the systemic circulation. 
MATERIALS AND METHODS 
Animals, diets and infection 
The experimental protocol was approved by the animal welfare officer of the 
Agricultural University, Wageningen, The Netherlands. Specific pathogen-free male Wistar 
rats (WU, Harlan, Zeist, The Netherlands), 9 weeks old and with a mean body weight of 
about 290 g, were housed individually in metabolic cages in a room with controlled 
temperature (22-24 °C), relative humidity (50-60%) and light/dark cycle (lights on from 6 
AM to 6 PM). During the experimental period of almost 4 weeks, 3 groups of 8 rats each 
were fed a purified diet that differed only in CaHPQ, content. The basal diet contained (per 
kg) 200 g acid casein, 505 g dextrose, 100 g palm oil, 100 g corn oil, 50 g cellulose and 35 g 
mineral mix (without calcium) and 10 g vitamin mix as previously described [13]. Varying 
amounts of CaHP04.2H20 (20, 60 and 180 mmol/kg; Merck, Darmstadt, Germany) were 
added to the basal diet in exchange for dextrose. After preparation, samples of the diets were 
dry ashed for mineral analyses. Calcium was measured using an atomic aborption 
spectrophotometer (Model 1100, Perkin Elmer Corp., Norwalk, CT, USA). The phosphate 
content of the diets was determined spectrophotometrically according to the method of Fiske 
and Subbarow [14]. The diets were administered to the animals as a porridge (demineralized 
water was added and mixed with the dry diets to obtain a dry weight of 68%). Food and 
demineralized drinking water were supplied ad libitum. Food intake was recorded every day 
and body weight every 3 days. 
Animals were acclimatized to the housing and dietary conditions for 11 days, after 
which they were orally infected with S. enteritidis (clinical isolate, phage type 1). In the 
morning, all rats were infected orally by gastric gavage with 0.5 mL of saline containing 3% 
(wt/vol) sodium bicarbonate with 5.108 viable S. enteritidis. The exact viable count of 5. 
enteritidis in the inoculum was determined by plating on Brilliant Green Agar (Oxoid, 
Basingstoke, England). Before, and on days 1, 3, 6 and 9 after salmonella infection, fresh 
fecal samples were collected directly from the anus of the animals by gently massaging the 
abdomen. The number of salmonella in feces was quantified by plating on Modified Brilliant 
Green Agar (Oxoid), with a bacteriological technique as described elsewhere [15]. 
Sulfamandelate (Oxoid) was added to the agar plates to suppress swarming bacteria, like 
proteus. The detection limit of the method used to quantify salmonella in feces was lCr 
colony-forming units/g feces. Feces were also collected 3 days before salmonella infection 
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and on days 3,4 and 5 after infection for biochemical analyses. Complete 24 h urine samples 
were collected for 2 successive weeks, starting 1 day before infection. 
In a second infection study with rats, the effects of the low- and high-calcium diet on 
the initial translocation of S. enteritidis to the ileal Peyer's patches, mesenteric lymph nodes 
(MLN), and spleen were quantified by microbiological plating techniques at day 2 after oral 
infection. In addition, weight and sterility of these organs were also determined in non-
infected animals consuming these diets. Characteristics of the rats, housing conditions, 
composition of the diets, and the administration and dose of salmonella were as described 
above. At the section day, the rats were killed by carbon dioxide inhalation. First, the spleen 
and all MLN were excised aseptically, weighed, homogenized (Ultraturrax Pro200, Pro 
Scientific Inc. Monroe, CT, USA) in sterile saline, 10-fold diluted and plated on Brilliant 
Green Agar (Oxoid) as previously described [16]. Second, the ileum (defined as the last 12 
cm of the small intestine proximal to the cecum) was pulled out and freed of contents by 
flushing with 5 mL of sterile saline. Thereafter, all Peyer's patches of this intestinal segment 
were excised, weighed, homogenized (Ultraturrax Pro200) in sterile saline, serially diluted 
and plated on Modified Brilliant Green Agar (Oxoid) containing sulfamandelate (Oxoid). 
Viable salmonella counts were expressed as the total log10 colony-forming units in each organ. 
In a third experiment, the effect of dietary calcium on the capacity of macrophages and 
other phagocytic cells to produce oxidation products of nitric oxide (NOJ on stimulation was 
evaluated. Two groups of 6 rats each were intraperitoneally injected with S. enteritidis 
lipopolysaccharides (lyophilized phenol extract, 1 mg/kg dissolved in 1 mL sterile saline; 
Sigma Chemical Co., St. Louis, MO, USA) after adaptation to either the low- or high-
calcium diet (characteristics of the rats, housing conditions and the composition of the diets as 
described above). Urinary NOx excretion was determined in 24 h urine samples collected on 
successive days before and after the injection of lipopolysaccharides. 
Total feces analyses 
Feces were freeze dried for dry weight determination. For total nitrogen 
determination, feces were digested with a mixture of sulfuric acid, hydrogen peroxide, 
potassium sulfate and mercuric oxide, followed by colorimetric determination of the ammonia 
formed [17]. After acidification of freeze dried feces (1:50 wt/vol, final concentration 1 M 
HC1), phospholipids were extracted from feces according to the procedure described by Bligh 
and Dyer [18]. Briefly, a miscible system is obtained by adding a freshly prepared mixture of 
chloroform/methanol (1:2 vol/vol) to acidified feces (3.75:1 vol/vol). After mixing, the 
suspension was centrifuged for 5 minutes at 2,500 g (Heraeus, Sepatech GmbH, Osterode, 
Germany) to precipitate nonsoluble material. Chloroform and double-distilled water were 
added to the clear supernatant to obtain a final chloroform/methanol/watermixture of 10:10:9 
vol/vol/vol. Samples were again thorougly mixed and subsequently centrifuged for 5 minutes 
at 2,500 g (Heraeus, Sepatech GmbH, Osterode, Germany). The chloroform layer was 
carefully removed. After evaporation of chloroform, the residue was destructed (15 minutes 
at 180 °C) with a perchloric acid (70%)/hydrogen peroxide (30%) mixture (5:1 vol/vol, total 
volume 120 uL). Liberated phosphate was determined with a sensitive, colorimetric assay 
[19]. Using this procedure, recoveries of phosphatidylcholine and lysophosphatidylcholine 
(egg yolk) were always >85%. After dry ashing and destruction (15 minutes at 180°C) with 
a perchloric acid (70%)/hydrogenperoxide (30%) mixture (3:1 vol/vol, total volume 600 uL) 
of freeze dried feces, iron was measured using an atomic absorption spectrophotometer 
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(Model 1100, Perkin Elmer). In the same dry ashed and destructed samples, calcium and total 
phosphate were measured as described for the diets. Inorganic phosphate was extracted from 
freeze-dried feces with 5% (wt/vol) trichloroacetic acid and measured as described above. 
The amount of organic phosphate in feces was calculated by subtracting the inorganic 
phosphate concentration from the total phosphate concentration. 
Fecal water analyses 
Fecal water was prepared by reconstituting freeze dried samples with demineralized 
water to 30% dry weight, which reflects the dry weight percentage of colonic contents [20]. 
After homogenizing, the samples were incubated for 1 h at 37 °C in a shaking waterbath, 
followed by centrifugationfor 20 minutes at 12,000 g (Hettich, Micro-rapid 1306, Tuttlingen, 
Germany). The aspirated supernatant was centrifuged for 2 minutes at 14,000 g (Eppendorf 
5415). After determination of the pH of the supernatants at 37 °C, fecal water was stored at -
20 °C until further use. Cytotoxicity of fecal water was determined using a human erythrocyte 
suspension as described previously [12]. Briefly, fecal water was added to washed human 
erythrocytes (final hematocrit 5%) and incubated for 2 h at 37 °C. Remaining intact 
erythrocytes were pelleted by centrifugation(l minute at 1,500 g; Eppendorf 5415), washed, 
acidified with trichloroacetic acid (final 5 % wt/vol) and subsequently centrifuged (1 minute at 
10,000 g). Their potassium content was measured in the supernatant by atomic emission 
spectrophotometry (Perkin Elmer 1100). Simultaneously, erythrocytes were incubated in 
saline (0% potassium release) and in double-distilled water (100% potassium release). The 
cytotoxicity of fecal water was calculated and expressed as a percentage of maximal lysis. 
Bile acids in fecal water were determined using a fluorimetric enzymatic assay [21]. Iron was 
measured in demineralized water-diluted fecal water as described for total feces. 
Analysis of NOx in urine 
The NOx (nitrite and nitrate) concentration in urine was determined by automated flow 
injection analysis. Briefly, diluted urine is passed over a cadmium column that reduces nitrate 
to nitrite, followed by reaction of nitrite with Griess reagent [22]. The colored product was 
measured spectrophotometrically at 538 nra. Recovery of nitrate or nitrite added to rat urines 
always exceeded 96%. Urinary NOx concentration was multiplied by the urine volume 
produced in 24 h to obtain total urinary NOx excretion per day. 
Statistics 
Results are presented as means ± SE (n=6 or 8). Differences between the means of 
the pre-infection period and the post-infection period in the first study were tested by 
Student's t test for paired samples (two-sided). Within one period, differences between the 
three calcium groups were tested by analysis of variance, followed by Fisher's least 
significant difference test (one-sided). Differences between the low- and high-calcium groups 
in the other two experiments were tested by Student's t test (one-sided). Differences were 
regarded as significant if P<0.05. A commercial package was used for all statistics 
(SPSS/PC + v2.0, SPSS Inc. Chicago, USA). 
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RESULTS 
Animals, food intake, and fecal output 
At the start of the experiment, mean body weight of the animals was 293 g. Food 
intake (mean 16 g dry wt/d) and body weight gain (mean 3 g/d) were not significantly 
affected by the different diets or the infection. Dietary calcium increased wet and dry daily 
fecal output in a dose-dependent manner (Table 1; P<0.05). After the infection there were no 
obvious signs of diarrhea. The daily output of wet and dry feces did not change significantly. 
Considering the unchanged food intake and body weight gain and absence of diarrhea, one 
may say that a relatively mild infection was inflicted on the animals. 
Effect of dietary calcium on fecal excretion and intestinal translocation of salmonella 
The first day after salmonella infection, rats fed the high-calcium diet had a 
significantly lower salmonella excretion in feces than rats fed the low- or medium-calcium 
diets (Figure 1; P<0.05). Already on day 3 after infection, the population levels of 
salmonella in feces had already decreased markedly in rats fed the medium- or high-calcium 
diets. In contrast, rats fed the low-calcium diet had a much lower colonization resistance: they 
continued to excrete high numbers of salmonella until day 6 after infection. 
The impaired colonization resistance of rats fed the low-calcium diet coincided with a 
progressive increase in urinary NOx excretion, reaching its maximum at day 6 after infection 
(Figure 2; P<0.05). However, rats fed the medium- and high-calcium diets had a 
significantly smaller infection-induced increase in urinary NOx excretion. The medium- and 
high-calcium groups showed similar kinetics of urinary NOx excretion. The inhibiting effect 
of dietary calcium on salmonella translocation as quantified by the reduced NOx output in 
urine, was supported by the results of the tissue cultures in the second infection experiment. 
Table 1 Effect of dietary calcium on fecal output, mineral, organic phosphate, phospholipid, 
and nitrogen excretion in feces before infection of the rats. 
Fecal excretion low-calcium medium-calcium high-calcium 
Wet weight (g/d) 1.58 + 0.12a 1.92 + 0.07" 2.82 + 0.1T 
Dry weight (g/d) 0.99 ± 0.06a 1.20 ± 0.04" 1.74 + 0.07c 
Ca 0tmol/d) 88 ± 8a 493 + 18b 2442 + 89c 
Pi (/miol/d) 55 ± 4a 186 ± 10" 1256 + 55c 
Fe (itmol/d) 5.63 ± 0.35a 6.43 ± 0.22" 9.04 ± 0.63c 
P„ 0*mol/d) 37 ± 7a 58 + 6b 247 ± 59c 
PL (/xmol/d) 3.48 + 0.24a 4.18 ± 0.19" 6.59 + 0.40c 
N (mmol/d) 1.08 ±0.11" 1.26 ± 0.10" 2.03 ± 0.04" 
Results are expressed as means ± SE (n=8). Values in the same row not sharing the same superscript 
are significantly different (P<0.05). Abbreviations: Ca calcium, P> inorganic phosphate, Fe iron, P0 
organic phosphate, PL phospholipids, and N nitrogen. 
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Compared with the low-calcium group, the high-calcium group had significantly lower viable 
salmonella counts in the ileal Peyer's patches and spleen (Table 2). Equally important, only 4 
of 8 animals fed the high-calcium diet had viable salmonella in their spleen, whereas the 
spleen of all animals fed the low-calcium diet was infected (P < 0.05). The mean viable counts 
in spleen of the high-calcium group was calculated using the detection limit (150 colony-
forming units) for the four negative samples. The infection-induced increase in weight of the 
MLN was significantly less in the high-calcium group than in the low-calcium group. The 
high-calcium group also tended to have lower viable salmonella counts in the MLN, although 
this did not reach significance (Table 2). 
Dietary calcium did not affect the capacity of the inducible NOx-generating system to 
respond to bacterial stimuli. No significant difference in urinary NOx exretion could be 
observed when rats were intraperitoneally injected with 5. enteritidis lipopolysaccharides 
(Figure 3). 
Effect of dietary calcium on mineral, organic phosphate, phospholipid and nitrogen 
excretion in feces 
As expected, fecal calcium excretion increased with dietary calcium intake (Table 1, 
P<0.05).Calcium supplementation also increased fecal iron excretion (Table 1, P<0.05). 
This resulted in a significantly decreased apparent iron absorption in the high-calcium group 
O) 
LL 
O 
o 
c 
o 
E 
to 
00 
"cc 
o 
a> 
Day 
Figure 1 Effect of a low- ( • 20 mmol/kg), medium- ( • 60 mmol/kg), and high-calcium ( • 
180 mmol/kg) diet on fecal salmonella excretion in rats orally infected with 5.108 
viable 5. enteritidis on day 0. Results are expressed as means + SE (n=8). The 
asterisk denotes that the indicated group is significantly different from the other two 
groups (P<0.05). SEs are either smaller than symbols or indicated by bars. 
Abbreviation: CFU colony-forming units. 
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Figure 2 Effect of a low- ( • 20 mmol/kg), medium- (T 60 mmol/kg), and high-calcium ( • 
180 mmol/kg) diet on daily urinary NOx excretion of rats before and after on oral 
challenge with 5.108 S. enteritidis on day 0. Results are expressed as means + SE 
(n=8). The asterisk denotes that NO, excretion of the low-calcium group is 
significantly different from the other two groups (P< 0.05). 
(P<0.05), calculated by subtracting fecal iron excretion from dietary iron intake. Mean 
apparent iron absorption of the low-calcium, medium-calcium and high-calcium groups was 
3.45 + 0.23, 3.21 + 0.23, and 1.81 + O.53umol/d, respectively. Fecal inorganic phosphate 
excretion increased with dietary calcium supplementation, because of the formation of 
insoluble calcium phosphate (Table 1, P < 0.05). Dietary calcium also stimulated the excretion 
of organic phosphate, phospholipids and nitrogen in feces (Table 1, P <0.05). 
Effect of dietary calcium on the composition and cytotoxicity of fecal water 
Dietary calcium increased the pH of fecal water in a dose-dependent manner: the pH 
before infection was 6.7, 6.8, and 7.0 for the low-, medium-, and high-calcium group, 
respectively (P<0.05). After infection, the pH of fecal water of the low-calcium group was 
significantly increased to 7.3 (P<0.05), whereas no significant infection-induced change in 
pH was found in the other two groups. An inverse dose-dependent relationship existed 
between dietary calcium and the concentration of bile acids in fecal water (Figure 4A). The 
infection had no significant effect on this parameter. The fatty acid concentration in fecal 
water (mean 1.55 mM) was not affected by dietary calcium or the infection (data not shown). 
Calcium supplementation decreased the solubility of iron in feces. Animals fed the low-
calcium diet had a significantly higher iron concentration in fecal water than their medium-
and high-calcium-fed counterparts (Figure 4B, P<0.05). With the exception of the high-
calcium group, a small but significant increase of the iron concentration was observed after 
infection. The cytotoxicity assay showed that the cytotoxic activity of fecal water was dose-
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Table 2 Effect of dietary calcium and oral 5. enteritidis infection on weight and viable 
salmonella counts of the ileal Peyer's Patches, MLN, and spleen of rats. 
Organ 
Peyer's patches 
Weight (mg) 
Salmonella (log,0) 
MLN 
Weight (mg) 
Salmonella (log
 ]0) 
Spleen 
Weight (mg) 
Salmonella (log
 10) 
Non-infected 
Low-calcium 
38 ± 3a 
n.d. 
110 ± 10a 
n.d. 
640 + 40a 
n.d. 
High-calcium 
44 ± 5a 
n.d. 
110 ± 10a 
n.d. 
620 ± 40* 
n.d. 
2 Days after infection 
Low-calcium 
70 ± 9 " 
4.93 ± 0.09a 
160 ± 10b 
4.49 ± 0.08a 
670 ± 20a 
2.72 ± 0.10a 
High-calcium 
59 + 7" 
4.31 ± 0.32" 
120 ± 10" 
4.24 ± 0.26a 
680 ± 20a 
2.38 ±0.11" 
Results are expressed as means + SE (n=8). Values in the same row not sharing the same superscript 
are significantly different (P < 0.05). Abbreviation: n.d. not detected. 
dependently decreased by dietary calcium (Figure 5). Erythrocytes incubated with 80 uL of 
fecal water of the low-calcium group were lysed completely. Therefore, we also tested 40 uL 
of fecal water of this group, to reveal a possible difference in lytic activity between the pre-
and post-infection period. However, no significant infection-induced difference could be 
detected in any group. 
DISCUSSION 
The present study clearly demonstrates that dietary calcium is very effective in 
reducing the severity of a salmonella infection. An important parameter in studies of the 
resistance to gastrointestinal infections is the colonization resistance [23]. The results of the 
fecal excretion of salmonella show that the colonization resistance to this pathogen was 
markedly impaired when the animals were fed the low-calcium diet (Figure 1). In contrast, 
rats fed the medium- and high-calcium diets had a significantly better colonization resistance 
as indicated by a rapid decline in fecal salmonella excretion. From these results it can be 
stated that dietary calcium inhibits colonization and thus shortens fecal shedding of the 
pathogen, which is supported by our study using various whole-milk products [12]. Probably 
even more important than reducing the duration of carriage are the significant inhibitory 
effects of calcium supplementation on the translocation of salmonella across the gut wall, as 
measured by the lower urinary NOx excretion (Figure 2) and by the reduction in viable 
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Figure 3 Effect of a low- ( • 20 mmol/kg) and high-calcium ( • 180 mmol/kg) diet on urinary 
NOx excretion of rats before and after an intraperitoneal injection with S. enteritidis 
lipopolysaccharides(l mg/kg) on day 0. Results are expressed as means ± SE (n=6). 
SEs are either smaller than symbols or indicated by bars. 
salmonella counts in the ileal Peyer's patches and spleen (Table 2). The infection-induced 
increase in MLN weight was also significanlty less in the calcium-supplemented group and 
viable salmonella counts tended to be lower. We have shown previously that, in contrast to 
classical tissue culture techniques, urinary excretion of NOx is a more sensitive and 
quantitative biomarker for the severity of systemic infections [16]. Another advantage is that 
this method makes it possible to follow non-invasively the time course of the infection. 
Gianotti et al. [24] showed that organ cultures notably underestimate total bacterial 
translocation, mostly because this method only counts the still viable bacteria but not the 
bacteria already killed after invasion. In their experiments less than 0.01% of the total 
bacteria translocated to the mesenteric lymph nodes was still viable. In agreement, the results 
of our earlier study showed that large differences in oral salmonella dose (100-fold) do not 
give distinct counts of viable salmonella in the MLN, whereas highly significant differences in 
urinary NOx excretion were observed [16]. However, despite the limitations of tissue cultures, 
in the present study the results obtained with this classical technique merely agree with the 
results obtained with our new NOx method to quantitate the total bacterial translocation. 
Translocation of salmonella species from the gut lumen to the systemic circulation starts by 
penetration of the ileal Peyer's patches [25]. The subsequent infection of the mesenteric 
lymph nodes, liver and spleen takes about 2 days [26], which remarkably correlates with the 
onset of the rise in daily NOx excretion. The reduced urinary NOx output in the calcium-
supplemented groups is due to an inhibitory effect of calcium on intestinal translocation 
processes because dietary calcium did not affect urinary NOx excretion after intraperitoneal 
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Figure 4 Effect of dietary calcium on the concentration of (A) bile acids and (B) iron in fecal 
water before (filled bars) and after (striped bars) oral infection with 5.108 S. 
enteritidis. Results are expressed as means ± SE (n=8). Bars not sharing the same 
letter are significantly different (P<0.05). 
injection of rats with lipopolysaccharides of S. enteritidis (Figure 3). As discussed earlier 
[16], the kinetics of urinary NOx excretion after injection of lipopolysaccharides (Figure 3) is 
much faster than that observed after an oral infection (Figure 2). 
For now, we can only speculate about the mechanism by which calcium exerts its 
protective effect against gastrointestinal infections. Dietary calcium induces gastric acid 
secretion, by stimulating gastrin release [27]. This might explain the significantly reduced 
fecal salmonella excretion of rats fed the high-calcium diet the first day after oral infection 
(Figure 2). In the intestine, dietary calcium exerts cytoprotective effects on epithelial cells. 
Earlier studies showed that in the upper small intestine calcium forms an insoluble complex 
with phosphate [20, 28]. Cytotoxic components in the intestinal lumen, such as bile acids and 
fatty acids, are strongly precipitated by amorphous calcium phosphate, thereby decreasing the 
cell-damaging potential and reducing epitheliolysis [29, 30]. Comparable results were 
obtained in the present study. Calcium decreased the cytotoxicity of fecal water (Figure 5), 
probably by reducing the bile acid concentration in fecal water (Figure 4A). By lowering the 
cytotoxicity of intestinal contents and reducing epithelial cell damage, the mucosal integrity 
and resistance to infection might have been enhanced by supplemental calcium. 
The protective effects of calcium are probably not limited to the intestinal mucosa, but 
also have major consequences for the intestinal microflora. In that context, it is remarkable 
that dietary calcium phosphate stimulated the fecal excretion of organic phosphate, 
phospholipids, and nitrogen (Table 1). A similar effect of dietary calcium on the fecal output 
of organic phosphate has also been observed in humans [28]. Fecal nitrogen excretion is 
regarded as a marker of bacterial mass, despite the presence of endogenous and non-absorbed 
dietary nitrogen. Gestel et al. [31] showed that both fecal nitrogen and fecal output of 
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Figure 5 Effect of a low- (20 mmol/kg), medium- (60 mmol/kg), and high-calcium (180 
mmol/kg) diet on the cytotoxicity of fecal water before (filled bars) and after (striped 
bars) oral infection with 5.10s S. enteritidis. For all groups, 80 juL of fecal water was 
used in the hemolysis assay. To detect a possible difference in cytotoxicity between 
the pre-infection and post-infection periods in the low-calcium group, 40 /xL of fecal 
water was also used in the assay for this group. Results are expressed as means + SE 
(n=8). Bars not sharing the same letter are significantly different (P<0.05). 
diaminopimelic acid, another indicator of bacterial mass, increased when rats were fed diets 
containing fermentable fiber. In the present study fecal phospholipid and nitrogen excretion 
were highly correlated (r=0.83, p<0.05). Although these parameters also significantly 
correlated with fecal organic phosphate excretion, the calcium-induced increase in organic 
phosphate output notably exceeded the calcium-stimulated fecal excretion of phospholipids 
and nitrogen (Table 1). Many bacteria can accumulate excess phosphate in the form of 
polyphosphate granules, which are not hydrolyzed by 5% trichloroacetic acid treatment [32]. 
Thus, the more than proportional increase in organic phosphate probably reflects bacterial 
synthesis of polyphosphate. Taken together, these effects on fecal excretion of organic 
phosphate, phospholipids and nitrogen indicate that dietary calcium phosphate increases the 
fecal excretion of bacteria. Stimulation of bacterial growth may be of relevance because the 
endogenous intestinal microflora is an extremely important determinant of host defense 
mechanism [23, 33]. For instance, selective elimination of (facultative) anaerobic bacterial 
groups by treatment with antibiotics markedly impairs the colonization resistance and enables 
intestinal potential pathogens to reach extra-intestinal organs [34, 35]. An optimal resident 
flora adequately prevents pathogens colonizing by producing antimicrobial substances, like 
short-chain fatty acids, and by competing for nutrients and adhesion sites on the intestinal 
epithelium [33]. So, it is conceivable that an increase in the number of gut bacteria results in 
an enhanced resistance to salmonella. As mentioned above, the reduced cytotoxicity of 
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intestinal contents in the medium- and high-calcium supplemented groups (Figure 5) might not 
only protect the enterocytes, but also surround the endogenous flora with a less agressive 
environment. The proposed trophic effect of dietary calcium phosphate on the endogenous 
microflora and its relevance for the resistance to salmonella will be investigated in future 
experiments. 
From in-vitro studies it is known that divalent cations, like calcium and magnesium, 
play a regulatory role in the expression of virulence genes of salmonella [36]. For instance, 
low concentrations of extracellular calcium induces salmonella to express the pag genes, 
which may increase its survival in the phagosomes of macrophages, as calcium is < 50 ^ M in 
this intracellular compartment. Vescovi et al. [36] also showed that these virulence genes are 
repressed when salmonella is present in extracellular fluids (i.e. at calcium levels of > 1 
mM). In fact, several studies have shown that the concentration of calcium in the intestinal 
lumen is even substantially higher [20, 29, 37] and supplemental dietary calcium does not 
influence the systemic calcium concentration [38]. Therefore, the observed impaired 
resistance of rats on a low-calcium diet cannot be attributed to an increased expression of 
virulence genes of salmonella. Furthermore, we have shown earlier that growth of the 
salmonella strain used in the present infection studies did not depend on the environmental 
calcium concentration [12]. 
Soluble iron is an essential nutrient for growth of most bacteria, except some 
lactobacilli [39]. Considering that about 1 uM of available iron is already adequate to 
maintain maximal bacterial growth [39], it seems unlikely that the calcium-induced reduction 
in luminal iron solubility (Figure 4B) improved the resistance to infection by inhibiting 
pathogen growth in the intestine. On the other hand, in situations of systemic iron overload 
the susceptibility for infections, including salmonellose, is increased [40, 41]. Furthermore, 
iron is a catalyst in the generation of reactive oxygen species and plays a critical role in 
inflammatory processes, for instance induced by bacterial infections [42]. For these reasons, 
coprecipitation of iron by calcium phosphate in the intestinal lumen can be helpful to 
minimize epithelial cell damage and to maximize the resistance against pathogens. 
In conclusion, in strictly controlled studies with rats we have shown for the first time 
that dietary calcium not only greatly improves the colonization resistance to S. enteritidis, but 
also reduces translocation of this pathogen across the intestine to the systemic circulation. 
Lowering the cytotoxicity of intestinal contents, thereby reducing the damage inflicted to 
epithelial cells as well as to the resident microflora, and/or precipitating iron might be 
important mechanisms by which calcium exerts its protective effect. An adequate supply of 
dietary calcium seems to be effective in reducing the severity of gastrointestinal infections. 
Especially for immunocompromised patients and patients in intensive care units receiving 
elemental liquid diets, who are particularly vulnerable to contract gut-derived bacterial 
infections [43], this may be of significant importance. 
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ABSTRACT 
Lactulose fermentation by the intestinal microflora acidifies the gut contents, resulting 
in an increased colonization resistance to acid-sensitive pathogens. The extent of fermentation 
should be controlled to prevent acid-induced epithelial cell damage. Considering the buffering 
capacity of calcium phosphate and its intestinal cytoprotective effects, we studied whether 
supplemental calcium phosphate adds to the increased resistance to intestinal infections by 
lactulose fermentation. In a strictly controlled experiment, rats were fed a purified low-
calcium control diet, a low-calcium/lactulose diet or a high-calcium/lactulose diet, and 
subsequently infected orally with Salmonella enteritidis. Lactulose fermentation lowered the 
pH and increased the lactic acid concentration of the intestinal contents, which significantly 
reduced excretion of this pathogen in feces; thus it improved the colonization resistance. This 
agreed with the high sensitivity of S. enteritidis to lactic acid (main metabolite of lactulose 
fermentation) in-vitro. Calcium phosphate decreased translocation of salmonella to the 
systemic circulation, an effect independent of lactulose. The unfavorable increased 
cytotoxicity of fecal water caused by lactulose fermentation was more than counteracted by 
supplemental calcium phosphate. Moreover, calcium phosphate stimulated lactulose 
fermentation, as judged by the reduced lactulose excretion in feces and increased lactic acid, 
ammonia, and fecal nitrogen excretion. In conclusion, extra calcium phosphate added to a 
lactulose diet improves the resistance to colonization and translocation of salmonella. This is 
probably mediated by a calcium-induced stimulation of lactulose fermentation by the intestinal 
microflora and reversion of the lactulose-mediated increased luminal cytotoxicity, which 
reduces damage inflicted on the intestinal mucosa. 
INTRODUCTION 
The disaccharide lactulose (4-O-B-D-galactopyranosyl-a-D-fructofuranose) is a drug 
mainly used as a laxative and as treatment for portosystemic encephalopathy [1]. Following 
oral administration, lactulose reaches the lower gut unaltered because it is neither absorbed 
nor hydrolyzed by host digestive enzymes. Although its action is not fully understood, it is 
supposed to depend on extensive fermentation by the intestinal microflora, resulting in 
enhanced bacterial growth, acidification of the gut contents because of the production of lactic 
acid and short-chain fatty acids, trapping of ammonia, and stimulation of ammonia 
incorporation into bacterial protein [2]. Many Gram-negative bacteria like bacteroides, 
Escherichia coli, salmonella and proteus seem to be incapable of degrading lactulose, in 
contrast with many Gram-positive intestinal bacteria, such as lactobacilli and streptococci [3]. 
Lactulose therapy has also been used successfully in the management of foodborne intestinal 
infections and inflammatory bowel diseases [4-6]. Although they are probably one of the 
prerequisites for the above-mentioned beneficial effects of lactulose, the acidic metabolites 
generated during strong fermentation have to be at least partially neutralized, to prevent 
damage to the intestinal mucosa. High concentrations of short-chain fatty acids (for instance 
acetic acid) may induce injury to the colon which is characterized by degeneration and 
extrusion of enterocytes, increased permeability and epithelial cell proliferation [7-9]. 
Therefore, the extent of intestinal fermentation should certainly be controlled. That aim might 
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be achieved by calcium phosphate supplementation. Dietary calcium phosphate increases the 
buffering capacity, diminishes the cytotoxic activity of the gut contents and decreases 
epithelial cell proliferation [10-12]. In addition, we previously showed that dietary calcium 
strongly improves the colonization resistance to salmonella infection [11]. 
The main purpose of the present study was to test the hypothesis that supplemental 
calcium phosphate adds to the potential beneficial effect of lactulose fermentation on intestinal 
infections. Therefore, we first performed an in-vitro study to compare the bactericidal activity 
of lactic acid for S. enteritidis and Lactobacillus acidophilus. In addition, the resistance to 
colonization and translocation of S. enteritidis was studied in a strictly controlled experiment 
with rats on a purified low-calcium control diet, low-calcium/lactulose diet or high-
calcium/lactulose diet. S. enteritidis was chosen as model pathogen because it is an 
increasingly important food-pathogen [13] and the course and pathology of a salmonella 
infection resembles that of other common human pathogens, like Campylobacter, Listeria 
monocytogenes and some pathogenic Escherichia coli species [14]. 
MATERIALS AND METHODS 
Bactericidal activity of lactic acid in-vitro 
The bactericidal effect of lactic acid on S. enteritidis (clinical isolate, phage type 1) 
and L. acidophilus (NIZO B224, collection of our institute) were compared in an in-vitro 
experiment. S. enteritidis was cultured and stored as described earlier [15]. L. acidophilus 
was routinely stored at -80 °C in sterile skim milk containing 0.5% (wt/vol) yeast extract and 
20% (vol/vol) glycerol. A few days before use, a vial containing the lactobacillus strain was 
quickly thawed, plated on agar plates according to De Man, Rogosa and Sharpe (MRS; 
Merck, Darmstadt, Germany) and incubated overnight at 37 °C in an anaerobic jar 
(Anoxomat, Mart bv Microbiology Automation, Lichtenvoorde, The Netherlands). 
Precultures of 5. enteritidis and L. acidophilus were prepared by inoculating a few colonies 
from appropriate agar plates in Brain Heart Infusion broth (BHI; Difco, Detroit, MI, USA) 
and MRS broth (Merck) respectively, followed by overnight aerobic incubation at 37 *C. The 
next day, bacteria were collected by centrifugation(15 minutes at 5,000 g), washed once and 
resuspended in sterile saline to prepare stock suspensions. The bactericidal activity of 
increasing concentrations of L(+)-lactic acid (Acros Organics, Geel, Belgium) in a citric acid 
buffer (50 mM, pH 5.0, ionic strength set at 154 mM with sodium chloride, BDH Chemicals 
Ltd, Poole, England), was tested by inoculating the sterile test medium with the stock 
suspensions (final 2%), followed by a 2 hours aerobic incubation at 37 °C. Thereafter, several 
dilutions of the incubates in phosphate-buffered saline were plated on Brilliant Green Agar 
(BGA; Oxoid, Basingstoke, England) and MRS agar (Merck) to determine the viable counts 
of 5. enteritidis and L. acidophilus, respectively. BGA plates were incubated aerobically for 
one day and MRS plates were incubated anaerobically for 2 days at 37 °C. The whole 
experiment was performed in triplicate. 
Animals, diets, and infection 
The experimental protocol was approved by the animal welfare officer of the 
Agricultural University, Wageningen, The Netherlands. Specific pathogen-free male Wistar 
rats (WU, Harlan, Winkelmann GmbH, Borchen, Germany), 8 weeks old and with a mean 
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body weight of about 225 g, were housed individually (n=8 per diet) in metabolic cages in a 
room with controlled temperature (22-24 °C), relative humidity (50-60%) and light/dark cycle 
(light, 6.00-18.00 h). During the experimental period of almost 3 weeks, the animals were fed 
purified diets. The first group (LCa) received a low-calcium control diet (calcium 20 
mmol/kg) consisting of: 200 g acid casein, 502 g dextrose, 100 g palm oil, 100 g corn oil, 50 
g cellulose, 35 g mineral mix and 10 g vitamin mix as described elsewhere [16], and 3,44 g 
CaHP04.2H20 (Merck). The second group (LCa/LACT) consumed a low-calcium diet 
(calcium 20 mmol/kg) supplemented with 10% (wt/wt) lactulose (purity 99%; Solvay Duphar, 
Weesp, The Netherlands). The third group (HCa/LACT) received a high-calcium diet 
(calcium 180 mmol/kg), also supplemented with 10% (wt/wt) lactulose. Lactulose and extra 
calcium phosphate were added at the expense of dextrose. After preparation, samples of the 
diets were dry ashed for mineral analyses. Calcium and iron were measured using an atomic 
absorption spectrophotometer (Model 1100, Perkin Elmer Corp, Norwalk, USA). Phosphate 
was determined spectrophotometrically [17]. The diets were supplied to the animals as a 
porridge (double-distilled water was mixed with the dry diets to obtain 68% dry weight). The 
rats had free access to food and demineralized drinking water. Food intake was recorded 
every 3 days and body weight every 4 days. 
Before infection, non-fasted blood samples were collected by orbital-punction (after 
diethyl ether anesthesia). Plasma samples were prepared by low-speed centrifugation (10 
minutes at 1,500 g; Eppendorf 5415) of the heparinized blood, and stored at -20 °C until 
analysis. Plasma urea concentrations were determined using a colorimetric kit (Procedure No. 
640, Sigma Chemical Co., St. Louis, USA). 
Animals were acclimatized to housing and dietary conditions for 10 days, after which 
they were orally infected by gastric gavage with 1 mL of saline containing 3% (wt/vol) 
sodium bicarbonate with S. enteritidis (same isolate as used in the in-vitro experiment). The 
inoculum contained 4.108 S. enteritidis per mL, as determined by plating on BGA. The 
virulence of the strain used is sustained by routine oral passage in Wistar rats, followed by 
isolation of translocated salmonella from liver or spleen. Before, and on days 1,5, and 8 after 
salmonella infection, fresh individual fecal samples were collected. Feces were thoroughly 
mixed and homogenized in saline (1:3 wt/vol). Calibrated sterile loops were used to plate the 
fecal homogenates on Modified BGA (Oxoid) containing the detergent Sulfamandelate 
(Oxoid), to suppress swarming bacteria like proteus. Applying a rapid bacteriological 
technique, introduced and validated by Giaffer et al. [18], a set of partially overlapping 
streaks were made on the selective plates. Subsequently, the plates were cultured aerobically 
for 20 hours at 37 °C. 
Analyses of nitric oxide oxidation products (NOx) in urine 
Complete 24 h urine samples were collected for 8 days, starting one day before 
infection. NOx (nitrite and nitrate) concentration was determined by automated flow injection 
analysis. Briefly, diluted urine is passed over a cadmium column to reduce nitrate to nitrite, 
followed by reaction of nitrite with Griess reagent [19]. The red azo-dye formed was 
measured spectrophotometrically at 538 nm. Urinary NOx concentration was multiplied by the 
urine volume produced in 24 h to obtain daily urinary NOx excretion. Recovery of nitrite or 
nitrate added to rat urines always exceeded 90%. 
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Total feces analyses 
Feces were quantitatively collected 3 days before salmonella infection and on days 2, 
3 and 4 after infection. Feces were freeze dried for dry weight determination. For 
determination of unfermented lactulose, 13 volumes of distilled water were added per mg of 
freeze dried feces. After homogenization, samples were heated for 5 minutes at 95 °C to 
denature glycosidases, followed by centrifugation (5 minutes at 10,000 g; Eppendorf 5415). 
Supematants were cleared from hydrophobic substances on octadecyl columns (100 mg; 
Varian, Harbor City, USA). Water-eluates were analyzed for lactulose by HPLC [20]. 
Recoveries of lactulose added to feces varied between 96 and 113%. For lactic acid 
determination, dry feces were acidified with 1.0 M perchloric acid (1:40 wt/vol), mixed and 
subsequently centrifuged (2 minutes at 10,000 g; Eppendorf 5415). The supernatant was 
neutralized to pH 7 by adding 2.0 M potassium bicarbonate (2:1 vol/vol), followed by 
centrifugation (2 minutes at 10,000 g; Eppendorf 5415). D- and L-lactic acid in the 
supematants were separately determined using a colorimetric enzymatic kit (Nr. 1112821, 
Boehringer Mannheim, Germany). Recoveries of lactic acid added to feces were >90%. For 
ammonia determination, feces were acidified with 5% perchloric acid (1:20 wt/vol), 
incubated for 15 minutes at 37 °C, followed by centrifugation (2 minutes at 14,000 g; 
Eppendorf 5415). The aspirated supernatant was neutralized to pH 7 by adding 3.0 M KOH 
in 250 mM 3-N-morpholino-propanesulfonicacid (10:3 vol/vol). After mixing, samples were 
centrifuged (2 minutes at 14,000 g; Eppendorf 5415). Ammonia in the supematants was 
determined using a colorimetric kit originally designed to measure urea (Procedure No. 640, 
Sigma Chemical Co.). However, by omitting the first incubation step with urease, ammonia 
can be determined directly. Recovery of ammonium chloride added to feces was >85%. 
Fecal nitrogen was determined as described elsewhere [21]. Briefly, feces were totally acid-
digested, followed by colorimetric determination of the ammonia formed. Fecal mucins were 
extracted and determined as described earlier [11], with some modifications. Before analysis, 
interfering pigments were removed from watery fecal extracts by filtration (Ultrafree-MC 
NMWL, cut-off 30,000 D, Millipore, Bedford, USA) during centrifugation (30 minutes at 
3,000 g; Eppendorf 5415). Subsequently, mucins on the filter membranes were washed once 
with an equal volume of methanol (100%) to remove remaining pigments (centrifugation for 
another 30 minutes at 3,000 g). After drying of the membrane-inserts by air, the mucin 
retentate was resolubilized in the original volume of phosphate-buffered saline. Mucins were 
measured using a specific fluorimetric assay [22]. Standard solutions of N-
acetylgalactosamine (Sigma) were used to calculate the amount of oligosaccharide side-chains 
liberated from mucins. Fecal mucins are therefore expressed as nmol oligosaccharide 
equivalents. Using this procedure, recoveries of porcine stomach mucin (Sigma) added to 
freeze dried feces always exceeded 90%. After destruction (15 minutes at 180 °C) with a 
perchloric acid (70%)/hydrogen peroxide (30%) mixture (3:1 vol/vol) of freeze dried feces, 
calcium, total phosphate and iron were measured as described for the diets. Inorganic 
phosphate was extracted from freeze-dried feces with 5% (wt/vol) trichloroacetic acid and 
measured as described above. The amount of organic phosphate in feces was calculated by 
subtracting the inorganic phosphate concentration from the total phosphate concentration. In 
the trichloroacetic acid extracts sodium and potassium were analyzed by atomic emission 
spectrophotometry (Model 1100, Perkin Elmer). Total bile acids were extracted from freeze 
dried feces with a t-butanol/water mixture (1:1 vol/vol) as described previously [23]. Extracts 
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were assayed for bile acids using a fluorimetric, enzymatic assay [24]. Recovery of 
deoxycholic acid (Sigma) added to feces always exceeded 90%. 
Fecal water analyses 
Fecal water was prepared by reconstituting freeze dried feces with demineralized 
water to 30% dry weight, which reflects the dry weight percentage of colonic contents [10]. 
Samples were thorougly mixed and subsequently incubated (1 h at 37 °C) in a shaking 
waterbath. After centrifugation for 20 minutes at 12,000 g (Hettich, Micro-rapid 1306, 
Tuttlingen, Germany), the aspirated supernatant was centrifuged again for 2 minutes at 
14,000 g (Eppendorf 5415). The pH of the supernatants was measured at 37 "C. Fecal waters 
were stored at -20 °C until further use. The cytotoxic activity was determined with an 
erythrocyte assay as described previously [11] and validated elsewhere [25]. The incubations 
were of physiological ionic strength (154 mM) and buffered at pH 7 (final 100 mM 3-N-
morpholino-propanesulfonicacid; Sigma). After acidification with HC1 (final 1 M), bile acids 
were extracted from fecal water three times with diethyl ether. After evaporation of diethyl 
ether from pooled fractions, the residue was resolubilized in methanol. Bile acids in the 
methanol extracts were quantified using the same method as described for total feces. 
Recoveries of a cholic acid/deoxycholic acid (Sigma) mixture, added to fecal waters, varied 
between 80 and 120%. Iron was measured in distilled-water-diluted fecal water as described 
for the diets. 
Statistics 
Results of the in-vitro experiment are presented as means ± SD (n=3). Results of the 
infection experiment are presented as means ± SE (n=8). Within one dietary group, 
infection-induced changes were tested by Student's t test for paired samples (one-sided). 
Within one period (before or after infection), differences between diet groups were tested for 
their significance, using analysis of variance (ANOVA). In addition, Fisher's protected least 
significant difference test (one-sided), modified for multiple comparisons, was used to identify 
dietary groups that differed from each other. The level of significance was preset at p < 0.05. 
A commercially available statistical package was used for all statistics (SPSS/PC+ version 
2.0, SPSS Inc, Chicago, USA). 
RESULTS 
Bactericidal activity of lactic acid in-vitro 
S. enteritidis was much more sensitive to the bactericidal activity of lactic acid thanL. 
acidophilus (Figure 1). Killing of S. enteritidis started at a lactic acid concentration of 20 mM 
and was complete at 40 mM lactic acid. In contrast, even a concentration as high as 50 mM 
lactic acid did not affect the viability of L. acidophilus. At 75 mM lactic acid, the highest 
concentration tested, the number of colony-forming units was reduced by a factor of 100 
only. 
Animals, food intake, and diarrhea markers 
All data from one animal in the LCa/LACT group were excluded from the study 
results because of oropharyngeal reflux of the S. enteritidis suspension which resulted in 
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Figure 1 Bactericidal effect of lactic acid on S. enteritidis (T) and L. acidophilus (•) in-vitro. 
Increasing concentrations of lactic acid were added to a citric acid buffer (50 mM, pH 
5.0, physiological ionic strength). After 2 h incubation, survival of the bacteria was 
determined by plating techniques. Values are means + SD of triplicate incubations. 
When SDs are not shown they are smaller than the size of the symbols. 
pneumonia. At the start of the experiment mean body weight of the rats was 223 g. Weight 
gain of the LCa/LACT group was significantly less when compared with the other two 
groups, even before infection. At the end of the experiment (day 8 post-infection) body 
weights were 281 + 7, 250 + 7, and 273 + 10 g for the LCa, LCa/LACT, and HCa/LACT 
groups, respectively. During the experiment, the LCa and HCa/LACT group consumed 14.5 
g dry food per day, whereas the LCa/LACT group ate approximately 3 g less (p<0.05). 
Before infection, lactulose increased dry fecal output only in combination with high-calcium 
(Table 1, p<0.05). The infection stimulated fecal dry weight excretion in both lactulose 
groups (Table 1, p<0.05). Especially of the LCa/LACT group, no proper assessment of 
fecal wet weight excretion or the dry/wet weight ratio could be made because of drying up of 
fecal pellets during collection in the metabolic cages. For that reason, hydratation of feces 
was determined by the concentration of the electrolytes sodium and potassium. Before 
infection, the summed concentration of these electrolytes in feces increased in the order LCa 
< HCa/LACT < LCa/LACT (Table 1, all p<0.05). A significant infection-induced 
increase in fecal electrolyte concentration was observed only in the two low-calcium groups, 
in contrast to the calcium-supplemented group (Table 1). Lactulose supplementation 
significantly stimulated fecal mucin excretion, which was most pronounced in combination 
with low-calcium (Table 1, p<0.05). After infection, fecal mucin excretion increased 
significantly in both low-calcium groups, whereas no infection-induced stimulation was 
observed in the HCa/LACT group (Table 1, p < 0.05). The infection had no defined effect on 
body weight gain or food intake. 
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Table 1 Effect of a low-calcium (LCa), low-calcium/lactulose (LCa/LACT), and high-
calcium/lactulose (HCa/LACT) diet on fecal output, fecal electrolytes, and mucin 
excretion before and after oral infection with S. enteritidis. 
Variable Infection LCa LCa/LACT HCa/LACT 
Dry weight (g/d) Before 0.79 ± 0.03a 
After 0.81 ± 0.04a 
Sodium and potassium (^ mol/g) Before 34 ± 3" 
After 75 ± 17a! 
Mucins (jtmol equivalents/d) Before 1.7 + 0.1" 
After 5.7 ± 0.7a! 
0.59 + 0.14" 
1.01 ±0.20a! 
154 + 14" 
175 + 15b! 
31.3 ± 5.7" 
51.7 ± 9.9b! 
1.39 ± 0.10c 
1.71 ±0.13b! 
75 + T 
88 + lla 
13.6 ± 2.7C 
14.3 ± 5.5C 
Values are means ± SE (n=8). Values in the same row not sharing the same letter are significantly 
different (P<0.05). The note of exclamation indicates a significant infection-induced change 
(P<0.05). 
Resistance to colonization and translocation of salmonella 
The lactulose fed rats had a significantly improved colonization resistance to 
salmonella. The first day after infection of the rats, lactulose feeding reduced fecal salmonella 
excretion approximately 1000-fold when compared with the low-calcium control group 
(Figure 2, p<0.05). Probably due to large inter-individual variation in the response to 
infection in the lactulose supplemented groups, no significant differences in fecal salmonella 
output were observed later in the experiment. Despite comparable fecal salmonella excretions 
of the LCa/LACT and HCa/LACT groups, these groups differed markedly in their resistance 
to translocation of salmonella, as measured by urinary NOx excretion (Figure 3). Independent 
of dietary lactulose, both low-calcium groups showed a rapid, progressive increase in daily 
urinary NO, output. In contrast, total infection-induced urinary NOx excretion (expressed as 
the area under the NOx curve after infection, corrected for baseline NOx excretion) of the 
HCa/LACT group was significantly less (p<0.05). 
Cytotoxicity and composition of fecal water 
Dietary lactulose strongly reduced the pH of fecal water (Figure 4A). Fecal water of 
the HCa/LACT group was more acidic than that of the LCa/LACT group (Figure 4A, 
p<0.05). Considering the low pH of the fecal waters, the cytotoxicity assay was performed 
in a buffered (pH 7) system. Compared with the low-calcium control group, lactulose 
significantly increased the cytotoxic activity of fecal water. This adverse effect of lactulose 
was counteracted by supplemental calcium. In fact, fecal water of the HCa/LACT group had 
the lowest cytotoxic activity (Figure 4B, p<0.05). Lactulose did not significantly affect the 
concentration of bile acids in fecal water, whereas calcium decreased the concentration of 
these surfactants (Figure 4C, p<0.05). Lactulose greatly increased the solubility of iron in 
feces, an effect which was reversed by dietary calcium (Figure 4D, p<0.05). The infection 
did not significantly affect the cytotoxicity, pH or iron concentration of fecal water. Only in 
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Figure 2 Effect of a low-calcium diet (O), low-calcium/lactulose diet (•), or a high-
calcium/lactulose diet (T) on fecal excretion of 5. enteritidis after oral administration 
of 4.108 colony-forming units of this pathogen to rats on day 0. Results are expressed 
as means + SE (n=8). SEs are either smaller than symbols or indicated by bars. The 
asterisk denotes that fecal salmonella excretion of the indicated group is significantly 
different from the other groups (P<0.05). Abbreviation: CFU colony-forming units. 
the LCa group was a significant infection-induced increase in the bile acid concentration of 
fecal water observed (+ 0.59 mM). 
Composition of total feces 
Lactulose decreased daily fecal excretion of calcium and inorganic phosphate when 
combined with low-calcium (Table 2, P<0.05). As expected, daily fecal output of these 
minerals was substantially higher in the HCa/LACT group (p<0.05). Fermentation of 
lactulose by the intestinal microflora was more complete in the high-calcium group. Daily 
lactulose excretion in feces was 3.9 umol in the HCa/LACT group, whereas the LCa/LACT 
group excreted more than 20 times as much (Table 2, p < 0.05). Daily fecal excretion of lactic 
acid, a product of lactulose fermentation, was strongly increased by supplemental calcium 
(Table 2, p<0.05). The contribution of D-lactic acid to total lactic acid excretion was 0%, 
9% and 37% for the LCa, LCa/LACT and HCa/LACT groups, respectively. Lactulose 
consumption increased fecal ammonia excretion, which was further stimulated by 
supplemental calcium (Table 2, p<0.05). The lactulose-induced stimulation of fecal nitrogen 
excretion was notably increased by supplemental calcium (Table 2, p<0.05). The 
contribution of ammonia to total fecal nitrogen excretion did not exceed 3% in any group. 
The HCa/LACT group had an increased excretion of organic phosphate in feces (Table 2, 
p<0.05). In combination with low calcium, lactulose decreased fecal bile acid excretion 
(Table 2, p<0.05). 
80 Chapter 5 
_ 
• o 
o 
F 3 . 
X 
o 
z 
>* 1 _ 
CO 
c 
i _ 
-> 
50 
40 
30 
20 
10 
Area 
(ymol/8d) 
!^±* 
156 ±35 
130 ± 18 
70 ±31 
Day 
Figure 3 Effect of a low-calcium diet (O), low-calcium/lactulose diet (•), or a high-
calcium/lactulose diet (T) on the kinetics of urinary NOx excretion of rats before and 
after an oral challenge with 4.108 viable 5. enteritidis on day 0. In addition, the area 
under the NOx time curve after infection is presented. Results are expressed as means 
+ SE (n=8). The asterisk denotes that the infection-induced NOx excretion of the 
indicated group is significantly different from the other groups (P < 0.05). 
Plasma urea concentration 
Before infection, lactulose consumption significantly decreased plasma urea 
concentration (p<0.05). Plasma urea concentrations were 4.49 ± 0.25, 3.38 ± 0.24, and 
3.11 ±0.25 mM for the LCa, LCa/LACT, and HCa/LACT groups respectively. 
DISCUSSION 
The present study clearly shows that dietary calcium phosphate substantially adds to 
the beneficial effect of supplemental lactulose on the resistance to S. enteritidis. Lactulose 
markedly enhanced the resistance to colonization of salmonella. The first day after infection 
of the rats, fecal excretion of viable salmonella was reduced more than 1000-fold when a 
lactulose diet was consumed (Figure 2). An important product of lactulose fermentation in the 
rat (Table 2) and human [3, 26] intestine is lactic acid, which appeared to be strongly 
bactericidal for S. enteritidis (Figure 1). Notwithstanding the improvement of the colonization 
resistance, lactulose did not affect translocation of salmonella, as measured by the kinetics of 
urinary NOx excretion (Figure 3). We have previously shown that urinary excretion of 
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Figure 4 Effect of a low-calcium diet, low-calcium/lactulose diet, and high-calcium/lactulose 
diet on (A) the pH of fecal water, (B) cytotoxicity, (C) bile acid concentration, and 
(D) iron concentration of fecal water before infection of the rats. Results are expressed 
as means ± SE (n=8). Bars not sharing the same letter are significantly different 
(P<0.05). 
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Table 2 Effect of a low-calcium (LCa), low-calcium/lactulose (LCa/LACT), and high-
calcium/lactulose (HCa/LACT) diet on several fecal excretion variables before 
infection of the rats. 
Fecal excretion LCa LCa/LACT "~ HCa/LACT " 
Calcium Ozmol/d) 53.2 ± 6.2" 9.6 ± 2.5b 1363 ± 105c 
Inorganic phosphate (/^ mol/d) 30.2 ± 2.3a 10.9 ± 2.9b 650 ± 44c 
Lactulose (/^ mol/d) 0" 90.8 + 35.3" 3.9 ± 0.7C 
Lactic acid (fimol/d) 1.6 ± 0.5" 26.3 ± 12.8" 122 + 21' 
Ammonia (junol/d) 15.9 + 1.6" 39.5 ± 13.2" 70.5 ± 8.7C 
Nitrogen (mmol/d) 0.90 ± 0.04a 1.39 + 0.28" 2.69 ± 0.22c 
Organic phosphate (junol/d) 32.3+1.4" 30.6 + 6.9" 145 ± 15" 
Bile acids (^mol/d) 15.1 + 1.1" 7.7 ± 1.5" 14.3 ± 1.3" 
Values are means ± SE (n=8). Values in the same row not sharing the same letter are significantly 
different (P< 0.05). 
oxidation products of nitric oxide (nitrite and nitrate) is a sensitive biomarker to quantify 
bacterial translocation across the gut wall [15]. A major advantage is that in contrast to tissue 
cultures, urinary NOx excretion reflects the systemic pathogen load of the host. Upon 
intestinal bacterial translocation and the subsequent systemic infection, nitric oxide is 
produced by many infected cells: for instance macrophages, Kupffer cells and neutrophils 
[27]. Moreover, tissue cultures do not estimate the total bacterial translocation because this 
method only counts the still viable bacteria and not the large majority of translocated bacteria 
that is killed after invasion [28]. The initial site of salmonella translocation seems to be the 
ileal Peyer's patches [29]. Particularly the specialized antigen-sampling M cells are exploited 
by this invasive pathogen to gain access to host tissues [30]. Fermentation of lactulose by the 
endogenous microflora, resulting in acidification of the intestinal contents (Figure 4A), is 
believed to be the basis for the therapeutic effect of this disaccharide on intestinal infections 
[3]. Considering that the majority of the endogenous microflora resides in the lower gut 
(cecum and colon), whereas the small intestine is relatively sparsely populated [31], it is not 
directly feasible that translocation processes can be influenced by lactulose. Indeed, the pH-
lowering effect of lactulose fermentation in the human [2] and rat [32] ileum is limited: the 
pH of the soluble phase of ileal contents drops from 7.5 to 7.0 after lactulose 
supplementation. Although the small intestine does not have the luxuriant bacterial flora of the 
colon, lactobacilli are predominant species in this region of the gastrointestinal tract [33]. 
Several investigations have shown that these bacteria exert an antagonistic action towards 
food-borne pathogens (for review, see Mital and Garg [33]), including salmonella [34]. 
Moreover, the lactobacilli are well-capable of fermenting lactulose [35] and are rather 
insensitive to the lactic acid formed, certainly when compared with the salmonella species 
used in this study (Figure 1). If, in the present study, a growth advantage by lactulose 
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supplementation was achieved for these lactic acid bacteria in the ileum, it was apparently not 
enough to improve the competition with and resistance to translocation of salmonella. In 
contrast to the lack of protection of lactulose against translocation of salmonella, the present 
study clearly shows that supplemental calcium phosphate is well-capable of diminishing 
translocation (Figure 3). Thus, whereas the appreciated activity of lactulose is limited to the 
lower gut, calcium phosphate already exerts protection in the small intestine, reducing the 
severity of the systemic infection. That the HCa/LACT group had the best resistance to 
salmonella infection, was supported by the absence of significant infection-induced increases 
in fecal sodium and potassium concentration and mucin excretion (Table 1), which are 
diarrhea markers [36, 37]. In both low-calcium groups (with or without lactulose), fecal 
mucin output and the concentration of fecal electrolytes increased significantly after infection. 
Before infection, lactulose supplementation increased the fecal electrolyte concentration, the 
effect being most pronounced in combination with a low-calcium diet. Similar effects of 
lactulose on fecal sodium and potassium concentrations, in addition to softening of stools, 
have been reported in human studies [38, 39]. 
The observed lactulose fermentation-mediated increased colonization resistance to S. 
enteritidis in this study, might also be relevant for the resistance to other pathogenic bacteria. 
During lactulose therapy, the pH of human proximal colonic contents drops below 5 [2]. With 
the exception of shigella [40], common human pathogens like Campylobacter,Escherichia coli 
and Vibrio cholerae share their acid-sensitivity with S. enteritidis. All these pathogens are 
largely killed in the acid stomach, considering that the viable oral inoculum necessary to 
cause intestinal disease in humans is very high (> 107) [14]. 
A mechanism which might account for the dietary calcium-induced improvement of 
the barrier function of the intestinal mucosa is the formation of an amorphous calcium 
phosphate complex in the small intestine, which precipitates cytotoxic bile acids and fatty 
acids, thereby reducing epithelial cell damage [12, 41]. In the present study, the cytotoxicity 
of fecal water was highest in the LCa/LACT group, intermediate in the LCa group, and 
lowest in the HCa/LACT group (Figure 4B, p<0.05). Considering the lactulose 
fermentation-induced drop in the pH of fecal water (Figure 4A), the cytotoxicity assay was 
performed in a buffer of neutral pH, precluding simple acid-induced lysis. Excluding a direct 
effect of the low pH by these precautions, lactulose obviously increased the cytotoxicity of 
fecal water in combination with a low-calcium diet. This unfavorable stimulation of the cell 
damaging activity of intestinal contents by lactulose fermentation was more than reversed by 
supplemental calcium phosphate. In accordance with its lowest cytotoxicity, fecal water of the 
HCa/LACT group also had the lowest concentration of cytotoxic bile acids (Figure 4C, 
p < 0.05). In the LCa/LACT group, the combination of a high bile acid concentration in fecal 
water and an enhanced protonation and absorption of these surfactants resulted in a decreased 
daily fecal excretion of bile acids (Table 2). When luminal calcium phosphate was limited, 
fermentation of lactulose greatly increased the intestinal solubility of iron (Figure 4D). 
Remarkably, coprecipitation of iron by calcium phosphate [11] was absolutely not 
counteracted by the acidic colonic environment. To minimize epithelial cell damage and to 
maximize the barrier function of the mucosa, the solubility of iron in the intestinal lumen 
should be low because iron is a catalyst in Fenton-like reactions, resulting in lipid 
peroxidation and depletion of antioxidant defenses [42]. The increased luminal cytotoxicity 
and potential iron-mediated peroxidative damage during extensive intestinal fermentations 
might account for the compensatory mucosal hyperproliferationin several studies [7,9]. 
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ABSTRACT 
We have shown recently that dietary calcium phosphate (CaP,) has a trophic effect 
on the intestinal microflora and strongly protects against intestinal salmonella infection. It 
was speculated that precipitation of intestinal surfactants, like bile acids and fatty acids, by 
CaPi reduced luminal cytotoxicity and favored growth of the microflora. Because 
lactobacilli may have antagonistic activity against pathogenic bacteria, the main purpose of 
the present study was to examine whether this dietary CaPrinduced protection is mediated 
by a reinforcement of endogenous lactobacilli. In-vitro, Salmonella enteritidis appeared to 
be insensitive to bile acids and fatty acids, whereas Lactobacillus acidophilus was rapidly 
killed by physiologically relevant concentrations of these surfactants. Additionally, after 
adaptation to a purified diet differing only in CaPj content (20 and 180 mmol 
CaHP04.2H20/kg), rats (n=8) were orally infected with S. enteritidis. Besides reducing the 
cytotoxicity and the concentration of bile acids and fatty acids of ileal contents and fecal 
water, CaP( notably changed the composition of ileal bile acids into a less cell-damaging 
direction. Significantly increased numbers of ileal and fecal lactobacilli were detected in 
non-infected, CaPrsupplemented animals. Moreover, dietary CaP; significantly reduced 
translocation of salmonella to extra-intestinal organs and improved the colonization 
resistance, as judged by the decreased urinary NOx and fecal salmonella excretion, 
respectively. In accordance less viable salmonella were detected in ileal contents and on the 
ileal mucosa in the CaP; group. In conclusion, reducing the intestinal surfactant 
concentration by dietary CaP; strengthens the endogenous lactobacilli and increases the 
resistance to salmonella. 
INTRODUCTION 
Serious concern about the wide-spread use of antibiotics and the subsequent growing 
antimicrobial resistance call for alternative approaches to prevent and handle intestinal 
infections. Dietary intervention might be important to strengthen host resistance to 
intestinal pathogenic bacteria. In strictly controlled studies with rats, we have recently 
shown that dietary CaP; not only shortened fecal shedding of salmonella but also reduced 
translocation of this pathogen across the intestine to the systemic circulation [1, 2]. It was 
noticed that dietary CaPj had a trophic effect on the intestinal microflora, considering the 
increased fecal excretion of several bacterial mass markers [2]. Stimulation of bacterial 
growth may be of relevance because the endogenous microflora is an extremely important 
determinant of host defense against intestinal pathogens [3-5]. Besides an appreciation of 
the protective endogenous gut flora in general, several investigations have shown that orally 
administered lactobacilli exert antagonistic action against intestinal and foodborne 
pathogens (for review see [6]). Competition for luminal nutrients and adhesion sites on the 
intestinal epithelium, and the production of antimicrobial compounds, like organic acids 
and hydrogen peroxide, may account for this inhibitory action [6]. Many important 
intestinal pathogens, for instance salmonella, Campylobacter and Escherichia coli species, 
mainly elaborate their noxious effects in the small intestine [7]. The predominance of 
lactobacilli in this relatively sparsely populated region of the intestinal tract might explain 
their functionality in combating intruding microbes [8]. It is known that supplemental 
dietary CaPj reduces the cytotoxicity of intestinal contents by precipitating luminal 
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surfactants, like bile acids and fatty acids [9, 10]. A less harsh environment might favor 
growth of the resident microflora and improve their antagonistic action towards pathogenic 
bacteria. It is conceivable that lactobacilli and other Gram-positive bacteria, lacking the 
outermembranous lipopolysaccharide screen, are particularly vulnerable to the intestinal 
surfactant concentration. Therefore, they might benefit most by the lowered luminal 
cytotoxicity induced by dietary CaPj. 
The main purpose of the present study was to test the hypothesis that the inhibitory 
effects of dietary CaPj on salmonella colonization and translocation are mediated by a 
stimulation of the protective endogenous lactobacilli. Therefore, we first performed an in-
vitro study to compare the bactericidal activity of bile acids and fatty acids to S. enteritidis 
and L. acidophilus. Additionally, the proposed stimulating effect of supplemental CaP, on 
the endogenous lactobacilli and the subsequent resistance to salmonella were verified in a 
strictly controlled infection experiment with rats on either a low- or a high-CaP, purified 
diet. Special attention was paid to the composition of the microflora in the ileum because 
this is the most relevant part of the intestinal tract in this infection model, as mentioned 
above. 
MATERIALS AND METHODS 
Bactericidal activity of bile acids and fatty acids in-vitro 
5. enteritidis (clinical isolate, phage type 1) and L. acidophilus (NIZO B224, 
collection of our institute) were cultured and stored as described earlier [1, 11]. Precultures 
of S. enteritidis and L. acidophilus were prepared by inoculating a few colonies from 
appropriate agar plates in Brain Heart Infusion broth (BHI; Difco, Detroit, MI, USA) and 
De Man, Rogosa, and Sharpe broth (MRS; Merck, Darmstadt, Germany) respectively, 
followed by overnight aerobic incubation at 37 °C. The next day, bacteria were collected by 
centrifugation (20 min at 3,500 g; Heraeus, Sepatech GmbH, Osterode, Germany), washed 
once, and resuspended in sterile saline to prepare stock suspensions. The bactericidal 
activity of increasing concentrations (total 0-4 mM) of conjugated bile acids 
(taurodeoxycholic acid and taurochenodeoxycholic acid 1:2 mol/mol, sodium salts; Sigma 
Chemical Co., St. Louis, MO, USA), deconjugated bile acids (deoxycholic acid and 
chenodeoxycholic acid 1:2 mol/mol, sodium salts; Sigma) and the fatty acid C12:0 (lauric 
acid; Fluka Chemie AG, Buchs, Switzerland) in a buffer (250 mM 3-N-
morpholinopropanesulfonic acid, adjusted to physiological pH and ionic strength) was 
determined by inoculating the sterilized testmedia with the stock suspensions (final 1% 
vol/vol, corresponding with approximately 107 viable bacteria/mL testmedium), followed 
by a 4 h aerobic incubation at 37 °C. Immediately after inoculation of the testmedia and 
after 4 h at 37 °C small samples were taken from the incubates, serially diluted in saline and 
plated on Brilliant Green Agar (BGA; Oxoid, Basingstoke, England) and MRS Agar 
(Merck) to determine the viable counts of 5. enteritidis and L. acidophilus, respectively. 
The BGA plates were incubated aerobically for one day at 37 °C and the MRS plates for 2 
days at 37 °C in an anaerobic cabinet (Coy Laboratory products Inc., Ann Arbor, MI, 
USA). The whole experiment was performed in triplicate. 
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Animals, diets and infection 
The experimental protocol was approved by the animal welfare officer of the 
Agricultural University, Wageningen, The Netherlands. Four groups of specific pathogen-
free, male Wistar rats (WU, Harlan, Zeist, The Netherlands; n=8 per group), 8 weeks old, 
were housed individually in metabolic cages in a room with controlled temperature (22-24 
°C), relative humidity (50-60%), and light/dark cycle (lights on from 6 AM to 6 PM). The 
animals were fed purified diets differing only in CaP( content. The control diet contained 20 
mmol and the supplemented diet 180 mmol CaHP04.2H20/kg diet. The exact composition 
of the diets is provided in Table 1. After preparation, the calcium content of the diets was 
checked in dry ashed samples using an atomic absorption spectrophotometer (model 1100; 
Perkin Elmer Corp., Norwalk, CT, USA). The animals had free access to daily fresh 
prepared porridges (demineralized water was added and mixed with the dry diets to obtain a 
final dry weight of 68%) and demineralized drinking water. Food intake was recorded 
every day and body weight every 2-3 days. 
After acclimatizing to the housing and dietary conditions for 10 days, 1 control 
group and 1 CaPrsupplemented group were orally infected with S. enteritidis (same strain 
as described for the in-vitro experiment), suspended in 0.5 mL of saline containing 3% 
(wt/vol) sodium bicarbonate, by gastric gavage. The exact administered dose was 6.108 
viable salmonella as determined by plating on Brilliant Green Agar (Oxoid). The other 2 
groups were gavaged with sterile 0.5 mL saline containing 3% (wt/vol) sodium bicarbonate 
only. The virulence of the salmonella strain used is sustained by routine oral passage in 
Wistar rats, followed by isolation of translocated salmonella from liver or spleen. 
Microbiological analyses and dissection of the animals 
Before and 1, 3 and 6 days after infection, fresh fecal samples were collected 
directly from the anus of the animals and analyzed for viable salmonella. For that purpose, 
10-fold dilutions of the feces in saline were plated on Modified Brilliant Green Agar 
(Oxoid) containing sulfamandelate (Oxoid), and incubated overnight at 37 °C. The detection 
Table 1 Composition of the purified diets. 
Ingredient (g/kg diet) Control CaP, 
Acid casein 200 20(3 
Dextrose 502 474 
Palm oil 100 100 
Corn oil 100 100 
Cellulose 50 50 
Mineral mix1 35 35 
Vitamin mix1 10 10 
CaHP04.2H20 3.44 30.98 
1
 The vitamin mix and mineral mix (without calcium) were prepared as prescribed elsewhere [29]. 
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limit of this method was 102 colony-forming units of salmonella/g feces. The numbers of 
lactobacilli and enterobacteria were also determined in the feces collected at day 6 after 
infection. Feces were handled as described for salmonella culture, except that Rogosa Agar 
(Oxoid) and Levine Agar (Oxoid) plates were used for the quantification of lactobacilli and 
enterobacteria, respectively. The Levine plates were incubated for 1 day at 37 °C and the 
Rogosa plates for 3 days at 37 °C in an anaerobic cabinet (Coy Laboratory products Inc.). 
After collection of the fecal samples at day 6 after infection, the rats were killed by 
carbon dioxide inhalation. The distal ileum (defined as the last 12 cm of the small intestine 
proximal to the cecum) was pinched off and excised. Sterile saline (500 /*L) was injected 
into the ileal lumen and mixed with the ileal contents by turning the ileum up side down 5 
times. The total numbers of salmonella, lactobacilli, and enterobacteria in the ileal lavages 
were determined with the same microbiological technique as described for feces. 
Subsequently, the ilea were freed of remaining contents by rinsing with 5 mL of sterile 
saline, followed by longitudinal dissection. Using a sterile spatula, the ileal mucosa was 
scraped off to collect the bacteria adhering to the ileal epithelium. Scrapings were 
suspended in sterile saline, homogenized (Ultraturrax Pro200, Pro Scientific Inc., Monroe, 
CT, USA) and serially diluted in saline. Viable salmonella, lactobacilli, and enterobacteria 
were quantified as described for feces. However, to compare the number of bacteria in the 
ileal lavages with their number found in the ileal scrapings, results were expressed as total 
numbers instead of colony forming units per g ileal lavage or g ileal scraping. 
Chemical analyses of feces and ileal contents 
All feces produced by each animal at day 3, 4 and 5 after infection was 
quantitatively collected and pooled per animal for chemical analyses. At the same time, this 
was also done for the non-infected animals. Feces were freeze dried and subsequently 
grinded to obtain homogeneous samples. Sodium and potassium were extracted from freeze 
dried feces with 5% trichloroacetic acid (1:25 wt/vol) and analyzed by atomic emission 
spectrophotometry (Model 1100, Perkin Elmer). Fecal ammonia was determined using a 
colorimetric kit as described earlier [1]. The sodium, potassium, and ammonia 
concentrations were used to calculate the fecal wet weight %, assuming that these 
electrolytes are the main cations in feces and intestinal contents have an osmolarity of 300 
mOsmol/L. Fecal L- and D-lactic acid were determined with a colorimetric enzymatic assay 
as described earlier [1]. 
Fecal water was prepared as described earlier [1] and stored at -20 °C until further 
use. To dispose insoluble material, ileal contents were centrifuged (5 min at 15,000 g; 
Eppendorf 5415, Merck, Darmstadt, Germany) and the supernatants were collected and 
stored at -20 °C. The cytotoxicity of fecal water (40 pL) was determined with an 
erythrocyte assay as described previously [12] and validated elsewhere [13]. The same bio-
assay was used to determine the cytotoxicity of the ileal contents (10 /xL). The total bile 
acid concentration of fecal water was determined with a fluorimetric assay as described 
earlier [1]. The composition of bile acids in ileal lavages was determined by HPLC as 
described earlier [14], but preceded by some purification. Before HPLC analyses, the ileal 
lavages were diluted with double-distilled water and cleared from hydrophilic substances on 
octadecyl columns (500 mg; 1ST, Mid-Glamorgan, England). The water eluates were 
discarded, whereas the methanol eluates were sampled and analyzed for its bile acid 
composition. The synthetic steroid 56-cholanic acid-7ct,12a-diol (Steraloids Inc., Wilton, 
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NH, USA) was used as internal standard. Using this procedure, recoveries of 
taurodeoxycholic acid and cholic acid (both Sigma) added to the ileal lavages always 
exceeded 93 %. The total concentration of ileal bile acids was calculated by adding up the 
concentrations of all individual bile acids appearing in the chromatogram. The conjugated 
or deconjugated nature of the unknown bile acids was determined using bile salt hydrolase 
as described elsewhere [15]. For extraction of fatty acids, fecal water and ileal contents 
were acidified with HC1 (final concentration 1 and 4 M for fecal water and ileal contents, 
respectively). To improve the recovery, methanol (final 20%) was added to the acidified 
ileal contents, whereas this was not necessary for fecal water. Subsequently fatty acids were 
extracted 3 times with 10 volumes of diethyl ether. After evaporation of diethyl ether, fatty 
acids were resolubilized in ethanol and quantified using a colorimetric, enzymatic assay 
(NEFA-C, Wako Chemicals, Neuss, Germany). Addition of a mixture of lauric acid and 
palmitic acid to fecal water and ileal contents resulted in >93% and >85% recovery, 
respectively. 
Analysis of NOx in urine 
Complete 24-hour urine samples were collected for 7 days, starting 1 day before 
infection. Oxytetracycline (approximately 100 times the minimal inhibitory concentration 
for most aerobes; Sigma) was added to the urine collection vessels of the metabolic cages to 
prevent bacterial deterioration. The concentration of NOx (nitrite and nitrate) was 
determined with automated flow injection analysis. Briefly, diluted urine is passed over a 
cadmium column to reduce nitrate to nitrite, followed by reaction of nitrite with Griess 
reagent [16]. The purple colored product was measured spectrophotometrically at 538 nm. 
Recovery of nitrate added to rat urines always exceeded 95 %. Daily urinary NOx excretion 
was calculated by multiplication of the NOx concentration with the urine volume produced 
in 24 hours. 
Statistics 
Results are expressed as means + SE (n=8). Analysis of variance (ANOVA) and 
Student's t test (one-sided) were used to identify significant differences among the groups. 
A P value <0.05 was considered significant. 
RESULTS 
Bactericidal activity of bile acids and fatty acids in-vitro 
In the absence of bile acids and fatty acids (control incubation), the viability of S. 
enteritidis and L. acidophilus did not change during the 4 h aerobic incubation. S. 
enteritidis was practically insensitive to bile acids, even at high concentrations (Figure 1A). 
In contrast, conjugated bile acids and especially unconjugated bile acids were strongly 
bactericidal for L. acidophilus. Similar effects were observed with lauric acid. S. enteritidis 
was completely unaffected, whereas 2 mM of this fatty acid was sufficient to kill all L. 
acidophilus present in the incubates (Figure IB). The bactericidal activity of bile acids and 
fatty acids for the lactobacillus seemed to be an immediate effect, because almost similar 
effects of these surfactants on the viability of this strain were obtained when the incubation 
time was shorter (0 or 2 h; data not shown). 
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Figure 1 Bactericidal activity of (A) a mixture of conjugated bile acids (filled lines) and 
unconjugated bile acids (dotted lines), and (B) the fatty acid lauric acid for S. 
enteritidis (•) and L. acidophilus (•) in-vitro. The viability of these bacterial 
strains was determined by standard microbiological plating techniques after a 4 h 
incubation at 37 °C. Results are expressed as % of the incubation without added bile 
acids or fatty acid. Values are means of triplicate incubations and SDs are smaller 
than symbols or indicated by bars. 
Animals, food intake and fecal output 
At the start of the experiment mean body weight of the animals was 252 g. Dietary 
CaPj did not affect body weight gain of non-infected animals (mean 5.2 g/d), whereas 
salmonella infection significantly reduced growth of the rats in both diet groups (mean 4.3 
g/d). Food intake (mean 18 g/d dry matter) was not significantly affected by dietary CaP; or 
the infection. Non-infected animals had a mean calculated fecal wet weight percentage of 
37%, which increased to 45% in the control group after infection (P<0.05) indicating 
slight diarrhea. No significant change in fecal wet weight % was observed in the CaPr 
supplemented group after infection (mean 39%). CaP, supplementation significantly 
stimulated total fecal lactic acid output (control 1.91 + 0.31 and CaP, 12.19 ± 2.72 
/imol/d). L-lactic acid comprised 53 ± 2% of total lactic acid in the control group and 67 
± 2% in the CaP; group. The infection did not significantly change fecal lactic acid 
excretion (data not shown). 
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Figure 2 Effect of dietary calcium phosphate (CaP;) on the cytotoxicity, bile acid (BA) 
and fatty acid (FA) concentration of ileal lavages and fecal water of non-
infected rats. Results are expressed as means ± SE (n=8). The asterisk 
indicates a significant difference (P<0.05). 
Cytotoxicity and chemical composition of ileal contents and fecal water 
The cytotoxicity of ileal lavages was significantly decreased in the CaPr 
supplemented group (Figure 2). Dietary CaPj approximately halved the total bile acid and 
fatty acid concentration of ileal lavages (P<0.05, Figure 2). In addition, major changes 
were observed in the composition of ileal bile acids due to CaPj supplementation (Table 2). 
Dietary CaP, significantly decreased the total concentration of unconjugated bile acids 
(control 1.43 ± 0.54 and CaPj 0.34 ± 0.08 mM). The molar ratio of known secondary to 
primary bile acids was decreased 2-fold in the CaP, group (P<0.05). Substantial amounts 
of 4 unknown bile acids were detected in the ileal lavages (Table 2). The in-vitro incubation 
experiments with bile salt hydrolase resulted in a complete disappearance of peak B, C and 
D in the chromatogram and a concomitant increase in free 8-muricholic acid and peak A. 
This indicates that peak B, C and D are taurine or glycine conjugates of B-muricholic acid 
and the unidentified bile salt A. Additional analyses are currently performed to identify the 
exact nature of the unknown bile acids. Salmonella infection had no significant effect on the 
total concentration of bile acids and fatty acids in ileal lavages (data not shown). Animals 
fed the CaPrsupplemented diet had a significantly reduced cytotoxicity of fecal water and 
concomitantly decreased concentration of bile acids and fatty acids in fecal water (Figure 
2). The infection significantly increased the concentration of bile acids (146%) and fatty 
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Table 2 Effect of dietary calcium phosphate (CaPi) on the bile acid composition of the 
soluble fraction of ileal lavages before infection of the rats. 
Bile acid (/*M) 
co-Muricholic acid 
a-Muricholic acid 
B-Muricholic acid 
Cholic acid 
Glycocholic acid 
12-Ketolithocholic acid 
Taurocholic acid 
Chenodeoxycholic acid 
Deoxycholic acid 
Glycochenodeoxycholic acid 
Glycodeoxycholic acid 
Taurochenodeoxycholic acid 
Taurodeoxycholic acid 
Unknown bile acids 
A (unconjugated) 
B (conjugated) 
C (conjugated) 
D (conjugated) 
Control 
24 + 13 
77 ± 27 
53 + 35 
974 + 402 
706 + 274 
14 ± 10 
542 ± 227 
20 ± 16 
29 ± 16 
29 ± 17 
32 ± 14 
22 ± 8 
52 ± 22 
240 + 110 
139 + 80 
158 ± 68 
281 + 74 
CaPj 
10 + 7 
21 ± 8 * 
24 ± 13 
205 ± 62 * 
306 ± 150 
23 ± 12 
686 ± 320 
n.d. * 
n.d. * 
3 ± 3 
2 + 2 * 
9 ± 4 
20 ± 8 
53 + 23 * 
73 + 35 
168 ± 88 
109 ± 35 * 
Results are expressed as means + SE (n=8). Known bile acids are listed in order of appearance in 
the HPLC chromatogram. The concentrations of unknown bile acids is calculated using, the 
response factor of 6-muricholic acid. Abbreviation: n.d. not detected. The asterisk denotes a 
significant difference from the control group (P<0.05). 
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Figure 3 Effect of dietary calcium phosphate (CaPj) on (A) fecal salmonella excretion after 
oral infection of the rats and (B) the infection-induced increase in urinary NOx 
excretion. Symbols: • infected control group, T infected CaP-supplemented 
group, and the corresponding open symbols represent the non-infected groups. No 
salmonella was detected in feces of non-infected animals. Results are expressed as 
means + SE (n=8). The asterisk indicates a significant difference from the control 
group (P<0.05). 
acids (211%) in fecal water of the control group,and the cytotoxicity tended to be higher 
(P=0.11). In contrast, no significant infection-induced changes in these parameters were 
observed in the CaPrsupplemented group (data not shown). 
Resistance to colonization and translocation of salmonella 
In comparison with the control group, fecal salmonella excretion of the CaPj group 
was 10-100 times less after oral infection (P<0.05, Figure 3A). In accordance, 
significantly reduced viable salmonella were measured in ileal lavages and ileal scrapings of 
the CaP; group (Table 3). The improved colonization resistance of rats fed the CaPr 
supplemented diet coincided with a significantly reduced translocation of S. enteritidis, as 
measured by the decreased infection-induced urinary NOx excretion (Figure 3B). 
Composition of the intestinal microflora 
Dietary CaPj stimulated the intestinal lactobacilli as judged by the significantly 
increased viable counts of these lactic acid bacteria in ileal contents, ileal scrapings, and 
feces of non-infected animals (Table 3). In addition, the ileal enterobacteria were also 
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Table 3 Effect of dietary calcium phosphate (CaP,) and oral 5. enteritidis infection on the 
number of lactobacilli, enterobacteria, and salmonella in ileal lavages, ileal 
scrapings and feces of rats. 
Ileal lavage (log10) 
Lactobacilli 
Enterobacteria 
Salmonella 
Ileal scraping (log10) 
Lactobacilli 
Enterobacteria 
Salmonella 
Feces (log,0/g) 
Lactobacilli 
Enterobacteria 
Salmonella 
Non 
Control 
5.46 + 0.12a 
3.57 ± 0.19a 
n.d. 
3.44 + 0.21a 
1.96 ± 0.11* 
n.d. 
7.68 ± 0.15" 
7.16 + 0.20" 
n.d. 
-infected 
CaP, 
5.86 ±0.10 b 
4.54 ± 0.27" 
n.d. 
4.06 + 0.24" 
2.36 ± 0.20a 
n.d. 
7.96 + 0.10b 
6.64 ± 0.17" 
n.d. 
Infected 
Control CaR 
5.34 + 0.12a 5.53±0.18a 
4.73 ± 0.24" 4.19 ± 0.44ab 
2.96 ± 0.24a 2.07 ± 0.37" 
4.14 + 0.22" 3.98 + 0.35ab 
4.57 ± 0.09b 3.49 ± 0.52c 
4.56 ± 0.09a 3.34 ± 0.48" 
7.57 ± 0.1 la 7.77 ± 0.08ab 
7.24±0.10a 6.88±0.20ab 
5.01 ± 0.16a 4.20 + 0.44" 
The intestinal flora was analyzed 6 days after oral infection of the rats as was the flora of their non-
infected counterparts. Results are expressed as means ± SE (n=8). Abbreviation: n.d. not 
detected. Different superscripts in the same row indicate significant differences (P<0.05). 
increased by CaP; (Table 3). Most of these dietary CaPrmediated effects on the endogenous 
microflora were no longer present after infection of the rats with salmonella (Table 3). 
DISCUSSION 
The present study indicates for the first time that the protective effects of dietary 
CaP; against S. enteritidis infection might be mediated by modulation of the endogenous 
microflora, and a stimulation of the intestinal lactobacilli in particular. In agreement with 
our earlier studies [2, 12], the colonization resistance to salmonella was greatly improved 
by dietary CaPi( as fecal shedding of this pathogen was significantly reduced. We now 
show, that this coincides with a diminished colonization of the ileal epithelium by this 
pathogen. Compared with the control group, approximately 10 times less viable salmonella 
were detected in scrapings of the ileal mucosa and ileal lavages of the CaPj group. The 
observation that salmonella was still present in the ileum 6 days after the oral introduction 
of this pathogen indicates that salmonella not simply passaged but truly colonized the ileal 
epithelium. It is known that the ileum is the initial intestinal region exploited by salmonella 
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to gain access to deeper host tissues, resulting in a systemic infection [17]. The CaPr 
mediated reduction in colonization of the ileal mucosa by salmonella resulted in a decreased 
translocation of this pathogen, considering the significantly reduced urinary NOx excretion 
after infection. We have shown previously that urinary NOx excretion is a more valid and 
quantitative biomarker to assess total intestinal bacterial translocation than classical 
microbiological organ cultures [2, 11]. Though obvious signs of diarrhea were absent, the 
more severe infection of the control group was also reflected in a significantly increased 
fecal wet weight %, as calculated by the concentration of fecal electrolytes. In contrast, the 
wet weight % of feces of the CaPrsupplemented group after infection did not differ from 
that of non-infected animals. 
The most interesting finding of the present study is the modulation of the intestinal 
microflora by dietary CaP,, which might be the responsible mechanism for the observed 
protective effects of dietary CaP^ The endogenous microflora is an extremely important 
determinant of host defense against intruding pathogenic bacteria [3, 4]. Elimination of 
parts of the protective intestinal microflora by use of antibiotics in man [18, 19] and 
animals [5] is frequently accompanied with unintended opportunistic infections. An optimal 
endogenous microflora outcompetes invading pathogens for adhesion sites on the intestinal 
mucosa and luminal nutrients. In addition, many products of the vivid bacterial metabolism 
in the intestine, for instance lactic acid and short-chain fatty acids, can damage allochtonous 
pathogens and prevent them from colonizing the epithelium [1, 3]. In a former study, we 
showed that dietary CaP, has a trophic effect on the rat intestinal microflora in general. 
CaPrsupplementation increased fecal excretion of dry weight, nitrogen, phospholipids and 
organic phosphate, which are supposed markers of bacterial mass [2]. A similar effect of 
dietary calcium was found in humans [10]. This phenomenon is now extended because the 
present study clearly shows that dietary CaPj changed the composition of the endogenous 
microflora and stimulated the lactobacilli. Besides an increased excretion of these lactic 
acid bacteria in feces, significantly increased numbers were found in the ileal lumen and 
adhering to the ileal epithelium. Rather suggestive is the observation that the extent of the 
rise of intestinal lactobacilli and the increase of fecal lactic acid excretion due to CaP> 
supplementation were roughly comparable. As mentioned above, translocation of 
salmonella mainly takes place in the ileum [17]. Because lactobacilli are predominant 
species in this region of the gastrointestinal tract of man and animals [8], they might play 
an important role in the resistance to colonization and translocation of food-borne 
pathogens. Though it is not proved yet that autochtonous lactobacilli are antagonistic 
towards invading bacteria, orally administered lactobacilli are reported to be protective. For 
instance, Hudault et al. [20] showed that L. acidophilus administration to mice improved 
their colonization and translocation resistance to Salmonella typhimurium. Additionally, in 
a number of clinical investigations ingestion of lactic acid bacteria bacteria resulted in 
shortening of the duration of antibiotic-associated diarrhea [21], the prevention of recurrent 
relapses of Clostridium difficile colitis [22] and amelioration of acute rotavirus enteritis in 
children [23]. In the present study, salmonella obviously disturbed the resident flora as the 
specific CaPj-induced composition of the intestinal microflora was no longer present after 
infection. 
An explanatory mechanism by which dietary CaPj strengthens the intestinal 
lactobacillus flora might involve bile acids and fatty acids. The present in-vitro experiment 
showed that L. acidophilus was much more sensitive for the surface-active properties of 
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bile acids and fatty acids than S. enteritidis. In line with results reported earlier [24, 25], 
the more hydrophobic, unconjugated bile acids are stronger bactericidal than their 
conjugated counterparts. The range of surfactant concentrations used in the in-vitro 
experiment was physiologically relevant, because comparable concentrations were 
determined in ileal contents and fecal water. Moreover, to obtain sufficient material from 
the ileal lumen for analyses, the ileal contents were diluted (approximately 3-fold) with 
some saline. So, the reported bile acid and fatty acid concentration in ileal lavages even 
underestimate the in-vivo situation. In agreement with results reported earlier [9, 10, 25], 
bile acids and fatty acids are strongly adsorbed to and precipitated by intestinal CaP„ 
resulting in a significantly decreased concentration of these surfactants in fecal water. CaPj 
also reduced the bile acid and fatty acid concentration of the water phase of ileal contents. 
In the small intestine the majority of the bile acids is still conjugated with either taurine or 
glycine because extensive bacterial deconjugation of bile acids just takes place in the colon 
[26]. In general, unconjugated bile acids and glycine-conjugated bile acids were stronger 
precipitated by amorphous CaP, than taurine-conjugated bile acids, in agreement with our 
earlier study [27]. The present study clearly shows that dietary CaP, significantly changed 
the composition of ileal bile acids. The total concentration of unconjugated bile acids, as 
well as the ratio of secondary to primary bile acids was significantly decreased by CaPi; 
indicating a CaPrmediated shift to a less cytotoxic bile acid pool. This might also have 
favored growth of the endogenous lactobacilli. Extrapolation to the human situation is 
probably permissible. As shown earlier in a human intervention trial, dietary calcium 
significantly decreased the ratio of dihydroxy bile acids to trihydroxy bile acids and thus 
decreased the cytotoxicity of the duodenal bile acid pool [28]. Though, no direct evidence 
is present yet demonstrating that dietary calcium stimulates the endogenous lactobacilli in 
humans. 
Besides a trophic effect of dietary CaP, on the endogenous lactobacilli, CaPj also 
stimulated the enterobacteria in the ileum. Though one can consider this as an unwanted 
side-effect, one can also argue that these normal residents of the intestinal microflora 
contribute to the colonization resistance. In fact, due to homology, enterobacteria might be 
better competitors with salmonella for adhesion sites on the intestinal mucosa and nutrients 
for growth than lactobacilli. 
In conclusion, by precipitating fatty acids and bile acids in the intestinal lumen and 
changing the composition of ileal bile acids into a less cytotoxic one, supplemental CaPj 
creates a less aggressive environment for the endogenous lactobacilli and stimulates their 
growth. The increased numbers of intestinal lactobacilli might have improved the resistance 
to colonization and translocation of salmonella in rats. The growth-promoting activity of 
dietary CaPt for the endogenous lactobacilli is probably also relevant for the functionality of 
probiotic strains used in foods. It is generally accepted that lactobacilli used as dietary 
adjunct must be able to survive the hostile environment in the gastro-intestinal tract and 
proliferate [6]. That aim might be achieved better when an adequate CaP( intake is ensured. 
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SUMMARY 
Gastrointestinal infections are still a major health problem, not only in developing 
countries. Even in Europe and the United States about 10-15 % of the population contracts 
an intestinal infection each year, mostly of foodborne origin. The growing resistance of 
pathogens to antibiotics stresses the importance to prevent and treat intestinal infections by 
other means. Modulation of the diet to improve host resistance to foodborne infections 
might be an attractive, alternative approach. The diet determines the composition of 
intestinal contents, which in turn affects the gastrointestinal survival of pathogens, the 
protective endogenous microflora and the epithelial barrier function. These parameters 
ultimately determine the susceptibility of the host to intestinal infectious disease. Scientific 
interest in dietary modulation of the resistance to intestinal infections is just emerging. 
Notwithstanding the results of numerous in-vitro studies, strictly controlled infection 
studies showing the importance of the diet (supplemented with pre- or probiotics) to inhibit 
or ameliorate intestinal infections in-vivo are scarce. Even less is known about the potential 
protective effect of dietary calcium on the resistance to intestinal infections. At the same 
time, evidence accumulates showing that calcium is likely an antipromoter of colon 
carcinogenesis. In the intestine, calcium forms an insoluble complex with phosphate which 
strongly binds bile acids and fatty acids. In soluble form, these surfactants are highly 
irritating to the intestinal epithelium. Therefore, precipitation of bile acids and fatty acids 
by calcium phosphate decreases luminal cytotoxicity, resulting in diminished epithelial cell 
damage and reduced epithelial proliferation. This may also be relevant for host resistance to 
intestinal infections. A reduced epithelial cell damage may strengthen the mucosal barrier 
function. In addition, it can be speculated that the decreased cytotoxicity of intestinal 
contents by calcium phosphate may stimulate growth of the protective endogenous 
microflora and improve its antagonistic activity towards invading pathogens. Figure 1 
summarizes the hypothetical mechanism by which dietary calcium phosphate may decrease 
the severity of an intestinal infection, for instance caused by salmonella. 
The strictly-controlled experimental studies described in this thesis mainly focused 
on the proposed protective effect of dietary calcium phosphate on the resistance to intestinal 
infections. The rat was chosen as animal model and the invasive pathogen Salmonella 
enteritidis as infective agent. Salmonellosis is one of the most common foodborne, bacterial 
infections in the world and its pathology in humans and rodents is quite similar. The first 
study of this thesis investigated the application of urinary nitrate excretion as a marker of 
intestinal bacterial translocation (chapter 2). To study dietary modulation of host resistance 
to translocation of pathogens a non-invasive, sensitive and quantifiable marker is needed. 
Classical organ cultures do not meet those criteria. Nitric oxide (NO) is produced by 
inducible nitric oxide synthase of phagocytes upon contact with bacteria or cell wall 
components of bacteria, like lipopolysaccharides. To prevent damage to host cells, NO is 
rapidly oxidized to nitrite and nitrate (summed as NOx) and these are quantitatively excreted 
in urine. It was shown that intraperitoneally injected S. enteritidis lipopolysaccharides 
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Figure 1 Mechanism by which dietary calcium phosphate may decrease the severity of 
an intestinal salmonella infection. 
transiently increased the urinary NOx output within a certain dose-range. Concomitant 
administration of a competitive inhibitor of nitric oxide synthase (NG-nitro-L-arginine 
methyl ester) almost completely abolished the rise in NOx excretion. Importantly, 
increasing the oral dose of viable S. enteritidis resulted in a time- and dose-dependent 
exponential increase in urinary NOx excretion. Translocation was a prerequisite for 
provoking a NOx response, because neither orally administered, heat-killed S. enteritidis 
nor non-invasive, enterotoxigenic Escherichia coli (data not shown) induced an increase in 
NOx excretion above base-line level. Total urinary NOx excretion after infection of the rats 
with viable 5. enteritidis and weight of the mesenteric lymph nodes were highly correlated. 
After validation of this new translocation marker, the effect of different milk 
products (low-calcium milk, milk, milk acidified with hydrochloric acid, and pasteurized 
yogurt) on the resistance of rats to S. enteritidis was studied (chapter 3). Compared with the 
low-calcium milk group, all high-calcium groups had an increased colonization resistance, 
as judged by the strongly reduced fecal salmonella excretion in time. The yogurt-fed rats 
had the best colonization resistance. Before infection, the bile acid concentration and 
cytotoxicity of fecal water of the low-calcium milk group were significantly higher than 
those of the high-calcium groups. The reduced resistance of the low-calcium milk group 
corresponded with strong infection-induced disturbances of normal intestinal physiology. 
For instance, the apparent iron absorption was reduced and considerable increases in 
cytotoxicity of fecal water, fecal mucin and alkaline phosphatase excretion were observed 
in this group. The least infection-induced changes in luminal parameters were noticed in the 
yogurt-fed rats. Surprisingly, no infection-induced increase in urinary NOx excretion was 
observed in this study (data not shown). 
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As the milk-based diets differed in several respects, another strictly controlled 
infection study was performed with rats on purified diets differing only in calcium 
phosphate (20, 60 and 180 mmol/kg) content (chapter 4). Compared with the low-calcium 
group, the medium- and high-calcium group shedded 10-1000 times less salmonella in their 
feces and thus had a substantially improved colonization resistance. Calcium 
supplementation also reduced translocation of salmonella, considering the diminished 
urinary NOx excretion and decreased viable salmonella counts in the ileal Peyer's patches 
and spleen. As shown earlier, the bile acid concentration and cytotoxicity of fecal water 
were decreased by dietary calcium phosphate. This resulted in an increased fecal output of 
several bacterial mass markers, indicating a stimulation of the endogenous microflora. 
Besides an enhanced fecal dry weight excretion, dietary calcium phosphate also increased 
fecal nitrogen, phospholipid and organic phosphate output. 
The non-digestible disaccharide lactulose is well-fermented by the intestinal 
microflora and has been used successfully in the treatment of certain intestinal infections. 
The organic acids (e.g. lactic acid) formed during bacterial lactulose fermentation probably 
play an important role in this protection. Nevertheless, excess acid production may damage 
the intestinal epithelium and even impair the mucosal barrier function. Considering the 
above-mentioned resistance-enhancing effects of dietary calcium phosphate and its ability to 
increase the intestinal buffering capacity, the possible superiority of a combination of 
dietary lactulose and calcium phosphate to improve host resistance was studied (chapter 5). 
S. enteritidis appeared to be very sensitive to lactic acid in-vitro, whereas Lactobacillus 
acidophilus (as a representative of the protective endogenous microflora) was unaffected. 
The infection experiment showed that dietary lactulose decreased fecal shedding of 
salmonella, thus increased the colonization resistance. The protective effects of lactulose 
were limited to the cecum and colon because this disaccharide did not decrease 
translocation of salmonella, as measured by urinary NOx excretion. In agreement with the 
study described above, calcium phosphate significantly inhibited translocation of 
salmonella. It is known that mucosal invasion of salmonella mainly takes place in the ileum, 
a region of the intestinal tract with a relatively less dense bacterial population. Obviously, 
the fermentation of lactulose in the ileum is limited and not sufficient to prevent 
translocation of salmonella. Supplementation of a lactulose diet with calcium phosphate 
reversed the unfavorable increased cytotoxicity of fecal water. In addition, calcium 
phosphate stimulated lactulose fermentation, as judged by the reduced lactulose excretion in 
feces and increased fecal lactic acid, ammonia, and nitrogen excretion. 
Finally, it was investigated whether the calcium phosphate-induced protection 
against colonization and translocation of salmonella was mediated by a stimulation of the 
intestinal lactobacilli (chapter 6). In-vitro, L. acidophilus was rapidly killed by 
physiologically relevant concentrations of fatty acids and (un)conjugated bile acids. In 
contrast, even high concentrations of these surfactants did not affect the viability of S. 
enteritidis. Calcium phosphate-supplementation reduced the cytotoxicity and the 
concentration of bile acids and fatty acids in ileal contents and fecal water of rats. 
Moreover, calcium phosphate notably changed the composition of ileal bile acids into a less 
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cell-damaging direction. Consequently, significantly increased numbers of lactobacilli were 
detected in ileal contents, on the ileal mucosa and in feces of non-infected, calcium 
phosphate-supplemented animals. At the same time, the calcium phosphate group had less 
viable salmonella in ileal contents, on the ileal mucosa and in feces. In accordance, the 
infection-induced urinary NOx excretion was diminished by calcium phosphate 
supplementation. 
CONCLUDING REMARKS 
The following conclusions can be drawn from the experimental studies described in 
this thesis: 
1. The NOx (sum of nitrite and nitrate) excretion in urine is a sensitive, non-invasive 
marker to quantify intestinal bacterial translocation and to follow the course of a 
systemic infection (chapter 2). 
2. Milk or milk products, naturally rich in calcium, improve the colonization resistance of 
rats to salmonella. Compared with milk, pasteurized yogurt has an additional protective 
effect. The increased resistance to salmonella infection by these products is 
accompanied with reduced infection-induced disturbances of normal intestinal 
physiology (chapter 3). 
3. Dietary calcium phosphate strongly increases the colonization and translocation 
resistance of rats to salmonella. Calcium phosphate precipitates intestinal bile acids, 
reduces the cytotoxicity of fecal water and increases fecal bacterial mass excretion 
(chapter 4). Therefore, the protective effect of calcium phosphate might be mediated by 
a stimulation of the endogenous microflora in general and enhancing its antagonistic 
activity towards pathogens and/or by strengthening the epithelial barrier function. 
4. 5. enteritidis is very sensitive to lactic acid, an important bacterial fermentation product 
of lactulose. Dietary lactulose improves the colonization resistance of rats to salmonella 
but does not protect against translocation of this pathogen in the ileum. Supplementation 
of a lactulose diet with calcium phosphate notably stimulates lactulose fermentation, 
probably by increasing the luminal buffering capacity. Morover, it reverses the 
unfavorable fermentation-mediated increase in luminal cytotoxicity and diminishes 
translocation of salmonella (chapter 5). 
5. Lactobacilli are very sensitive to intestinal surfactants. By precipitating bile acids and 
fatty acids in the intestinal lumen and changing the composition of the ileal bile acids 
into a less cytotoxic one, supplemental calcium phosphate creates a less aggressive 
environment for the endogenous lactobacilli and stimulates their growth. The increased 
numbers of intestinal lactobacilli (especially in the ileum) might have improved the 
resistance to colonization and translocation of salmonella in rats (chapter 6). 
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ADDITIONAL REMARKS 
Besides these relatively direct conclusions of the experiments described in this 
thesis, additional remarks should be made and some important questions need to be 
answered. For instance, the application of urinary NOx excretion as a translocation marker 
in dietary intervention studies needs discussion. What are the implications of the results 
obtained with rats for the human situation and for the development of products containing 
probiotics? Finally, alternative mechanisms for the protective effect of dietary calcium 
phosphate and suggestions for further research are presented. 
Application of urinary NOx excretion as translocation marker 
The application of urinary NOx excretion as a marker of intestinal bacterial 
translocation is not limited to salmonella infections nor to rats only. The production of NO 
by phagocytes is a rapid, aspecific response to many bacteria and bacterial components. 
Furthermore, this non-invasive method is also applicable in humans. Patients suffering 
from gut-derived septicemia also have elevated serum and urinary NOx levels. The 
measurement of urinary NO, excetion as a translocation marker appeared to be very useful 
in the dietary intervention studies described in this thesis, except in the study testing several 
milk products (chapter 3). No increase in urinary NOx excretion was observed after the oral 
challenge with S. enteritidis in that study (data not shown). There were no indications that 
the administered salmonella strain had lost its virulence. As usual, before use S. enteritidis 
was passaged in Wistar rats and subsequently isolated from liver or spleen. In addition, 
DNA analysis of this strain showed that the most important virulence plasmid was still 
present (data not shown). As the composition of the milk-based diets (chapter 3) was 
markedly different from the composition of the purified diets used in the other studies 
(chapter 2, 4-6), an effect of the diet on the NOx production capacity of phagocytes could 
not be excluded. However, in a recently executed experiment, milk-fed rats and rats fed a 
purified diet had a similar high increase in urinary NOx excretion after an intraperitoneal 
injection with lipopolysaccharides, showing that the milk diet did not impair the NO 
production capacity of phagocytes (data not shown). Therefore, the possibility remains that 
the absence of the NOx response in rats fed milk-based diets and challenged with an oral 
dose of salmonella indicates that these diets completely prevented translocation of this 
invasive pathogen. This intriguing possibility certainly needs further study. 
Extrapolation to the human situation 
The infection experiments described in this thesis were conducted with rats. The 
complete absence of literature data about protective effects of calcium on intestinal 
infections did not justify the immediate performance of human intervention studies. What's 
more, well-controlled infection studies are difficult to perform in healthy subjects. 
However, the course and pathology of salmonellosis in rats is largely similar to that in 
humans. In both species the infective dose of S. enteritidis is of the same magnitude and 
salmonellosis can result in an extra-intestinal, systemic infection. For these reasons, the rat 
is a convenient and relevant model to study dietary effects on the resistance to salmonella 
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infection. Nevertheless, caution should be taken in directly extrapolating the observed 
beneficial effects of dietary calcium phosphate in rats to the human situation. The protective 
effect of calcium phosphate might be mediated by stimulation of the endogenous microflora 
and lactobacilli in particular (chapters 4 and 6). As mentioned in the General introduction 
section (Table 1), the intestinal microflora in humans and rats may be different, especially 
in quantitative respects. The total bacterial load of the small intestine is higher in rats than 
in man. However, as far as classical microbiological techniques can define, the differences 
on genera level seem to be small. In rats, as well as in humans lactobacilli are one of the 
predominant bacterial species in the ileum. Based on this, one of the first subjects of further 
study should be to verify the trophic effect of dietary calcium phosphate on intestinal 
lactobacilli in humans. In this regard it is important that the dose of calcium phosphate as 
administered to the rats is also feasible in the human diet. The main sources of dietary 
calcium are milk and dairy products, which account for approximately 70% of our daily 
calcium intake. A study described in this thesis (chapter 4) showed that a concentration of 
60 mmol calcium per kg dry feed already gave significant protection against salmonella. 
Assuming that an average adult consumes about 500 g dry matter per day and considering 
that 1 liter of milk contains 30 mmol (or 1200 mg) calcium, this amount of milk (or dairy 
product) would be sufficient to improve the resistance to salmonella. As mentioned above, 
it is not easy to perform infection studies in humans. Nevertheless, possibilities do exist. 
For instance, dietary modulation of the colonization resistance to a safely-applicable, live, 
attenuated, oral vaccine can be studied. The hypothesis is that dietary calcium phosphate 
decreases the efficacy of a vaccine containing a Gram-negative pathogen. 
Implications for the efficacy of probiotics 
The final experiment described in this thesis shows that dietary calcium phosphate 
increases the numbers of autochtonous lactobacilli in the intestinal tract (chapter 6). By 
precipitating intestinal bile acids and fatty acids and decreasing the cytotoxicity of luminal 
contents, calcium phosphate improves the survival of lactobacilli and stimulates their 
growth. This may also have important implications for the efficacy of probiotics added to 
foodstuffs. At the moment, lactobacilli and bifidobacteria are the genera most frequently 
used as adjunct in probiotic products. To improve intestinal microbial balance and to 
increase the resistance of the flora to pathogens, the probiotic needs to be alive. It may be 
expected that, analogous to the autochtonous lactobacilli, the composition of the diet and 
subsequently the composition of gastrointestinal contents also determine the gastrointestinal 
survival and thus the functional effects of a probiotic strain. In other words, there is likely a 
strong interaction between the composition of the diet and the functionality of a probiotic. 
Up to now, this possible interaction is completely overlooked by probiotic researchers. 
What's more, the variable results reported about health effects of probiotics may well be 
due to differences in dietary regimen between studies. Fortunately, probiotics are often 
added to milk or dairy products, though non-dairy products containing probiotics are also 
on the market today. Milk and dairy products have a high calcium content and equimolar 
amounts of phosphate. This dairy matrix is a probably a good vehicle to deliver probiotics 
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to the intestinal tract and to achieve functional effects. However, further investigations will 
be necessary to find optimal formula to administer priobiotics to the consumer. For that 
purpose, more synergy between microbiologists and nutritionists is needed in probiotic 
research. 
Alternative mechanisms for the protective effect of calcium phosphate 
Without doubt, the endogenous microflora is very important for the resistance to 
intestinal infections. The colonization resistance is the result of complex interactions 
between bacteria and can not be attributed to a single genus of intestinal bacteria. 
Nevertheless, lactobacilli might play an important role in the resistance to intestinal 
infections. The observed stimulation of the endogenous lactobacilli by supplemental calcium 
phosphate (chapter 6), especially in the ileum, might have resulted in the decreased 
colonization and translocation of salmonella in rats. Calcium phosphate supplementation 
also increased the numbers of enterobacteria in the ileum (chapter 6). Though, one can say 
that this is an undesirable side-effect, one can also argue that these normal residents of the 
intestinal tract are valuable for the colonization resistance. Due to homology, enterobacteria 
might be stronger competitors with salmonella for adhesion sites on epithelial cells and 
nutrients for growth. In this regard, the results of a few non-controlled experiments 
described in literature were disappointing, showing no or even adverse effects of orally 
administered enterobacteria in the prevention or therapy of intestinal infections. However, 
stimulation of host-specific, endogenous enterobacteria is probably a different and safer 
approach than the administration of host-foreign enterobacteria. As discussed earlier, the 
improvement of the resistance to salmonella might also be due to strengthening of the 
mucosal barrier function. Calcium phosphate-mediated precipitation of intestinal surfactants 
decreases the cytotoxicity of luminal contents (chapters 4 and 6) and is known to diminish 
epithelial cell damage. 
Besides an effect of dietary calcium on these determinants of host resistance, a 
direct effect of calcium phosphate on samonella in the intestine is also possible. Salmonella 
is a Gram-negative bacterium and its outermembrane is composed of lipopolysaccharides. 
Lipopolysaccharides are large, amphipathic molecules with a fatty acid-containing 
hydrophobic part and a saccharide-containing, hydrophilic part. Considering this structure, 
calcium phosphate might also have affinity for lipopoly saccharides, analogous to bile acids 
and fatty acids. Indeed, preliminary in-vitro experiments indicate that amorphous calcium 
phosphate binds and precipitates lipopoly saccharides. Moreover, calcium phosphate 
supplementation decreases the lipopolysaccharide concentration in rat and human fecal 
water (data not shown). Therefore, the observed protective effects might also be mediated 
by binding of salmonella to calcium phosphate in the intestinal tract and preventing the 
adhesion of this pathogen to the intestinal mucosa. Further research to verify this 
mechanism is in progress. 
The studied and suggested mechanisms by which dietary calcium phosphate might 
increase the resistance to salmonella do not exclude each other. However, knowledge of 
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their importance is essential for the design of human intervention trials. For that purpose, 
combined biochemical and microbiological in-vitro experiments and animal studies are very 
useful and really the only accessible way. Ultimately, the protective effects of dietary 
calcium phosphate against intestinal infections need to be verified in humans. As mentioned 
above, it is possible to perform well-controlled infection studies in humans. For instance, 
the effect of dietary calcium phosphate on the colonization resistance can be studied by 
measuring the fecal excretion of a safely-applicable, live, attenuated, oral vaccine. If 
confirmative, it seems also worthwhile to study the possible protective effects of calcium 
phosphate supplementation in subjects with inflammatory bowel diseases, who are generally 
prone to gut-derived septicemia. Research on modulation of the resistance to intestinal 
infections by calcium phosphate or other dietary components is still in an early stage, but 
the results presented in this thesis certainly encourage the exploration of dietary 
intervention in the prevention or treatment of intestinal infectious disease. 
Beinvloeding van de weerstand tegen darminfecties 
door de voeding 
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Het voorkomen van darminfecties 
Darminfecties zijn nog steeds een groot gezondheidsprobleem. Wereldwijd 
bezien wordt het aantal infecties waarbij acute diarree optreedt geschat op zo'n 3-5 
miljard gevallen, resulterend in 3-5 miljoen doden per jaar. In tegenstelling tot wat 
vaak gedacht wordt zijn darminfecties niet alleen een probleem in 
ontwikkelingslanden. In Nederland loopt jaarlijks 1 op elke 8 personen een 
voedselinfectie op. Vaak wordt de oorzaak van de infectie niet achterhaald. Als dat 
wel het geval is, wordt van de bacteriele pathogenen (ziekteverwekkers) meestal 
Campylobacter aangetroffen, gevolgd door salmonella. Hoewel men zich flink 
beroerd kan voelen als een voedselinfectie is opgelopen, blijft de schade meestal 
beperkt tot buikkrampen, diarree, misselijkheid en overgeven gedurende een aantal 
dagen. Toch kent ook iedereen de regelmatig opduikende kranteberichten dat 
inwoners van een verzorgings- of bejaardentehuis zijn overleden na het eten van 
bavarois of onvoldoende verhit voedsel. Bij ouderen en door ziekte verzwakte 
personen is blijkbaar de weerstand tegen een voedselinfectie verminderd. Hierdoor 
blijven de gevolgen soms niet beperkt tot een infectie van de darm, maar worden 
ook vitale organen zoals de lever gei'nfecteerd. Deze levensgevaarlijke situatie wordt 
bloedvergiftiging of sepsis genoemd. 
Het verloop van een darminfectie 
Alhoewel verschillende pathogenen een verschillend ziektebeeld oproepen, 
zijn er toch een aantal gemeenschappelijke fasen te onderkennen in het verloop van 
een darminfectie. De meest relevante voedselpathogenen (Campylobacter, 
salmonella, Escherichia coli) veroorzaken met name schade in de dunne darm. Om 
niet direct uitgespoeld te worden zullen ze zich moeten hechten aan de darmwand. 
De epitheelcellen van de darmwand hebben echter een korte levensduur. Na 4-6 
dagen worden ze afgestoten naar het darmlumen en uitgescheiden met de ontlasting. 
Eventueel aangehechte bacterien verdwijnen dan ook. Voor handhaving moeten 
bacterien zich dus constant vermenigvuldigen om hechting aan nieuw gevormde 
epitheelcellen mogelijk te maken. Hechting van ziekteverwekkende bacterien aan de 
darmwand of de door hen uitgescheiden toxines veroorzaken vaak schade aan 
epitheelcellen waardoor deze minder goed functioneren of zelfs stuk gaan. Sommige 
darminfecties kunnen zich uitbreiden naar andere delen van het lichaam. Salmonella 
bijvoorbeeld is in staat om, na hechting aan de darmwand, door de darmwand heen 
te dringen en via lymfe en bloed andere inwendige organen te infecteren. Het 
passeren van de darmwand door bacterien wordt 'translocatie' genoemd en resulteert 
in een levensbedreigende infectie. 
Verdedigingsmechanismen in het maagdarmkanaal 
Aangezien vrijwel geen enkel voedingsmiddel vrij is van 
(ziekteverwekkende) bacterien is het opmerkelijk dat we niet constant last hebben 
van darminfecties. Gelukkig beschikken we over een heel scala aan aspecifieke 
verdedigingsmechanismen in ons maagdarmkanaal. De eerste en zeer belangrijke 
barriere is de maag. De meeste ziekteverwekkende bacterien die met het voedsel 
worden ingenomen kunnen slecht tegen de zure maaginhoud en worden hierdoor 
grotendeels afgedood. Bacterien die de maagpassage overleven komen vervolgens in 
de dunne darm terecht. Hier is de zuurgraad weliswaar neutraal, maar is de 
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concentratie van toxische galzouten (uitgescheiden door de galblaas) en vetzuren 
(ontstaan door afbraak van vetten door spijsverteringsenzymen) dusdanig hoog dat 
voedselpathogenen het vaak niet overleven. Bovendien wordt in de gehele darm de 
darmwand van het darmlumen afgeschermd door een slijmlaag die moeilijk 
doordringbaar is voor bacterien. Daarnaast is de passage van de spijsbrij in de 
dunne darm snel, zodat bacterien gemakkelijk worden uitgespoeld. Het belangrijkste 
verdedigingsmechanisme van de dikke darm heeft te maken met zijn omvangrijke 
darmflora. Om precies te zijn: we hebben meer bacterien in onze darmflora dan dat 
ons lichaam uit cellen bestaat! Voor handhaving moet een voedselpathogeen 
competitie aangaan met de darmflora voor voedingsstoffen en hechtingsplaatsen op 
de darmwand. Daarnaast produceert de darmflora zure metabolieten (melkzuur en 
korte-keten vetzuren) die pathogenen kunnen afdoden. Naast deze aspecifieke 
afweermechanismen worden er ook antilichamen aan het darmlumen afgegeven die 
heel specifiek gericht zijn tegen een bepaalde bacterie. De produktie van deze 
antilichamen vergt echter behoorlijk wat tijd en is pas 1 week na infectie 
functioned. Het zorgt er wel voor dat bij herhaling van de infectie een pathogeen 
sneller onschadelijk gemaakt zal worden. 
Bij gezonde personen zullen al deze verdedigingsmechanismen er in de 
meeste gevallen voor zorgen dat met het voedsel ingenomen ziekterverwekkers 
efficient worden uitgeschakeld. Er zijn echter ook groepen personen waarbij deze 
verdedigingsmechanismen niet goed werken. Bekend is bijvoorbeeld dat de 
maagzuurproduktie bij ouderen vaak sterk verminderd is. Hierdoor overleeft een 
groter percentage van de voedselpathogenen de maag. De statistieken laten dan ook 
zien dat ouderen vaker darminfecties hebben dan jong volwassenen. Een andere 
groep die gevoelig is voor darminfecties zijn personen die behandeld zijn met 
antibiotica. Verschillende antibiotica onderdrukken de eigen darmflora. Hierdoor is 
deze niet meer in staat om voldoende competitie te leveren, waardoor pathogenen 
meer kans krijgen om te overleven en te hechten aan de darmwand. Na een kuur met 
antibiotica kunnen bijvoorbeeld ernstige Clostridium infecties optreden. 
Bei'nvloeding van de weerstand tegen darminfecties door de voeding 
De behandeling van infecties wordt steeds moeilijker omdat verschillende 
pathogenen resistent dreigen te worden tegen antibiotica of het inmiddels zelfs al 
zijn. Onderzoek naar alternatieven om darminfecties te voorkomen of te behandelen 
is dus erg belangrijk. Een aanpak zou kunnen zijn om met behulp van de voeding de 
weerstand tegen darminfecties te verhogen. Hoe kan voeding de weerstand tegen 
darminfecties bei'nvloeden? De samenstelling van de voeding bepaalt de 
samenstelling van de inhoud van het maagdarmkanaal. Dit heeft op zijn beurt een 
effect op de overleving van voedselpathogenen tijdens hun passage door het 
maagdarmkanaal. Daarnaast wordt de compositie en activiteit van de beschermende 
darmflora en de barrierefunctie van de darmwand beinvloed door componenten of 
voedingsstoffen in het darmlumen. Interacties tussen de ziekteverwekkende 
bacterien, de darmflora en de darmwand bepalen uiteindelijk de weerstand tegen 
pathogenen. Onderzoek naar de effecten van de voeding op de weerstand tegen 
darminfecties staat nog in de kinderschoenen. In de wetenschappelijke literatuur zijn 
weinig (correct opgezette) proeven beschreven. Toch is er op het moment, zowel in 
de wetenschappelijke wereld als in het bedrijfsleven, erg veel belangstelling voor 
'functional foods'. Dit zijn voedingsmiddelen waaraan specifieke stoffen (prebiotica) 
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of bacterien (probiotica) zijn toegevoegd met als doel de gezondheid van de 
consument te handhaven of te verbeteren. Gezondheid is natuurlijk een heel breed 
begrip, maar vaak streeft men naar het versterken of verbeteren van de darmflora 
waardoor uiteindelijk de weerstand tegen darminfecties kan toenemen. 
Hoe wordt weerstand tegen darminfecties gemeten? 
Voor het vaststellen van de effecten van de voeding op de weerstand tegen 
darminfecties zijn een tweetal parameters erg belangrijk. De eerste is het meten van 
de zogenaamde 'kolonisatieweerstand'. De kolonisatieweerstand is de weerstand die 
voedselpathogenen ondervinden bij hun pogingen om te hechten aan de darmwand 
en zich te vermenigvuldigen. Bij een lage kolonisatieweerstand kan een pathogeen 
zich goed handhaven en vermenigvuldigen en dit uit zich door een continue 
uitscheiding van grote aantallen van het pathogeen in de ontlasting. Bij een hoge 
kolonisatieweerstand kan een pathogeen zich slecht handhaven in de darm en is de 
uitscheiding in de ontlasting in de tijd gezien veel minder. Een tweede belangrijke 
weerstandsparameter is de 'translocatieweerstand'. Zoals boven vermeld, zijn 
sommige pathogenen (o.a. salmonella) in staat te transloceren, dus door de 
darmwand heen te dringen. De translocatieweerstand is de weerstand die een 
pathogeen ondervindt bij de invasie van inwendige organen vanuit de darm. De 
klassieke methode om de mate van translocatie te bepalen berust op de telling van 
het aantal pathogenen in bijvoorbeeld lever of milt met behulp van microbiologische 
kweektechnieken. Deze klassieke methode heeft jammer genoeg een groot aantal 
tekortkomingen. Het eerste nadeel is dat organen natuurlijk alleen van proefdieren 
verkregen kunnen worden en niet van mensen. Een ander nadeel is dat de 
microbiologische kweektechnieken nogal ongevoelig zijn en kleine veranderingen 
niet waarnemen. Het belangrijkste nadeel is misschien nog wel dat alleen de nog 
levende bacterien in organen geteld worden, terwijl het grootste deel van de 
pathogenen na translocatie wordt afgedood door het aspecifieke immuunsysteem. 
De experimenten: proefdieren versus mensen 
Voor het uitvoeren van voedingsexperimenten met mensen heeft men 
toestemming nodig van een Medisch Ethische Commissie. Zo'n commissie van 
deskundigen beoordeelt of de geplande handelingen en metingen in een humane 
proef ethisch verantwoord zijn en bijdragen aan het beantwoorden van de 
onderzoeksvraag. Als reeds positieve resultaten gerapporteerd zijn in proefdieren, 
zal eerder toestemming worden gegeven voor het daadwerkelijk uitvoeren van een 
humane proef. Zoals hierboven vermeld, zijn er weinig goed gecontroleerde 
proeven beschreven in de literatuur die laten zien dat de voeding de weerstand tegen 
darminfecties bei'nvloedt. We verkeren dus momenteel in een fase waarin vooral 
dierexperimenteel onderzoek nodig is om de effecten van voedingscomponenten vast 
te stellen en werkingsmechanismen te achterhalen. Als het werkingsmechanisme 
bekend is, heeft men namelijk beter inzicht in de noodzakelijke veranderingen in de 
voeding die nodig zijn voor het bereiken van het meest optimale effect. Kennis van 
het achterliggend mechanisme is vaak ook nodig om te bepalen welke metingen men 
moet verrichten in een latere humane proef om het effect van de voeding vast te 
stellen. 
De experimenten beschreven in dit proefschrift gaan over de effecten van de 
voeding op het verloop van een salmonella infectie in ratten. Je kunt je afvragen in 
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hoeverre een rat lijkt op de mens? Wat betreft salmonella infecties is reeds het een 
en ander bekend. De orale dosis die nodig is om ratten en mensen te infecteren is 
ongeveer gelijk. Ook het (tijds)verloop van de darminfectie en de mogelijkheid dat 
de infectie zich uitbreidt naar andere organen buiten de darm is voor rat en mens 
gelijk. Daarom is de rat een relevant en handig model voor de mens om de 
voedingseffecten op weerstand tegen infecties te onderzoeken. Natuurlijk zullen de 
bevindingen van deze dierexperimenten nu geverifieerd moeten worden bij mensen. 
Ontwikkeling van een nieuwe methode om bacteriele translocatie te meten 
Zoals hierboven beschreven, heeft de klassieke bepaling van de mate van 
translocatie van pathogenen nogal wat nadelen. Daarom is eerst een nieuwe methode 
ontwikkeld waarbij de uitscheiding van nitriet en nitraat (opgeteld als NOx) in de 
urine gebruikt wordt als maat voor translocatie. Urine is, zowel bij mensen als bij 
dieren, veel gemakkelijker en op verschillende tijdstippen te verzamelen. 
Stikstofmonoxide (NO) wordt o.a. geproduceerd door cellen van het aspecifieke 
immuunsysteem als afweerreactie op getransloceerde pathogenen. NO is een reactief 
molecuul en toxisch voor bacterien. Het lichaam beschermt zichzelf tegen dit 
molecuul door het snel om te zetten in NOx dat veel minder toxisch is. NOx wordt 
vervolgens uitgescheiden in de urine. Uit proeven is nu gebleken dat er een dosis-
afhankelijk verband is tussen de hoeveelheid oraal toegediende salmonella's, het 
aantal getransloceerde salmonella's en de uitscheiding van NOx in de urine. Door de 
dagelijkse NOx uitscheiding in de urine te meten kan dus het hele verloop van de 
translocatie tijdens een infectie gevolgd worden (hoofdstuk 2). 
Calciumfosfaat in de voeding beschermt tegen een salmonella infectie 
De laatste jaren staat calcium sterk in de belangstelling omdat het mogelijk 
het risico op het ontstaan van dikke darmkanker vermindert. In de darm vormt 
calcium een onoplosbaar complex met fosfaat afkomstig uit de voeding. Dit 
calciumfosfaat bindt en inactiveert toxische galzouten en vetzuren in de darm. Als 
de darminhoud minder toxisch is, is de schade aan het darmepitheel minder en 
wordt de celdelingssnelheid geremd. Die lagere celdelingssnelheid beschermt 
waarschijnlijk tegen het ontstaan van darmtumoren. Het lijkt op het eerste gezicht 
misschien wat vreemd, maar soortgelijke mechanismen beschermen mogelijk ook 
tegen darminfecties. Vermindering van de schade aan het darmepitheel door 
verlaging van de toxiciteit van de darminhoud, kan de barrierefunctie van de 
darmwand verbeteren. Hierdoor zal de weerstand tegen darminfecties toenemen. 
Deze hypothese over de beschermende effecten van calciumfosfaat in de 
voeding tegen salmonella is nu bevestigd in dierexperimenteel onderzoek. 
Toevoeging van (puur) calciumfosfaat aan de voeding beschermde tegen kolonisatie 
van salmonella. De dieren hadden minder salmonella in de inhoud van de dunne 
darm, minder salmonella gehecht aan de dunne darmwand en ook de uitscheiding 
van salmonella in de ontlasting was duidelijk minder. Nog belangrijker is dat 
calciumfosfaat ook beschermde tegen translocatie van salmonella in de dunne darm. 
Dit bleek zowel uit orgaankweken als uit een sterk verminderde stijging van de NOx 
uitscheiding in de urine na orale infectie (hoofdstuk 4 en 6). 
Normaal gesproken krijgen we geen puur calciumfosfaat binnen met de 
voeding. Fosfaat is ruim aanwezig in heel veel verschillende voedingsmiddelen. 
Calcium daarentegen wordt in onze voeding hoofdzakelijk geleverd door melk en 
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zuivelprodukten. De vraag is dus of consumptie van melkprodukten net zo goed 
beschermt tegen een salmonella infectie dan de toevoeging van puur calciumfosfaat 
aan de voeding. Dit bleek het geval te zijn. Consumptie van normale melk, 
aangezuurde melk en vooral yoghurt leidde tot een hoge kolonisatieweerstand tegen 
salmonella, terwijl consumptie van een een laag-calcium melk de weerstand sterk 
verminderde. De ernstige infectie in de laag-calcium melk groep ging gepaard met 
een sterke verstoring van de normale darmfysiologie. Zo was bijvoorbeeld de 
uitscheiding van slijm in de ontlasting sterk verhoogd en de absorptie van mineralen 
uit de voeding verminderd. Yoghurt bood de beste bescherming. Dit heeft te maken 
met het hoge melkzuurgehalte van yoghurt. Gebleken is dat salmonella gemakkelijk 
wordt afgedood door melkzuur (hoofdstuk 3 en 5). 
Wat is het mechanisme achter het beschermend effect van calciumfosfaat? 
Waarschijnlijk is niet een enkel mechanisme verantwoordelijk voor het 
positieve effect van calciumfosfaat, maar is het weerstands-verhogend effect het 
gevolg van een samenspel van meerdere mechanismen. In de darm vormen calcium 
en fosfaat een onoplosbaar complex. Celbeschadigende galzouten en vetzuren in de 
darm worden sterk gebonden aan calciumfosfaat, waardoor de toxiciteit van de 
darminhoud daalt. Als gevolg hiervan wordt er minder schade aan het darmepitheel 
toegebracht en verbetert de barrierefunctie van de darmwand. Uit proeven is nu ook 
gebleken dat de verminderde toxiciteit van de darminhoud niet alleen het 
darmepitheel beschermt maar ook de darmflora versterkt (hoofdstuk 4). De 
lactobacillen (onderdeel van de beschermende darmflora) bleken heel gevoelig te 
zijn voor galzouten en vetzuren. Verlaging van de concentratie van galzouten en 
vetzuren in de darm door extra calciumfosfaat in de voeding bevorderde de groei 
van de lactobacillen in de darm (hoofdstuk 6). Mogelijk heeft salmonella hierdoor 
meer competitie ondervonden op het gebied van voedingsstoffen, nodig voor 
bacteriele groei, en hechtingsplaatsen op het darmepitheel. Voorlopige experimenten 
laten zien dat er ook een direct effect van calciumfosfaat op salmonella is. 
Salmonella en componenten van de buitenmembraan van salmonella (de zogenaamde 
lipopolysaccharides) binden ook aan calciumfosfaat. Het is niet onwaarschijnlijk dat 
de weerstand tegen kolonisatie en translocatie is verbeterd door binding van 
salmonella aan calciumfosfaat, met als gevolg een verminderde hechting van dit 
pathogeen aan de darmwand. Momenteel wordt dit mechanisme verder onderzocht. 
Samenspel tussen calciumfosfaat en andere componenten in de voeding 
Prebiotica, suikers die niet verteerd kunnen worden door 
spijsverteringssappen in het maagdarmkanaal maar die wel een goed substraat zijn 
voor de darmflora, staan momenteel volop in de belangstelling van de 
voedingsmiddelenindustrie. Zoals boven vermeld kan een stimulatie van de 
darmflora leiden tot een verbeterde weerstand tegen darminfecties. De darmflora zet 
prebiotica om in zure produkten (onder andere melkzuur). Prebiotica in de voeding 
maken de darminhoud dus zuurder. Veel pathogenen, waaronder salmonella, 
worden afgedood door zuur. Echter, te veel zuurvorming in de darm beschadigt het 
darmepitheel. Daarom moet een balans worden gevonden tussen enerzijds voldoende 
zuurvorming ter afdoding van pathogenen en anderzijds het voorkomen van schade 
aan de darmwand. Het is nu gebleken dat toevoeging van calciumfosfaat aan een 
voeding met een potentieel prebioticum (lactulose) zorgt voor een verbeterde 
Samenvatting 121 
afdoding van salmonella in de darm en dat tegelijkertijd de toxiciteit van de 
darminhoud daalt waardoor het darmepitheel beter beschermd is (hoofdstuk 5). 
Conclusie 
Melkprodukten en calciumfosfaat in de voeding remmen de kolonisatie en 
translocatie van salmonella in proefdieren en verbeteren dus de weerstand tegen een 
salmonella infectie. Intermediair in het beschermend mechanisme is waarschijnlijk 
de binding van celbeschadigende galzouten en vetzuren aan calciumfosfaat in de 
darm waardoor de toxiciteit van de darminhoud daalt. Hierdoor vermindert de 
schade aan het darmepitheel en wordt de barrierefunctie versterkt. De verlaagde 
toxiciteit van de darminhoud is niet alleen goed voor de darmwand maar stimuleert 
ook de beschermende darmflora, met name de lactobacillen. De volgende stap is om 
deze weerstands-verhogende effecten van melkprodukten en calciumfosfaat te 
onderzoeken in mensen. 
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